10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 27, 2020

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                  to                    .

Commission File No. 0-121

KULICKE AND SOFFA INDUSTRIES, INC.

(Exact name of registrant as specified in its charter) 

Pennsylvania	23-1498399
(State or other jurisdiction of incorporation)	(IRS Employer
	Identification No.)

23A Serangoon North Avenue 5, #01-01 K&S Corporate Headquarters, Singapore 554369

(Address of principal executive offices and Zip Code)

(215) 784-6000

(Registrant's telephone number, including area code) 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, Without Par Value	KLIC	The Nasdaq Global Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒  No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒ 

As of July 24, 2020, there were 61,840,109 shares of the Registrant's Common Stock, no par value, outstanding.

KULICKE AND SOFFA INDUSTRIES, INC.

FORM 10 – Q

June 27, 2020

 Index

		Page Number
PART I - FINANCIAL INFORMATION
Item 1.	FINANCIAL STATEMENTS (Unaudited)
	Consolidated Condensed Balance Sheets as of June 27, 2020 and September 28, 2019	1
	Consolidated Condensed Statements of Operations for the three and nine months ended June 27, 2020 and June 29, 2019	2
	Consolidated Condensed Statements of Comprehensive Income for the three and nine months ended June 27, 2020 and June 29, 2019	3
	Consolidated Condensed Statements of Changes in Shareholders' Equity for the three and nine months ended June 27, 2020 and June 29, 2019	4
	Consolidated Condensed Statements of Cash Flows for the nine months ended June 27, 2020 and June 29, 2019	6
	Notes to Consolidated Condensed Financial Statements	7
Item 2.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	28
Item 3.	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	38
Item 4.	CONTROLS AND PROCEDURES	39
PART II - OTHER INFORMATION
Item 1.	LEGAL PROCEEDINGS	40
Item 1A.	RISK FACTORS	40
Item 2.	UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS	41
Item 6.	EXHIBITS	42
	SIGNATURES	43

PART I. - FINANCIAL INFORMATION

Item 1. – FINANCIAL STATEMENTS

KULICKE AND SOFFA INDUSTRIES, INC.

CONSOLIDATED CONDENSED BALANCE SHEETS (Unaudited)

(in thousands)

	As of
	June 27, 2020			September 28, 2019
ASSETS
Current assets:
Cash and cash equivalents	$	321,775		$	364,184
Short-term investments	194,000			229,000
Accounts and other receivable, net of allowance for doubtful accounts of $1,306 and $597, respectively	195,489			195,830
Inventories, net	114,194			89,308
Prepaid expenses and other current assets	13,735			15,429
Total current assets	839,193			893,751
Property, plant and equipment, net	55,826			72,370
Operating right-of-use assets	22,192			—
Goodwill	56,053			55,691
Intangible assets, net	38,207			42,651
Deferred tax assets	8,515			6,409
Equity investments	7,367			6,250
Other assets	2,112			2,494
TOTAL ASSETS	$	1,029,465		$	1,079,616
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Short-term debt	$	—		$	60,904
Accounts payable	49,659			36,711
Operating lease liabilities	5,471			—
Income tax payable	13,050			12,494
Accrued expenses and other current liabilities	74,624			64,533
Total current liabilities	142,804			174,642
Financing obligation	—			14,207
Deferred tax liabilities	34,508			32,054
Income tax payable	74,307			80,290
Operating lease liabilities	18,124			—
Other liabilities	10,078			9,360
TOTAL LIABILITIES	$	279,821		$	310,553
Commitments and contingent liabilities (Note 15)
Shareholders' equity:
Preferred stock, without par value: Authorized 5,000 shares; issued - none	$	—		$	—
Common stock, without par value: Authorized 200,000 shares; issued 85,364 and 85,364, respectively; outstanding 61,925 and 63,172 shares, respectively	536,487			533,590
Treasury stock, at cost, 23,439 and 22,192 shares, respectively	(387,302		)	(349,212		)
Retained earnings	607,733			594,625
Accumulated other comprehensive loss	(7,274		)	(9,940		)
TOTAL SHAREHOLDERS' EQUITY	$	749,644		$	769,063
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	$	1,029,465		$	1,079,616

The accompanying notes are an integral part of these consolidated condensed financial statements.

1

KULICKE AND SOFFA INDUSTRIES, INC.

CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS (Unaudited)

(in thousands, except per share data)

	Three months ended						Nine months ended
	June 27, 2020			June 29, 2019			June 27, 2020			June 29, 2019
Net revenue	$	150,450		$	127,109		$	445,488		$	400,225
Cost of sales	81,027			68,329			236,398			211,073
Gross profit	69,423			58,780			209,090			189,152
Selling, general and administrative	27,905			28,724			85,723			87,626
Research and development	30,547			28,229			87,906			87,609
Operating expenses	58,452			56,953			173,629			175,235
Income from operations	10,971			1,827			35,461			13,917
Interest income	1,374			3,956			6,888			11,647
Interest expense	(446		)	(632		)	(1,690		)	(1,137		)
Income before income taxes	11,899			5,151			40,659			24,427
Provision for income taxes	690			3,864			3,985			19,106
Share of results of equity-method investee, net of tax	58			—			158			72
Net income	$	11,151		$	1,287		$	36,516		$	5,249
Net income per share:
Basic	$	0.18		$	0.02		$	0.58		$	0.08
Diluted	$	0.18		$	0.02		$	0.57		$	0.08
Weighted average shares outstanding:
Basic	62,313			64,683			63,200			65,914
Diluted	62,833			65,431			63,755			66,597

 The accompanying notes are an integral part of these consolidated condensed financial statements.

2

KULICKE AND SOFFA INDUSTRIES, INC.

CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)

(in thousands)

	Three months ended						Nine months ended
	June 27, 2020			June 29, 2019			June 27, 2020			June 29, 2019
Net income	$	11,151		$	1,287		$	36,516		$	5,249
Other comprehensive income/(loss):
Foreign currency translation adjustment	745			(42		)	2,424			(1,430		)
Unrecognized actuarial loss on pension plan, net of tax	(5		)	(31		)	(71		)	(9		)
	740			(73		)	2,353			(1,439		)
Derivatives designated as hedging instruments:
Unrealized gain/(loss) on derivative instruments, net of tax	1,034			(49		)	(340		)	39
Reclassification adjustment for gain on derivative instruments recognized, net of tax	384			33			653			1,165
Net increase/(decrease) from derivatives designated as hedging instruments, net of tax	1,418			(16		)	313			1,204
Total other comprehensive gain/(loss)	2,158			(89		)	2,666			(235		)
Comprehensive income	$	13,309		$	1,198		$	39,182		$	5,014

The accompanying notes are an integral part of these consolidated condensed financial statements.

3

KULICKE AND SOFFA INDUSTRIES, INC.

CONSOLIDATED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Unaudited)

(in thousands)

	Common Stock					Treasury Stock			Retained Earnings			Accumulated Other Comprehensive Loss			Shareholders' Equity
	Shares		Amount
Balances as of September 28, 2019	63,173		$	533,590		$	(349,212	)	$	594,625		$	(9,940	)	$	769,063
Issuance of stock for services rendered	9		131			91			—			—			222
Repurchase of common stock	(224	)	—			(5,369		)	—			—			(5,369		)
Issuance of shares for equity-based compensation	800		(7,653		)	7,653			—			—			—
Equity-based compensation	—		3,387			—			—			—			3,387
Cumulative effect of accounting changes	—		—			—			(769		)	—			(769		)
Cash dividend declared	—		—			—			(7,651		)	—			(7,651		)
Components of comprehensive income:
Net income	—		—			—			13,477			—			13,477
Other comprehensive income	—		—			—			—			3,293			3,293
Total comprehensive income	—		—			—			13,477			3,293			16,770
Balances as of December 28, 2019	63,758		$	529,455		$	(346,837	)	$	599,682		$	(6,647	)	$	775,653
Issuance of stock for services rendered	8		142			79			—			—			221
Repurchase of common stock	(872	)	—			(18,522		)	—			—			(18,522		)
Issuance of shares for equity-based compensation	19		(185		)	185			—			—			—
Equity-based compensation	—		3,500			—			—			—			3,500
Cash dividend declared	—		—			—			(7,557		)	—			(7,557		)
Components of comprehensive income/(loss):
Net income	—		—			—			11,888			—			11,888
Other comprehensive loss	—		—			—			—			(2,785		)	(2,785		)
Total comprehensive income/(loss)	—		—			—			11,888			(2,785		)	9,103
Balances as of March 28, 2020	62,913		$	532,912		$	(365,095	)	$	604,013		$	(9,432	)	$	762,398
Issuance of stock for services rendered	9		102			84			—			—			186
Repurchase of common stock	(1,004	)	—			(22,358		)	—			—			(22,358		)
Issuance of shares for equity-based compensation	7		(67		)	67			—			—			—
Equity-based compensation	—		3,540			—			—			—			3,540
Cash dividend declared	—		—			—			(7,431		)	—			(7,431		)
Components of comprehensive income:
Net income	—		—			—			11,151			—			11,151
Other comprehensive income	—		—			—			—			2,158			2,158
Total comprehensive income	—		—			—			11,151			2,158			13,309
Balances as of June 27, 2020	61,925		$	536,487		$	(387,302	)	$	607,733		$	(7,274	)	$	749,644

4

	Common Stock				Treasury Stock			Retained Earnings			Accumulated Other Comprehensive Loss			Shareholders' Equity
	Shares		Amount
Balances as of September 29, 2018	67,143		$	519,244	$	(248,664	)	$	613,529		$	(3,902	)	$	880,207
Issuance of stock for services rendered	8		195		—			—			—			195
Repurchase of common stock	(1,233	)	—		(25,485		)	—			—			(25,485		)
Issuance of shares for equity-based compensation	642		—		—			—			—			—
Equity-based compensation	—		3,678		—			—			—			3,678
Cumulative effect of accounting changes	—		—		—			534			—			534
Cash dividend declared	—		—		—			(8,055		)	—			(8,055		)
Components of comprehensive income/(loss):
Net income	—		—		—			7,517			—			7,517
Other comprehensive loss	—		—		—			—			(182		)	(182		)
Total comprehensive income/(loss)	—		—		—			7,517			(182		)	7,335
Balances as of December 29, 2018	66,560		$	523,117	$	(274,149	)	$	613,525		$	(4,084	)	$	858,409
Issuance of stock for services rendered	10		195		—			—			—			195
Repurchase of common stock	(1,225	)	—		(26,922		)	—			—			(26,922		)
Issuance of shares for equity-based compensation	4		—		—			—			—			—
Equity-based compensation	—		3,107		—			—			—			3,107
Cash dividend declared	—		—		—			(8,057		)	—			(8,057		)
Components of comprehensive (loss)/income:
Net loss	—		—		—			(3,555		)	—			(3,555		)
Other comprehensive income	—		—		—			—			37			37
Total comprehensive (loss)/income	—		—		—			(3,555		)	37			(3,518		)
Balances as of March 30, 2019	65,349		$	526,419	$	(301,071	)	$	601,913		$	(4,047	)	$	823,214
Issuance of stock for services rendered	10		222		—			—			—			222
Repurchase of common stock	(1,538	)	—		(33,177		)	—			—			(33,177		)
Issuance of shares for equity-based compensation	16		—		—			—			—			—
Equity-based compensation	—		3,375		—			—			—			3,375
Cash dividend declared	—		—		—			(7,397		)	—			(7,397		)
Components of comprehensive income/(loss):
Net income	—		—		—			1,287			—			1,287
Other comprehensive loss	—		—		—			—			(89		)	(89		)
Total comprehensive income / (loss)	—		—		—			1,287			(89		)	1,198
Balances as of June 29, 2019	63,837		$	530,016	$	(334,248	)	$	595,803		$	(4,136	)	$	787,435

 The accompanying notes are an integral part of these consolidated condensed financial statements.

5

KULICKE AND SOFFA INDUSTRIES, INC.

CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (Unaudited)

(in thousands)

	Nine months ended
	June 27, 2020			June 29, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$	36,516		$	5,249
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	14,597			15,001
Equity-based compensation and employee benefits	11,056			10,772
Adjustment for doubtful accounts	709			(385		)
Adjustment for inventory valuation	3,197			2,059
Deferred income taxes	360			2,450
Loss/(gain) on disposal of property, plant and equipment	860			(19		)
Unrealized foreign currency translation	909			117
Share of results of equity-method investee	158			72
Changes in operating assets and liabilities:
Accounts and other receivable	(122		)	92,696
Inventories	(28,013		)	15,960
Prepaid expenses and other current assets	1,697			(10,623		)
Accounts payable, accrued expenses and other current liabilities	25,903			(48,148		)
Income tax payable	(5,428		)	(3,655		)
Other, net	282			1,635
Net cash provided by operating activities	62,681			83,181
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property, plant and equipment	(7,849		)	(9,665		)
Proceeds from sales of property, plant and equipment	—			39
Purchase of equity investments	(1,288		)	(5,000		)
Purchase of short-term investments	(234,000		)	(489,000		)
Maturity of short-term investments	269,000			534,000
Net cash provided by investing activities	25,863			30,374
CASH FLOWS FROM FINANCING ACTIVITIES:
Payment on debts	(147,143		)	(574		)
Payment for finance lease	(67		)	—
Repurchase of common stock	(46,851		)	(85,469		)
Common stock cash dividends paid	(22,796		)	(23,902		)
Proceeds from short-term debt	86,239			71,194
Net cash used in financing activities	(130,618		)	(38,751		)
Effect of exchange rate changes on cash and cash equivalents	(335		)	60
Changes in cash, cash equivalents and restricted cash	(42,409		)	74,864
Cash, cash equivalents and restricted cash at beginning of period	364,184			321,148
Cash, cash equivalents and restricted cash at end of period	$	321,775		$	396,012
CASH PAID FOR:
Interest	$	1,690		$	747
Income taxes, net of refunds	$	10,088		$	21,373

The accompanying notes are an integral part of these consolidated condensed financial statements. 

6

KULICKE AND SOFFA INDUSTRIES, INC.

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

Unaudited

NOTE 1: BASIS OF PRESENTATION

These consolidated condensed financial statements include the accounts of Kulicke and Soffa Industries, Inc. and its subsidiaries (the “Company”), with appropriate elimination of intercompany balances and transactions.

The interim consolidated condensed financial statements are unaudited and, in management's opinion, include all adjustments (consisting only of normal and recurring adjustments) necessary for a fair statement of results for these interim periods. The interim consolidated condensed financial statements do not include all of the information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and should be read in conjunction with the consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended September 28, 2019, filed with the Securities and Exchange Commission, which includes Consolidated Balance Sheets as of September 28, 2019 and September 29, 2018, and the related Consolidated Statements of Operations, Statements of Other Comprehensive Income, Changes in Shareholders' Equity and Cash Flows for each of the years in the three-year period ended September 28, 2019. The results of operations for any interim period are not necessarily indicative of the results of operations for any other interim period or for a full year.

Fiscal Year    

Each of the Company's first three fiscal quarters end on the Saturday that is 13 weeks after the end of the immediately preceding fiscal quarter. The fourth quarter of each fiscal year ends on the Saturday closest to September 30. Fiscal 2020 quarters end on December 28, 2019, March 28, 2020, June 27, 2020 and October 3, 2020. In fiscal years consisting of 53 weeks, the fourth quarter will consist of 14 weeks. Fiscal 2019 quarters ended on December 29, 2018, March 30, 2019, June 29, 2019 and September 28, 2019.

Nature of Business

The Company designs, manufactures and sells capital equipment and tools as well as services, maintains, repairs and upgrades equipment, all used to assemble semiconductor devices. The Company's operating results depend upon the capital and operating expenditures of semiconductor device manufacturers, integrated device manufacturers, outsourced semiconductor assembly and test providers (“OSATs”), and other electronics manufacturers including automotive electronics suppliers, worldwide which, in turn, depend on the current and anticipated market demand for semiconductors and products utilizing semiconductors. The semiconductor industry is highly volatile and experiences downturns and slowdowns which can have a severe negative effect on the semiconductor industry's demand for semiconductor capital equipment, including assembly equipment manufactured and sold by the Company and, to a lesser extent, tools, including those sold by the Company. These downturns and slowdowns have in the past adversely affected the Company's operating results. The Company believes such volatility will continue to characterize the industry and the Company's operations in the future.

Use of Estimates

The preparation of consolidated condensed financial statements requires management to make assumptions, estimates and judgments that affect the reported amounts of assets and liabilities, net revenue and expenses during the reporting periods, and disclosures of contingent assets and liabilities as of the date of the consolidated condensed financial statements. On an ongoing basis, management evaluates estimates, including but not limited to, those related to accounts receivable, reserves for excess and obsolete inventory, carrying value and lives of fixed assets, goodwill and intangible assets, the valuation estimates and assessment of impairment and observable price adjustments, income taxes, equity-based compensation expense, and warranties. Management bases its estimates on historical experience and on various other assumptions believed to be reasonable. As a result, management makes judgments regarding the carrying values of the Company's assets and liabilities that are not readily apparent from other sources. Authoritative pronouncements, historical experience and assumptions also are used as the basis for making estimates, and on an ongoing basis, management evaluates these estimates. Actual results may differ from these estimates.

Due to the Coronavirus (“COVID-19”) pandemic, there has been uncertainty and disruption in the global economy and financial markets. The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of June 27, 2020. While there was not a material impact to our consolidated financial statements as of and for the quarter ended June 27, 2020, these estimates may change, as new events occur and additional information is obtained, as well as other factors related to COVID-19 that could result in material impacts to our consolidated financial statements in future reporting periods.

7

KULICKE AND SOFFA INDUSTRIES, INC.

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

Unaudited (continued)

Vulnerability to Certain Concentrations

Financial instruments which may subject the Company to concentrations of credit risk as of June 27, 2020 and September 28, 2019 consisted primarily of trade receivables. The Company manages credit risk associated with investments by investing its excess cash in highly rated debt instruments of the U.S. government and its agencies, financial institutions, and corporations. The Company has established investment guidelines relative to diversification and maturities designed to maintain safety and liquidity. These guidelines are periodically reviewed and modified as appropriate. The Company does not have any exposure to sub-prime financial instruments or auction rate securities.

The Company's trade receivables result primarily from the sale of semiconductor equipment, related accessories and replacement parts, and tools to a relatively small number of large manufacturers in a highly concentrated industry. Write-offs of uncollectible accounts have historically not been significant. The Company actively monitors its customers' financial strength to reduce the risk of loss, including as a result of COVID-19.

The Company's products are complex and require raw materials, components and subassemblies having a high degree of reliability, accuracy and performance. The Company relies on subcontractors to manufacture many of these components and subassemblies and it relies on sole source suppliers for some important components and raw material inventory.

Foreign Currency Translation and Remeasurement

The majority of the Company's business is transacted in U.S. dollars; however, the functional currencies of some of the Company's subsidiaries are their local currencies. In accordance with ASC No. 830, Foreign Currency Matters (“ASC 830”), for a subsidiary of the Company that has a functional currency other than the U.S. dollar, gains and losses resulting from the translation of the functional currency into U.S. dollars for financial statement presentation are not included in determining net income, but are accumulated in the cumulative translation adjustment account as a separate component of shareholders' equity (accumulated other comprehensive income). The tax effect of currency translation adjustments related to unremitted foreign earnings no longer deemed to be indefinitely reinvested outside the U.S. is reflected in the determination of the Company’s net income or other comprehensive income (“OCI”). Gains and losses resulting from foreign currency transactions are included in the determination of net income.

The Company's operations are exposed to changes in foreign currency exchange rates due to transactions denominated in currencies other than the location's functional currency. The Company is also exposed to foreign currency fluctuations that impact the remeasurement of net monetary assets of those operations whose functional currency, the U.S. dollar, differs from their respective local currencies, most notably in Israel, Singapore and Switzerland. In addition to net monetary remeasurement, the Company has exposures related to the translation of subsidiary financial statements from their functional currency, the local currency, into its reporting currency, the U.S. dollar, most notably in the Netherlands, China, Taiwan, Japan and Germany. The Company's U.S. operations also have foreign currency exposure due to net monetary assets denominated in currencies other than the U.S. dollar.

Derivative Financial Instruments

The Company’s primary objective for holding derivative financial instruments is to manage the fluctuation in foreign exchange rates and accordingly is not speculative in nature. The Company’s international operations are exposed to changes in foreign exchange rates as described above. The Company has established a program to monitor the forecasted transaction currency risk to protect against foreign exchange rate volatility. Generally, the Company uses foreign exchange forward contracts in these hedging programs. These instruments, which have maturities of up to twelve months, are recorded at fair value and are included in prepaid expenses and other current assets, or accrued expenses and other current liabilities.

Our accounting policy for derivative financial instruments is based on whether they meet the criteria for designation as a cash flow hedge. A designated hedge with exposure to variability in the functional currency equivalent of the future foreign currency cash flows of a forecasted transaction is referred to as a cash flow hedge. The criteria for designating a derivative as a cash flow hedge include the assessment of the instrument’s effectiveness in risk reduction, matching of the derivative instrument to its underlying transaction, and the assessment of the probability that the underlying transaction will occur. For derivatives with cash flow hedge accounting designation, we report the after-tax gain / (loss) from the effective portion of the hedge as a component of accumulated other comprehensive income / (loss) and reclassify it into earnings in the same period in which the hedged transaction affects earnings and in the same line item on the Consolidated Condensed Statement of Operations as the impact of the hedged transaction. Derivatives that we designate as cash flow hedges are classified in the Consolidated Condensed Statement of Cash Flows in the same section as the underlying item, primarily within cash flows from operating activities.

The hedge effectiveness of these derivative instruments is evaluated by comparing the cumulative change in the fair value of the hedge contract with the cumulative change in the fair value of the forecasted cash flows of the hedged item.

8

KULICKE AND SOFFA INDUSTRIES, INC.

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

Unaudited (continued)

If a cash flow hedge is discontinued because it is no longer probable that the original hedged transaction will occur as previously anticipated, the cumulative unrealized gain or loss on the related derivative is reclassified from accumulated other comprehensive income / (loss) into earnings. Subsequent gain / (loss) on the related derivative instrument is recognized into earnings in each period until the instrument matures, is terminated, is re-designated as a qualified cash flow hedge, or is sold. Ineffective portions of cash flow hedges, as well as amounts excluded from the assessment of effectiveness, are recognized in earnings.

Cash Equivalents

The Company considers all highly liquid investments with original maturities of three months or less when purchased to be cash equivalents. Cash equivalents are measured at fair value based on level one measurement, or quoted market prices, as defined by ASC No. 820, Fair Value Measurements and Disclosures.

Equity Investments

The Company invests in equity securities in companies to promote business and strategic objectives. Equity investments are measured and recorded as follows:

• Equity method investments are equity securities in investees that provide the Company with the ability to exercise significant influence in which it lacks a controlling financial interest. Our proportionate share of the income or loss is recognized on a one-quarter lag and is recorded as share of results of equity-method investee, net of tax.

• Non-marketable equity securities are equity securities without readily determinable fair value that are measured and recorded using a measurement alternative that measures the securities at cost minus impairment, if any, plus or minus changes resulting from qualifying observable price changes.

Allowance for Doubtful Accounts

The Company maintains allowances for doubtful accounts for estimated losses resulting from its customers' failure to make required payments. If the financial condition of the Company's customers were to deteriorate, resulting in an impairment of their ability to make payments, including as a result of COVID-19, additional allowances may be required. If global or regional economic conditions deteriorate or political conditions were to change in some of the countries where the Company does business, including as a result of COVID-19, it could have a significant impact on the results of operations, and the Company's ability to realize the full value of its accounts receivable.

Inventories

Inventories are stated at the lower of cost (on a first-in first-out basis) or net realizable value. The Company generally provides reserves for obsolete inventory and for inventory considered to be in excess of demand. Demand is generally defined as 18 months forecasted future consumption for equipment, 24 months forecasted future consumption for spare parts, and 12 months forecasted future consumption for tools. Forecasted consumption is based upon internal projections, historical sales volumes, customer order activity and a review of consumable inventory levels at customers' facilities. The Company communicates forecasts of its future consumption to its suppliers and adjusts commitments to those suppliers accordingly. If required, the Company reserves the difference between the carrying value of its inventory and the lower of cost or net realizable value, based upon projections about future consumption, and market conditions. If actual market conditions are less favorable than projections, additional inventory reserves may be required.

Inventory reserve provision for certain subsidiaries is determined based on management's estimate of future consumption for equipment and spare parts. This estimate is based on historical sales volumes, internal projections and market developments and trends.

Property, Plant and Equipment

Property, plant and equipment are carried at cost. The cost of additions and those improvements which increase the capacity or lengthen the useful lives of assets are capitalized, while repair and maintenance costs are expensed as incurred. Depreciation and amortization are provided on a straight-line basis over the estimated useful lives as follows: buildings 25 years; machinery, equipment, furniture and fittings 3 to 10 years; toolings 1 year; and leasehold improvements are based on the shorter of the life of lease or life of asset. Purchased computer software costs related to business and financial systems are amortized over a five-year period on a straight-line basis. Land is not depreciated.

Valuation of Long-Lived Assets

In accordance with ASC No. 360, Property, Plant & Equipment ("ASC 360"), the Company's property, plant and equipment is tested for impairment based on undiscounted cash flows when triggering events occur, and if impaired, written-down to fair value

9

KULICKE AND SOFFA INDUSTRIES, INC.

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

Unaudited (continued)

based on either discounted cash flows or appraised values. ASC 360 also provides a single accounting model for long-lived assets to be disposed of by sale and establishes additional criteria that would have to be met to classify an asset as held for sale. The carrying amount of an asset or asset group is not recoverable to the extent it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset or asset group. Estimates of future cash flows used to test the recoverability of a long-lived asset or asset group must incorporate the entity's own assumptions about its use of the asset or asset group and must factor in all available evidence.

ASC 360 requires that long-lived assets be tested for recoverability whenever events or changes in circumstances indicate that their carrying amount may not be recoverable. Such events include significant under-performance relative to historical internal forecasts or projected future operating results; significant changes in the manner of use of the assets; significant negative industry or economic trends; or significant changes in market capitalization. During the three and nine months ended June 27, 2020, no "triggering" events occurred.

Accounting for Impairment of Goodwill

ASC No. 350, Intangibles-Goodwill and Other ("ASC 350") requires goodwill and other intangible assets with indefinite lives to be reviewed for impairment annually, or more frequently if circumstances indicate a possible impairment. We assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. If, after assessing the qualitative factors, a company determines that it is not more likely than not that the fair value of a reporting unit is less than its carrying value, then performing the impairment test is unnecessary. However, if a company concludes otherwise, then it is required to perform the goodwill impairment test. Following the Company's early adoption of ASU 2017-04, Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment in the third quarter of fiscal 2017, the requirement to perform a hypothetical purchase price allocation to measure goodwill impairment (i.e. step 2 of the goodwill impairment test) was eliminated. Accordingly, the Company's impairment test is performed by comparing the fair value of a reporting unit with its carrying value, and determining if the carrying amount exceeds its fair value.

As part of the annual evaluation, the Company performs an impairment test of its goodwill in the fourth quarter of each fiscal year to coincide with the completion of its annual forecasting and refreshing of its business outlook processes. On an ongoing basis, the Company monitors if a “triggering” event has occurred that may have the effect of reducing the fair value of a reporting unit below its respective carrying value. Adverse changes in expected operating results and/or unfavorable changes in other economic factors used to estimate fair values could result in a non-cash impairment charge in the future.

Impairment assessments inherently involve judgment as to the assumptions made about the expected future cash flows and the impact of market conditions on those assumptions. Future events and changing market conditions may impact the assumptions as to prices, costs, growth rates or other factors that may result in changes in the estimates of future cash flows. Although the Company believes the assumptions that it has used in testing for impairment are reasonable, significant changes in any one of the assumptions could produce a significantly different result. Indicators of potential impairment may lead the Company to perform interim goodwill impairment assessments, including significant and unforeseen customer losses, a significant adverse change in legal factors or in the business climate, a significant adverse action or assessment by a regulator, a significant stock price decline or unanticipated competition.

For further information on goodwill and other intangible assets, see Note 3 below.

Revenue Recognition

In accordance with ASC No. 606, Revenue from Contracts with Customers, the Company recognizes revenue when we satisfy performance obligations as evidenced by the transfer of control of our products or services to customers. In general, the Company generates revenue from product sales, either directly to customers or to distributors. In determining whether a contract exists, we evaluate the terms of the agreement, the relationship with the customer or distributor and their ability to pay.

The Company recognizes revenue from sales of our products, including sales to our distributors, at a point in time, generally upon shipment or delivery to the customer or distributor, depending upon the terms of the sales order. Control is considered transferred when title and risk of loss pass, when the customer becomes obligated to pay and, where applicable, when the customer has accepted the products or upon expiration of the acceptance period. For sales to distributors, payment is due on our standard commercial terms and is not contingent upon resale of the products.

Our business is subject to contingencies related to customer orders, including:

• Right of Return: A large portion of our revenue comes from the sale of equipment used in the semiconductor assembly process. Other product sales relate to consumable products, which are sold in high-volume quantities, and are generally

10

KULICKE AND SOFFA INDUSTRIES, INC.

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

Unaudited (continued)

maintained at low stock levels at customer's facility. Customer returns have historically represented a very small percentage of customer sales on an annual basis.

• Warranties: Our equipment is generally shipped with a one-year warranty against manufacturing defects. We establish reserves for estimated warranty expense when revenue for the related equipment is recognized. The reserve for estimated warranty expense is based upon historical experience and management's estimate of future expenses, including product parts replacement, freight charges and labor costs expected to be incurred to correct product failures during the warranty period.

• Conditions of Acceptance: Sales of our consumable products generally do not have customer acceptance terms. In certain cases, sales of our equipment have customer acceptance clauses which may require the equipment to perform in accordance with customer specifications or when installed at the customer's facility. In such cases, if the terms of acceptance are satisfied at our facility prior to shipment, the revenue for the equipment will be recognized upon shipment. If the terms of acceptance are satisfied at our customers' facilities, the revenue for the equipment will not be recognized until acceptance, which is typically obtained after installation and testing, is received from the customer.

Service revenue is generally recognized over time as the services are performed. For the three and nine months ended June 27, 2020, and June 29, 2019, the service revenue is not material.

The Company measures revenue based on the amount of consideration we expect to be entitled to in exchange for products or services. Any variable consideration such as sales incentives are recognized as a reduction of net revenue at the time of revenue recognition.

The length of time between invoicing and payment is not significant under our payment terms. In instances where the timing of revenue recognition differs from the timing of invoicing, we have determined our contracts generally do not include a significant financing component.

Shipping and handling costs billed to customers are recognized in net revenue. Shipping and handling costs paid by the Company are included in cost of sales.

Research and Development

The Company charges research and development costs associated with the development of new products to expense when incurred. In certain circumstances, pre-production machines that the Company intends to sell are carried as inventory until sold.

Income Taxes

In accordance with ASC No. 740, Income Taxes, deferred income taxes are determined using the balance sheet method. The Company records a valuation allowance to reduce its deferred tax assets to the amount expected, on a more likely than not basis, to be realized. While the Company has considered future taxable income and ongoing tax planning strategies in assessing the need for the valuation allowance, if it were to determine that it would be able to realize its deferred tax assets in the future in excess of its net recorded amount, an adjustment to deferred tax assets would increase income in the period when such determination is made. Likewise, should the Company determine it would not be able to realize all or part of its deferred tax assets in the future, an adjustment to deferred tax assets would decrease income in the period when such determination is made.

The Company determines the amount of unrecognized tax benefit with respect to uncertain tax positions taken or expected to be

taken on its income tax returns in accordance with ASC No. 740 Topic 10, Income Taxes, General (“ASC 740.10”). Under ASC 740.10, the Company utilizes a two-step approach for evaluating uncertain tax positions. Step one, or recognition, requires a company to determine if the weight of available evidence indicates a tax position is more likely than not to be sustained upon examination solely based on its technical merit. Step two, or measurement, is based on the largest amount of benefit, which is more likely than not to be realized on settlement with the taxing authority, including resolution of related appeals or litigation processes, if any.

Equity-Based Compensation

The Company accounts for equity-based compensation under the provisions of ASC No. 718, Compensation - Stock Compensation (“ASC 718”). ASC 718 requires the recognition of the fair value of the equity-based compensation in net income. Compensation expense associated with Relative TSR Performance Share Units is determined using a Monte-Carlo valuation model, and compensation expense associated with time-based and Special/Growth Performance Share Units is determined based on the number of shares granted and the fair value on the date of grant. See Note 10 for a summary of the terms of these performance-based awards. The fair value of the Company's stock option awards is estimated using a Black-Scholes option valuation model. The fair

11

KULICKE AND SOFFA INDUSTRIES, INC.

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

Unaudited (continued)

value of equity-based awards is amortized over the vesting period of the award and the Company elected to use the straight-line method for awards granted after the adoption of ASC 718.

Earnings per Share

Earnings per share (“EPS”) are calculated in accordance with ASC No. 260, Earnings per Share. Basic EPS include only the weighted average number of common shares outstanding during the period. Diluted EPS include the weighted average number of common shares and the dilutive effect of stock options, restricted stock awards, performance share units and restricted share units outstanding during the period, when such instruments are dilutive.

Accounting for Business Acquisitions

The Company accounts for business acquisitions in accordance with ASC No. 805, Business Combinations. The fair value of the net assets acquired and the results of operations of the acquired businesses are included in the Unaudited Consolidated Condensed Financial Statements from the acquisition date forward. The Company is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and results of operations during the reporting period. Estimates are used in accounting for, among other things, the fair value of acquired net operating assets, property, plant and equipment, deferred revenue, intangible assets and related deferred income taxes, useful lives of property, plant and equipment, and amortizable lives of acquired intangible assets. Any excess of the purchase consideration over the identified fair value of the assets and liabilities acquired is recognized as goodwill. The valuation of these tangible and identifiable intangible assets and liabilities is subject to further management review and may change materially between the preliminary allocation and end of the purchase price allocation period.

Restructuring Charges

Restructuring charges may consist of voluntary or involuntary severance-related charges, asset-related charges and other costs due to exit activities. We recognize voluntary termination benefits when an employee accepts the offered benefit arrangement. We recognize involuntary severance-related charges depending on whether the termination benefits are provided under an ongoing benefit arrangement or under a one-time benefit arrangement. If the former, we recognize the charges once they are probable and the amounts are estimable. If the latter, we recognize the charges once the benefits have been communicated to employees.

Recent Accounting Pronouncements

Leases

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which requires the recognition of lease assets and lease liabilities by lessees for those leases classified as operating leases under current GAAP.

Subsequently in July 2018, the FASB issued ASU 2018-11, Leases (Topic 842): Targeted Improvements, which provides additional information concerning the new leases standard in ASU 2016-02, Leases (Topic 842). The targeted improvements provide entities with additional and optional transition methods.

In November 2018, the FASB issued ASU 2018-20, Leases (Topic 842): Narrow-Scope Improvements for Lessors. This ASU provides guidance in several areas, including the accounting policy election for sales taxes and other similar taxes collected from lessees, accounting for certain lessor costs and accounting for variable payments for contracts with lease and nonlease components.

We adopted these ASUs utilizing the modified retrospective transition method through a cumulative-effect adjustment at the beginning of the first quarter of fiscal 2020. In addition, we elected the package of practical expedients permitted under the transition guidance that allowed us to apply prior conclusions related to lease definition, classification and initial direct costs. Additionally, the lease previously identified as build-to-suit leasing arrangement under legacy lease accounting (ASC 840), was derecognized pursuant to the transition guidance provided for build-to-suit leases in ASC 842 (see Note 9 below). Accordingly, the lease has been reassessed as an operating lease as of the adoption date under ASC 842, and is included on the Consolidated Condensed Balance Sheets. The adoption of these ASUs has resulted in an increase of approximately $23.8 million in operating lease liabilities and $22.2 million in right-of-use assets, decrease of approximately $14.5 million in financing obligation, decrease of approximately $15.3 million in property, plant and equipment, and an adjustment of $0.8 million to retained earnings after income tax effects on our Consolidated Condensed Balance Sheets.

Financial Instruments

In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. This ASU replaces the impairment methodology in current GAAP, which delays recognition of credit losses until it is probable a loss has been incurred, with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. This ASU will be effective for us

12

KULICKE AND SOFFA INDUSTRIES, INC.

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

Unaudited (continued)

beginning in our first quarter of fiscal 2021. We are currently evaluating the impact of the adoption of this ASU on our consolidated condensed financial statements.

Derivatives and Hedging

In August 2017, the FASB issued ASU 2017-12, Targeted Improvements to Accounting for Hedging Activities (Topic 815). The new guidance expands and refines hedge accounting for both financial and non-financial risks. The new guidance also modifies disclosure requirements for hedging activities. We adopted this ASU as of the beginning of the first quarter of 2020. The adoption of this ASU did not have a material impact on our consolidated condensed financial statements.

Collaborative Arrangements

In November 2018, the FASB issued ASU 2018-18, Collaborative Arrangements (Topic 808). This ASU clarifies that certain transactions between collaborative arrangement participants should be accounted for as revenue when the collaborative arrangement participant is a customer in the context of a unit of account and precludes recognizing as revenue consideration received from a collaborative arrangement participant if the participant is not a customer. This ASU will be effective for us in the first quarter of 2021 with early adoption permitted. This ASU requires retrospective adoption to the date we adopted ASC 606 by recognizing a cumulative-effect adjustment to the opening balance of retained earnings of the earliest annual period presented. We are currently evaluating the timing and the effects of the adoption of this ASU on our consolidated condensed financial statements.

Income Taxes

In February 2018, the FASB issued ASU 2018-02, Income Statement - Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects From Accumulated Other Comprehensive Income, which allows for a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the U.S. Tax Cuts and Jobs Act (the “TCJA”) and requires entities to provide certain disclosures regarding these stranded tax effects, if any. We adopted this ASU in the first quarter of 2020. The adoption did not have a material impact on our consolidated condensed financial statements.

In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740). The amendments in this ASU simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740 and clarify and amend existing guidance. This ASU will be effective for us in the first quarter of 2022 with early adoption permitted. We are currently evaluating the timing and the effects of the adoption of this ASU on our consolidated condensed financial statements.

13

KULICKE AND SOFFA INDUSTRIES, INC.

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

Unaudited (continued)

NOTE 2: BALANCE SHEET COMPONENTS

The following tables reflect the components of significant balance sheet accounts as of June 27, 2020 and September 28, 2019:

	As of
(in thousands)	June 27, 2020			September 28, 2019
Short-term investments, available-for-sale(1)	$	194,000		$	229,000
Inventories, net:
Raw materials and supplies	$	63,878		$	52,853
Work in process	41,757			32,026
Finished goods	39,663			33,742
	145,298			118,621
Inventory reserves	(31,104		)	(29,313		)
	$	114,194		$	89,308
Property, plant and equipment, net:
Land	$	2,182		$	2,182
Buildings and building improvements	22,542			41,961
Leasehold improvements	22,812			24,441
Data processing equipment and software	37,760			36,302
Machinery, equipment, furniture and fixtures	76,589			71,465
Construction in progress	6,578			6,512
	168,463			182,863
Accumulated depreciation	(112,637		)	(110,493		)
	$	55,826		$	72,370
Accrued expenses and other current liabilities:
Accrued customer obligations (2)	$	25,322		$	26,292
Wages and benefits	31,074			18,188
Dividend payable	7,431			7,582
Commissions and professional fees	2,486			2,024
Deferred rent	—			1,721
Severance	494			1,500
Other	7,817			7,226
	$	74,624		$	64,533

(1) All short-term investments were classified as available-for-sale and were measured at fair value based on level one measurement, or quoted market prices, as defined by ASC 820. The Company did not recognize any realized gains or losses on the sale of investments during the three and nine months ended June 27, 2020 and June 29, 2019.

(2) Represents customer advance payments, customer credit program, accrued warranty expense and accrued retrofit obligations.

NOTE 3: GOODWILL AND INTANGIBLE ASSETS

Goodwill

Intangible assets classified as goodwill are not amortized. The goodwill established in connection with our acquisitions represents the estimated future economic benefits arising from the assets we acquired that did not qualify to be identified and recognized individually. The goodwill also includes the value of expected future cash flows from the acquisitions, expected synergies with our other affiliates and other unidentifiable intangible assets. The Company performs an annual impairment test of its goodwill

14

KULICKE AND SOFFA INDUSTRIES, INC.

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

Unaudited (continued)

during the fourth quarter of each fiscal year, which coincides with the completion of its annual forecasting and refreshing of business outlook process.

The Company performed its annual impairment test in the fourth quarter of fiscal 2019 and concluded that no impairment charge was required. Any future adverse changes in expected operating results and/or unfavorable changes in other economic factors used to estimate fair values could result in a noncash impairment in the future.

During the three and nine months ended June 27, 2020, the Company reviewed qualitative factors to ascertain if a "triggering" event may have taken place that may have the effect of reducing the fair value of the reporting unit below its carrying value and concluded that no triggering event had occurred. While we have concluded that a triggering event did not occur during the quarter ended June 27, 2020, a prolonged COVID-19 pandemic could impact the results of operations due to changes to assumptions utilized in the determination of the estimated fair values of the reporting units that could be significant enough to trigger an impairment. Net sales and earnings growth rates could be negatively impacted by reductions or changes in demand for our products. The discount rate utilized in our valuation model could also be impacted by changes in the underlying interest rates and risk premiums included in the determination of the cost of capital.

The following table summarizes the Company's recorded goodwill by reporting segments as of June 27, 2020 and September 28, 2019:

	As of
(in thousands)	June 27, 2020		September 28, 2019
Capital Equipment	$	29,765	$	29,480
Aftermarket Products and Services ("APS")	26,288		26,211
Total goodwill	$	56,053	$	55,691

Intangible Assets

Intangible assets with determinable lives are amortized over their estimated useful lives. The Company's intangible assets consist primarily of developed technology, customer relationships and trade and brand names.

The following table reflects net intangible assets as of June 27, 2020 and September 28, 2019: 

	As of						Average estimated
(dollar amounts in thousands)	June 27, 2020			September 28, 2019			useful lives (in years)
Developed technology	$	88,591		$	87,209		7.0 to 15.0
Accumulated amortization	(52,327		)	(48,718		)
Net developed technology	$	36,264		$	38,491
Customer relationships	$	35,586		$	35,180		5.0 to 6.0
Accumulated amortization	(34,218		)	(31,862		)
Net customer relationships	$	1,368		$	3,318
Trade and brand names	$	7,285		$	7,219		7.0 to 8.0
Accumulated amortization	(6,710		)	(6,377		)
Net trade and brand names	$	575		$	842
Other intangible assets	$	2,500		$	2,500		1.9
Accumulated amortization	(2,500		)	(2,500		)
Net other intangible assets	$	—		$	—
Net intangible assets	$	38,207		$	42,651

15

KULICKE AND SOFFA INDUSTRIES, INC.

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

Unaudited (continued)

The following table reflects estimated annual amortization expense related to intangible assets as of June 27, 2020:

	As of
(in thousands)	June 27, 2020
Remaining fiscal 2020	$	1,845
Fiscal 2021	5,346
Fiscal 2022	4,380
Fiscal 2023	4,284
Fiscal 2024	4,284
Thereafter	18,068
Total amortization expense	$	38,207

 

NOTE 4: CASH, CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS

Cash equivalents consist of instruments with remaining maturities of three months or less at the date of purchase. In general, these investments are free of trading restrictions.

Cash, cash equivalents, and short-term investments consisted of the following as of June 27, 2020:

(in thousands)	Amortized Cost		Unrealized Gains		Unrealized Losses		Estimated Fair Value
Current assets:
Cash	$	165,213	$	—	$	—	$	165,213
Cash equivalents:
Money market funds (1)	126,555		—		—		126,555
Time deposits (2)	30,007		—		—		30,007
Total cash and cash equivalents	$	321,775	$	—	$	—	$	321,775
Short-term investments (2):
Time deposits	95,000		—		—		95,000
Deposits (3)	99,000		—		—		99,000
Total short-term investments	$	194,000	$	—	$	—	$	194,000
Total cash, cash equivalents and short-term investments	$	515,775	$	—	$	—	$	515,775

(1) The fair value was determined using unadjusted prices in active, accessible markets for identical assets, and as such they were classified as Level 1 assets in the fair value hierarchy.

(2) Fair value approximates cost basis.

(3) Represents deposits that require a notice period of three months for withdrawal.

16

KULICKE AND SOFFA INDUSTRIES, INC.

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

Unaudited (continued)

Cash, cash equivalents and short-term investments consisted of the following as of September 28, 2019:

(in thousands)	Amortized Cost		Unrealized Gains		Unrealized Losses		Estimated Fair Value
Current assets:
Cash	$	201,005	$	—	$	—	$	201,005
Cash equivalents:
Money market funds (1)	163,172		—		—		163,172
Time deposits (2)	7		—		—		7
Total cash and cash equivalents	$	364,184	$	—	$	—	$	364,184
Short-term investments (2):
Time deposits	130,000		—		—		130,000
Deposits (3)	99,000		—		—		99,000
Total short-term investments	$	229,000	$	—	$	—	$	229,000
Total cash, cash equivalents and short-term investments	$	593,184	$	—	$	—	$	593,184

(1) The fair value was determined using unadjusted prices in active, accessible markets for identical assets, and as such they were classified as Level 1 assets in the fair value hierarchy.

(2) Fair value approximates cost basis.

(3) Represents deposits that require a notice period of three months for withdrawal.

NOTE 5: EQUITY INVESTMENTS

Equity investments consisted of the following as of June 27, 2020 and September 28, 2019:

	As of
(in thousands)	June 27, 2020		September 28, 2019
Non-marketable equity securities (1)	$	6,275	$	5,000
Equity method investments	1,092		1,250
Total equity investments	$	7,367	$	6,250

(1) On January 30, 2019, the Company made a $5.0 million investment in one of our collaborative partners, over which the Company does not have significant influence. During the three and nine months ended June 27, 2020, there was no impairment or adjustment to the observable price.

NOTE 6: FAIR VALUE MEASUREMENTS

Accounting standards establish three levels of inputs that may be used to measure fair value: quoted prices in active markets for identical assets or liabilities (referred to as Level 1), inputs other than Level 1 that are observable for the asset or liability either directly or indirectly (referred to as Level 2) and unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities (referred to as Level 3).

Assets and Liabilities Measured and Recorded at Fair Value on a Recurring Basis 

We measure certain financial assets and liabilities at fair value on a recurring basis. There were no transfers between fair value measurement levels during the three and nine months ended June 27, 2020.

Fair Value Measurements on a Nonrecurring Basis

Our non-financial assets such as intangible assets and property, plant and equipment are carried at cost unless impairment is deemed to have occurred. Our equity method investments are recorded at fair value only if an impairment is recognized.

17

KULICKE AND SOFFA INDUSTRIES, INC.

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

Unaudited (continued)

Fair Value of Financial Instruments

Amounts reported as accounts receivables, prepaid expenses and other current assets, accounts payable and accrued expenses approximate fair value.

NOTE 7: DERIVATIVE FINANCIAL INSTRUMENTS

The Company’s international operations are exposed to changes in foreign exchange rates due to transactions denominated in currencies other than U.S. dollars. Most of the Company’s revenue and cost of materials are transacted in U.S. dollars. However, a significant amount of the Company’s operating expenses is denominated in local currencies, primarily in Singapore.

The foreign currency exposure of our operating expenses is generally hedged with foreign exchange forward contracts. The Company’s foreign exchange risk management programs include using foreign exchange forward contracts with cash flow hedge accounting designation to hedge exposures to the variability in the U.S. dollar equivalent of forecasted non-U.S. dollar-denominated operating expenses. These instruments generally mature within twelve months. For these derivatives, we report the after-tax gain or loss from the effective portion of the hedge as a component of accumulated other comprehensive income (loss), and we reclassify it into earnings in the same period or periods in which the hedged transaction affects earnings and in the same line item on the Consolidated Condensed Statements of Operations as the impact of the hedged transaction.

The fair value of derivative instruments on our Consolidated Condensed Balance Sheet as of June 27, 2020 and September 28, 2019 was as follows:

	As of
	June 27, 2020					September 28, 2019
(in thousands)	Notional Amount		Fair Value (Liability) Derivatives(1)			Notional Amount		Fair Value (Liability) Derivatives(1)
Derivatives designated as hedging instruments:
Foreign exchange forward contracts (2)	$	37,383	$	(284	)	$	33,834	$	(597	)
Total derivatives	$	37,383	$	(284	)	$	33,834	$	(597	)

(1) The fair value of derivative liabilities is measured using level 2 fair value inputs and is included in accrued expenses and other current liabilities on our Consolidated Condensed Balance Sheet.

(2) Hedged amounts expected to be recognized to income within the next twelve months.

The effects of derivative instruments designated as cash flow hedges in our Consolidated Condensed Statements of Comprehensive Income for the three and nine months ended June 27, 2020 and June 29, 2019 are as follows:

	Three months ended						Nine months ended
(in thousands)	June 27, 2020			June 29, 2019			June 27, 2020			June 29, 2019
Foreign exchange forward contract in cash flow hedging relationships:
Net gain/(loss) recognized in OCI, net of tax (1)	$	1,034		$	(49	)	$	(340	)	$	39
Net loss reclassified from accumulated OCI into income, net of tax(2)	$	(384	)	$	(33	)	$	(653	)	$	(1,165	)

(1) Net change in the fair value of the effective portion classified in OCI.

(2) Effective portion classified as selling, general and administrative expense.

NOTE 8: LEASES

We have entered into various non-cancellable operating and finance lease agreements for certain of our offices, manufacturing, technology, sales support and service centers, equipment, and vehicles. We determine if an arrangement is a lease, or contains a lease, at inception and record the leases in our financial statements upon lease commencement, which is the date when the underlying asset is made available for use by the lessor. Our lease terms may include one or more options to extend the lease terms, for periods from one year to 20 years, when it is reasonably certain that we will exercise that option. As of June 27, 2020, one option to extend

18

KULICKE AND SOFFA INDUSTRIES, INC.

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

Unaudited (continued)

the lease was recognized as a right-of-use ("ROU") asset, and a lease liability. We have lease agreements with lease and non-lease components, and non-lease components are accounted for separately and not included in our leased assets and corresponding liabilities. We have elected not to present short-term leases on the Consolidated Condensed Balance Sheet as these leases have a lease term of 12 months or less at lease inception.

Operating leases are included in operating ROU assets, current operating lease liabilities and non current operating lease liabilities, and finance leases are in included in property, plant and equipment, accrued expenses and other current liabilities, and other liabilities on the Consolidated Condensed Balance Sheet. As of June 27, 2020, our finance leases are not material.

The following table shows the components of lease expense:

	Three months ended			Nine months ended
(in thousands)	June 27, 2020			June 27, 2020
Operating lease expense  (1)	$	(1,646	)	$	(5,030	)

(1) Operating lease expense includes short-term lease expense, which is immaterial for the three and nine months ended June 27, 2020.

The following table shows the cash flows arising from lease transactions. Cash payments related to short-term leases are not included in the measurement of operating and finance lease liabilities, and, as such, are excluded from the amounts below:

	Nine months ended
(in thousands)	June 27, 2020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash outflows from operating leases	$	4,677

The following table shows the weighted-average lease terms and discount rates for operating leases:

	As of
	June 27, 2020
Operating leases:
Weighted-average remaining lease term (in years):	4.7
Weighted-average discount rate:	4.6	%

Future lease payments, excluding short-term leases, as of June 27, 2020, are detailed as follows:

(in thousands)	Operating leases
Remainder of 2020	$	1,658
2021	6,288
2022	5,635
2023	5,420
2024	2,985
Thereafter	4,385
Total minimum lease payments	26,371
Less: Interest	2,776
Present value of lease obligations	23,595
Less: Current portion	5,471
Long-term portion of lease obligations	$	18,124

19

KULICKE AND SOFFA INDUSTRIES, INC.

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

Unaudited (continued)

Future lease payments under operating leases prior to adoption ASC 842 were as follows:

			Payments due by fiscal year
(in thousands)	Total		2020		2021		2022		2023		2024		Thereafter
Operating lease obligations (1)	$	16,273	$	4,089	$	2,576	$	2,182	$	1,967	$	1,822	$	3,637

(1) Pursuant to ASC No. 840, Leases ("ASC 840"), for lessee's involvement in asset construction, the Company was considered to be the owner of the Building (as defined in Note 9 below) during the construction phase due to its involvement in the asset construction. As a result of the Company's continued involvement during the lease term, the Company did not fulfill the criteria to apply sale-leaseback accounting under ASC 840. Therefore, at completion of construction, the Building remained on the Consolidated Condensed Balance Sheet, and the corresponding financing obligation was reclassified to long-term liability. As of September 28, 2019, we recorded a financing obligation related to the Building of $15.0 million (see Note 9 below). The financing obligation is not reflected in the table above.

NOTE 9: DEBT AND OTHER OBLIGATIONS

Financing Obligation

On December 1, 2013, Kulicke & Soffa Pte Ltd. (“Pte”), the Company's wholly owned subsidiary, signed a lease with DBS Trustee Limited as trustee of Mapletree Industrial Trust (the “Landlord”) to lease from the Landlord approximately 198,000 square feet, representing approximately 70% of a building in Singapore as our corporate headquarters, as well as a manufacturing, technology, sales and service center (the “Building”). The lease has a 10-year non-cancellable term (the "Initial Term") and contains options to renew for two further 10-year terms. The annual rent and service charge for the Initial Term range from $4 million to $5 million Singapore dollars.

Pursuant to legacy ASC No. 840, Leases ("ASC 840"), we have classified the Building (build-to-suit leasing arrangement) on our Consolidated Condensed Balance Sheet as property, plant and equipment, which we are depreciating over its estimated useful life of 25 years. We concluded that the term of the financing obligation is 10 years. This is equal to the non-cancellable term of our lease agreement with the Landlord. At the inception of the lease, the asset and financing obligation recorded on the Consolidated Condensed Balance Sheet was $20.0 million, which was based on an interest rate of 6.3% over the Initial Term. As of September 28, 2019, the financing obligation related to the Building was $15.0 million, which approximates fair value (Level 2). The financing obligation will be settled through a combination of periodic cash rental payments and the return of the leased property at the expiration of the lease. We do not report rent expense for the property, which is deemed owned for accounting purposes. Rather, rental payments required under the lease are considered debt service and applied to the deemed landlord financing obligation and interest expense. The Building and financing obligation are being amortized in a manner that will not generate a gain or loss upon lease termination.

The build-to-suit leasing arrangement was derecognized pursuant to the transition guidance provided in ASC 842, which was effective beginning with the first quarter of 2020. Accordingly, the lease has been reassessed as an operating lease as of the adoption date under ASC 842, and is included on the Consolidated Condensed Balance Sheet. The adoption has resulted in a decrease of approximately $14.5 million in financing obligation, decrease of approximately $15.3 million in property, plant and equipment, and an adjustment of $0.8 million to retained earnings after income tax effects on our Consolidated Condensed Balance Sheet.

Bank Guarantees

On November 22, 2013, the Company obtained a $5.0 million credit facility with Citibank in connection with the issuance of bank guarantees for operational purposes. As of June 27, 2020, the outstanding amount under this facility was $3.2 million.

Credit Facilities

On February 15, 2019, the Company entered into a Facility Letter and Overdraft Agreement (collectively, the “Facility Agreements”) with MUFG Bank, Ltd., Singapore Branch (the “Bank”). The Facility Agreements provide the Company with an overdraft facility of up to $150.0 million (the “Overdraft Facility”) for general corporate purposes. Amounts outstanding under the Overdraft Facility, including interest, are payable upon thirty days written demand by the Bank. Interest on the Overdraft Facility is calculated on a daily basis, and the applicable interest rate is calculated at the overnight U.S. Dollar LIBOR rate plus a margin of 1.5% per annum. The Overdraft Facility is an unsecured facility per the terms of the Facility Agreements. The Facility Agreements contain customary non-financial covenants, including, without limitation, covenants that restrict the Company’s ability to sell or dispose of its assets, cease owning at least 51% of one of its subsidiaries (the "Subsidiary"), or encumber its assets with material security interests (including any pledge of monies in the Subsidiary’s cash deposit account with the Bank). The Facility Agreements also contain typical events of default, including, without limitation, non-payment of financial obligations when due, cross defaults to other

20

KULICKE AND SOFFA INDUSTRIES, INC.

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

Unaudited (continued)

material indebtedness of the Company or any breach of a representation or warranty under the Facility Agreements. As of June 27, 2020, there were no outstanding amounts under the Overdraft Facility.

NOTE 10: SHAREHOLDERS’ EQUITY AND EMPLOYEE BENEFIT PLANS

Common Stock and 401(k) Retirement Plan

The Company has a 401(k) retirement plan (the “Plan”) for eligible U.S. employees. The Plan allows for employee contributions and matching Company contributions from 4% to 6% based upon terms and conditions of the 401(k) Plan.

The following table reflects the Company’s contributions to the Plan during the three and nine months ended June 27, 2020 and June 29, 2019:

	Three months ended				Nine months ended
(in thousands)	June 27, 2020		June 29, 2019		June 27, 2020		June 29, 2019
Cash	$	410	$	428	$	1,119	$	1,291

Stock Repurchase Program

On August 15, 2017, the Company’s Board of Directors authorized a program (the "Program") to repurchase up to $100 million of the Company’s common stock on or before August 1, 2020. In 2018 and 2019, the Board of Directors increased the share repurchase authorization under the Program to $200 million and $300 million, respectively. The Company has entered into a written trading plan under Rule 10b5-1 of the Exchange Act to facilitate repurchases under the Program. The Program may be suspended or discontinued at any time and is funded using the Company's available cash, cash equivalents and short-term investments. Under the Program, shares may be repurchased through open market and/or privately negotiated transactions at prices deemed appropriate by management. The timing and amount of repurchase transactions under the Program depend on market conditions as well as corporate and regulatory considerations. During the three and nine months ended June 27, 2020, the Company repurchased a total of 1.0 million and 2.1 million shares of common stock under the Program at a cost of $22.4 million and $46.2 million, respectively. The stock repurchases were recorded in the periods they were delivered and accounted for as treasury stock in the Company's Consolidated Condensed Balance Sheet. The Company records treasury stock purchases under the cost method using the first-in, first-out (FIFO) method. Upon reissuance of treasury stock, amounts in excess of the acquisition cost are credited to additional paid-in capital. If the Company reissues treasury stock at an amount below its acquisition cost and additional paid-in capital associated with prior treasury stock transactions is insufficient to cover the difference between acquisition cost and the reissue price, this difference is recorded against retained earnings. As of June 27, 2020, our remaining stock repurchase authorization under the Program was approximately $50.9 million.

On July 3, 2020, the Board of Directors increased the share repurchase authorization under the Company’s existing share repurchase program by an additional $100 million to $400 million, and extended its duration through August 1, 2022.

Dividends

On May 29, 2020, February 20, 2020 and December 12, 2019, the Board of Directors declared a quarterly dividend of $0.12 per share of common stock. Dividends paid during the three and nine months ended June 27, 2020 totaled $7.6 million and $22.8 million, respectively. The declaration of any future cash dividend is at the discretion of the Board of Directors and will depend on the Company's financial condition, results of operations, capital requirements, business conditions and other factors, as well as a determination that such dividends are in the best interests of the Company's shareholders.

Accumulated Other Comprehensive Income

The following table reflects accumulated other comprehensive loss reflected on the Consolidated Condensed Balance Sheets as of June 27, 2020 and September 28, 2019: 

21

KULICKE AND SOFFA INDUSTRIES, INC.

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

Unaudited (continued)

	As of
(in thousands)	June 27, 2020			September 28, 2019
Loss from foreign currency translation adjustments	$	(5,321	)	$	(7,745	)
Unrecognized actuarial loss on pension plan, net of tax	(1,669		)	(1,598		)
Unrealized loss on hedging	(284		)	(597		)
Accumulated other comprehensive loss	$	(7,274	)	$	(9,940	)

Equity-Based Compensation

The Company has stockholder-approved equity-based employee compensation plans (the “Employee Plans”) and director compensation plans (the “Director Plans”) (collectively, the “Equity Plans”). As of June 27, 2020, 3.4 million shares of common stock are available for grant to its employees and directors under the 2017 Equity Plan, including previously registered shares that have been carried forward for issuance from the 2009 Equity Plan.

• Relative TSR Performance Share Units ("Relative TSR PSUs") entitle the employee to receive common shares of the Company on the award vesting date, if market performance objectives that measure relative total shareholder return (“TSR”) are attained. Relative TSR is calculated based upon the 90-calendar day average price of the Company's stock as compared to specific peer companies that comprise the GICS (45301020) Semiconductor Index. TSR is measured for the Company and each peer company over a performance period, which is generally three years. Vesting percentages range from 0% to 200% of awards granted. The provisions of the Relative TSR PSUs are reflected in the grant date fair value of the award; therefore, compensation expense is recognized regardless of whether the market condition is ultimately satisfied. Compensation expense is reversed if the award is forfeited prior to the vesting date.

• In general, stock options and Time-based Restricted Share Units ("Time-based RSUs") awarded to employees vest annually over a three-year period provided the employee remains employed by the Company. The Company follows the non-substantive vesting method for stock options and recognizes compensation expense immediately for awards granted to retirement eligible employees, or over the period from the grant date to the date retirement eligibility is achieved.

• Special/Growth Performance Share Units (“Special/Growth PSUs”) entitle the employee to receive common shares of the Company on the three-year anniversary of the grant date (if employed by the Company) if revenue growth targets set by the Management Development and Compensation Committee (“MDCC”) of the Board of Directors on the date of grant are met. If revenue growth targets are not met, the Special/Growth PSUs do not vest. Certain Special/Growth PSUs vest based on achievement of strategic goals over a certain time period or periods set by the MDCC. If the strategic goals are not achieved, the Special/Growth PSUs do not vest.

Equity-based compensation expense recognized in the Consolidated Condensed Statements of Operations for the three and nine months ended June 27, 2020 and June 29, 2019 was based upon awards ultimately expected to vest, with forfeitures accounted for when they occur.

The following table reflects Time-based RSUs, Relative TSR PSUs, Special/Growth PSUs and common stock granted during the three and nine months ended June 27, 2020 and June 29, 2019:

	Three months ended		Nine months ended
(shares in thousands)	June 27, 2020	June 29, 2019	June 27, 2020	June 29, 2019
Time-based RSUs	13	2	490	521
Relative TSR PSUs	5	1	163	166
Special/Growth PSUs	2	1	75	56
Common stock	9	10	26	28
Equity-based compensation in shares	29	14	754	771

The following table reflects total equity-based compensation expense, which includes Time-based RSUs, Relative TSR PSUs, Special/Growth PSUs and common stock, included in the Consolidated Condensed Statements of Operations during the three and nine months ended June 27, 2020 and June 29, 2019: 

22

KULICKE AND SOFFA INDUSTRIES, INC.

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

Unaudited (continued)

	Three months ended				Nine months ended
(in thousands)	June 27, 2020		June 29, 2019		June 27, 2020		June 29, 2019
Cost of sales	$	182	$	161	$	597	$	471
Selling, general and administrative	2,676		2,616		8,106		7,871
Research and development	867		820		2,353		2,430
Total equity-based compensation expense	$	3,725	$	3,597	$	11,056	$	10,772

The following table reflects equity-based compensation expense, by type of award, for the three and nine months ended June 27, 2020 and June 29, 2019:  

	Three months ended				Nine months ended
(in thousands)	June 27, 2020		June 29, 2019		June 27, 2020		June 29, 2019
Time-based RSUs	$	2,366	$	2,182	$	7,130	$	6,455
Relative TSR PSUs	908		1,020		2,210		3,213
Special/Growth PSUs	266		173		1,087		492
Common stock	185		222		629		612
Total equity-based compensation expense	$	3,725	$	3,597	$	11,056	$	10,772

NOTE 11: REVENUE AND CONTRACT LIABILITIES

The Company recognizes revenue when we satisfy performance obligations as evidenced by the transfer of control of our products or services to customers. In general, the Company generates revenue from product sales, either directly to customers or to distributors. In determining whether a contract exists, we evaluate the terms of the agreement, the relationship with the customer or distributor and their ability to pay. Service revenue is generally recognized over time as the services are performed. For the three and nine months ended June 27, 2020, and June 29, 2019, the service revenue is not material. Please refer to Note 1: Basis of Presentation - Revenue Recognition, for disclosure on the Company's revenue recognition and Note 14: Segment Information for disclosure of revenue by reportable segment and disaggregated revenue.

Contract Liabilities

Our contract liabilities are primarily related to advance payments received from customers to secure product in future periods where we have received amounts in advance of satisfying performance obligations and are reported in the accompanying Consolidated Condensed Balance Sheets within accrued expenses and other current liabilities.

Contract liabilities increase as a result of receiving new advance payments from customers and decrease as revenue is recognized from customers purchasing product under advance payment arrangements upon meeting the performance obligations.

The following table shows the changes in contract liability balances during the three and nine months ended June 27, 2020 and March 30, 2019:

	Three months ended						Nine months ended
(in thousands)	June 27, 2020			June 29, 2019			June 27, 2020			June 29, 2019
Contract liabilities, beginning of period	$	10,358		$	581		$	1,896		$	997
Revenue recognized	(13,401		)	(1,392		)	(19,218		)	(6,909		)
Additions	5,245			1,806			19,524			6,907
Contract liabilities, end of period	$	2,202		$	995		$	2,202		$	995

NOTE 12: EARNINGS PER SHARE

Basic income per share is calculated using the weighted average number of shares of common stock outstanding during the period. Stock options and restricted stock are included in the calculation of diluted earnings per share, except when their effect would be anti-dilutive.

23

KULICKE AND SOFFA INDUSTRIES, INC.

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

Unaudited (continued)

The following tables reflect a reconciliation of the shares used in the basic and diluted net income per share computation for the three and nine months ended June 27, 2020 and June 29, 2019: 

	Three months ended
(in thousands, except per share data)	June 27, 2020				June 29, 2019
	Basic		Diluted		Basic		Diluted
NUMERATOR:
Net income	$	11,151	$	11,151	$	1,287	$	1,287
DENOMINATOR:
Weighted average shares outstanding - Basic	62,313		62,313		64,683		64,683
Dilutive effect of Equity Plans			520				748
Weighted average shares outstanding - Diluted			62,833				65,431
EPS:
Net income per share - Basic	$	0.18	$	0.18	$	0.02	$	0.02
Effect of dilutive shares			—				—
Net income per share - Diluted			$	0.18			$	0.02

  

	Nine months ended
(in thousands, except per share data)	June 27, 2020					June 29, 2019
	Basic		Diluted			Basic		Diluted
NUMERATOR:
Net income	$	36,516	$	36,516		$	5,249	$	5,249
DENOMINATOR:
Weighted average shares outstanding - Basic	63,200		63,200			65,914		65,914
Dilutive effect of Equity Plans			555					683
Weighted average shares outstanding - Diluted			63,755					66,597
EPS:
Net income per share - Basic	$	0.58	$	0.58		$	0.08	$	0.08
Effect of dilutive shares			(0.01		)			—
Net income per share - Diluted			$	0.57				$	0.08

NOTE 13: INCOME TAXES

The following table reflects the provision for income taxes and the effective tax rate for the three and nine months ended June 27, 2020 and June 29, 2019: 

	Three months ended						Nine months ended
(dollar amounts in thousands)	June 27, 2020			June 29, 2019			June 27, 2020			June 29, 2019
Provision for income taxes	$	690		$	3,864		$	3,985		$	19,106
Effective tax rate	5.8		%	75.0		%	9.8		%	78.2		%

The decrease in provision for income taxes and in the effective tax rate for the three months ended June 27, 2020 as compared to the three months ended June 29, 2019 is primarily related to reversal of valuation allowances recorded against certain tax credits and loss carryforwards due to an increase in profitability in the corresponding jurisdictions in fiscal 2020. The decrease in provision for income taxes and the effective tax rate for the nine months ended June 27, 2020 as compared to the nine months ended June 29, 2019 is primarily related to reversal of valuation allowances recorded against certain tax credits and loss carryforwards due to an increase in profitability in the corresponding jurisdictions in fiscal 2020 and $10.2 million of provision for income taxes recorded

24

KULICKE AND SOFFA INDUSTRIES, INC.

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

Unaudited (continued)

in the first and second quarter of fiscal 2019 as an adjustment to the U.S. one-time transition tax resulting from the enactment of the TCJA.

For the nine months ended June 27, 2020, the effective tax rate is lower than the U.S. federal statutory tax rate primarily due to tax benefits from foreign income earned in lower tax jurisdictions, tax incentives, and tax credits, partially offset by the foreign minimum tax, deemed dividends, valuation allowances recorded against certain loss carryforwards, foreign withholding taxes, and tax liabilities from foreign operations.

NOTE 14: SEGMENT INFORMATION

Reportable segments are defined as components of an enterprise that engage in business activities for which discrete financial information is available and regularly reviewed by the chief operating decision maker (the “CODM”) in deciding how to allocate resources and to assess performance. The Company's Chief Executive Officer is the Company's CODM. The CODM does not review discrete asset information. The Company operates two reportable segments consisting of: (i) Capital Equipment; and (ii) Aftermarket Products and Services ("APS").

The following table reflects operating information by segment for the three and nine months ended June 27, 2020 and June 29, 2019: 

	Three months ended					Nine months ended
(in thousands)	June 27, 2020		June 29, 2019			June 27, 2020		June 29, 2019
Net revenue:
Capital Equipment	$	111,436	$	89,860		$	326,982	$	286,364
APS	39,014		37,249			118,506		113,861
Net revenue	150,450		127,109			445,488		400,225
Income/(loss) from operations:
Capital Equipment	1,045		(6,449		)	7,815		(10,563		)
APS	9,926		8,276			27,646		24,480
Income from operations	$	10,971	$	1,827		$	35,461	$	13,917

We have considered (1) information that is regularly reviewed by our CODM as defined by the authoritative guidance on segment reporting, in evaluating financial performance and (2) other financial data, including information that we include in our earnings releases but which is not included in our financial statements, to disaggregate revenues by end markets served. The principal category we use to disaggregate revenues is by the end markets served in the Capital Equipment segment.

The following table reflects net revenue by Capital Equipment end markets served for the three and nine months ended June 27, 2020 and June 29, 2019: 

	Three months ended				Nine months ended
(in thousands)	June 27, 2020		June 29, 2019		June 27, 2020		June 29, 2019
General Semiconductor	$	51,103	$	50,040	$	168,937	$	120,694
Automotive & Industrial	8,135		16,259		46,906		61,735
LED	36,135		15,194		58,193		39,730
Memory	5,618		2,501		25,471		41,813
Advanced Packaging	10,445		5,866		27,475		22,392
Total Capital Equipment revenue	$	111,436	$	89,860	$	326,982	$	286,364

25

KULICKE AND SOFFA INDUSTRIES, INC.

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

Unaudited (continued)

The following table reflects capital expenditures, depreciation expense and amortization expense for the three and nine months ended June 27, 2020 and June 29, 2019.

	Three months ended				Nine months ended
(in thousands)	June 27, 2020		June 29, 2019		June 27, 2020		June 29, 2019
Capital expenditures:
Capital Equipment	$	1,329	$	646	$	3,215	$	4,118
APS	2,122		1,490		5,335		5,194
	$	3,451	$	2,136	$	8,550	$	9,312
Depreciation expense:
Capital Equipment	$	1,713	$	1,800	$	4,747	$	5,540
APS	1,542		1,352		4,399		3,872
	$	3,255	$	3,152	$	9,146	$	9,412
Amortization expense:
Capital Equipment	$	973	$	989	$	2,925	$	2,999
APS	841		854		2,526		2,590
	$	1,814	$	1,843	$	5,451	$	5,589

NOTE 15: COMMITMENTS, CONTINGENCIES AND CONCENTRATIONS

Warranty Expense

The Company's equipment is generally shipped with a one-year warranty against manufacturing defects. The Company establishes reserves for estimated warranty expense when revenue for the related equipment is recognized. The reserve for estimated warranty expense is based upon historical experience and management's estimate of future warranty costs, including product part replacement, freight charges and labor costs incurred in correcting product failures during the warranty period.

The following table reflects the reserve for warranty activity for the three and nine months ended June 27, 2020 and June 29, 2019: 

	Three months ended						Nine months ended
(in thousands)	June 27, 2020			June 29, 2019			June 27, 2020			June 29, 2019
Reserve for warranty, beginning of period	$	14,368		$	13,885		$	14,185		$	14,475
Provision for warranty	3,331			3,143			9,749			8,874
Utilization of reserve	(3,189		)	(3,073		)	(9,424		)	(9,394		)
Reserve for warranty, end of period	$	14,510		$	13,955		$	14,510		$	13,955

Other Commitments and Contingencies

The following table reflects obligations not reflected on the Consolidated Condensed Balance Sheet as of June 27, 2020:

			Payments due by fiscal year
(in thousands)	Total		2020		2021		2022		2023		2024		thereafter
Inventory purchase obligation (1)	$	125,803	$	125,803	$	—	$	—	$	—	$	—	$	—

(1) The Company orders inventory components in the normal course of its business. A portion of these orders are non-cancellable, however, some orders impose varying penalties and charges in the event of cancellation.

26

KULICKE AND SOFFA INDUSTRIES, INC.

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

Unaudited (continued)

Concentrations

The following table reflects significant customer concentrations as a percentage of net revenue for the nine months ended June 27, 2020 and June 29, 2019:

	Nine months ended
	June 27, 2020	June 29, 2019
Micron Technology, Inc.	*	10.9	%

* Represented less than 10% of total net revenue

The following table reflects significant customer concentrations as a percentage of total accounts receivable as of June 27, 2020 and June 29, 2019:

	As of
	June 27, 2020		June 29, 2019
Xinye (HK) Electronics. Co (1)	14.9	%	*
Haoseng Industrial Company Limited (1)	13.1	%	*
Super Power International (1)	*		15.8	%
Forehope Electronic (Ningbo) Co Ltd	*		14.4	%
Micron Technology, Inc.	*		10.2	%

(1) Distributor of the Company's products.

* Represented less than 10% of total accounts receivable

NOTE 16: SUBSEQUENT EVENTS

On July 3, 2020, the Board of Directors increased the share repurchase authorization under the Company’s existing share repurchase program by an additional $100 million to $400 million, and extended its duration through August 1, 2022.

27

Item 2. - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward-Looking Statements

In addition to historical information, this filing contains statements relating to future events or our future results. These statements are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and are subject to the safe harbor provisions created by statute. Such forward-looking statements include, but are not limited to, statements with respect to our future revenue, increasing, continuing or strengthening, or decreasing or weakening, demand for our products, replacement demand, our research and development efforts, our ability to identify and realize new growth opportunities, our ability to control costs and our operational flexibility as a result of (among other factors):

• our expectations regarding the potential impacts on our business of the COVID-19 pandemic, including the economic and public health effects, and of governmental and other responses to these impacts;

• projected growth rates in the overall semiconductor industry, the semiconductor assembly equipment market, and the market for semiconductor packaging materials; and

• projected demand for ball bonder, wedge bonder, advanced packaging and electronic assembly equipment and for tools, spare parts and services.

Generally, words such as “may,” “will,” “should,” “could,” “anticipate,” “expect,” “intend,” “estimate,” “plan,” “continue,” “goal” and “believe,” or the negative of or other variations on these and other similar expressions identify forward-looking statements. These forward-looking statements are made only as of the date of this filing. We do not undertake to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.

Forward-looking statements are based on current expectations and involve risks and uncertainties. Our future results could differ significantly from those expressed or implied by our forward-looking statements. These risks and uncertainties include, without limitation, those described below and under the heading “Risk Factors” in this report and in our Annual Report on Form 10-K for the fiscal year ended September 28, 2019 (the “Annual Report”) and our other reports filed from time to time with the Securities and Exchange Commission. This discussion should be read in conjunction with the Consolidated Condensed Financial Statements and Notes included in this report, as well as our audited financial statements included in the Annual Report.

We operate in a rapidly changing and competitive environment. New risks emerge from time to time and it is not possible for us to predict all risks that may affect us. Given those risks and uncertainties, investors should not place undue reliance on forward-looking statements as predictions of actual results.

OVERVIEW

Kulicke and Soffa Industries, Inc. ("We," the "Company" or "K&S") is a leading provider of semiconductor and electronic assembly solutions serving the global automotive, consumer, communications, computing and industrial markets. Founded in 1951, we pride ourselves on establishing foundations for technological advancement-creating, pioneering interconnect solutions that enable performance improvements, power efficiency, form-factor reductions and assembly excellence of current and next-generation semiconductor devices. Leveraging decades of development and process technology expertise, our expanding portfolio provides equipment solutions, aftermarket products and services supporting a comprehensive set of interconnect technologies including wire bonding, advanced packaging, lithography, and electronics assembly. Dedicated to empowering technological discovery, always, we collaborate with customers and technology partners to push the boundaries of possibility, enabling a smarter future.

We design, manufacture and sell capital equipment and tools used to assemble semiconductor devices, including integrated circuits (“ICs”), high and low powered discrete devices, light-emitting diodes (“LEDs”), and power modules. In addition, we have a portfolio of equipment that is used to assemble components onto electronic circuit boards. We also service, maintain, repair and upgrade our equipment and sell consumable aftermarket tools for our and our peer companies' equipment. Our customers primarily consist of semiconductor device manufacturers, integrated device manufacturers ("IDMs"), outsourced semiconductor assembly and test providers (“OSATs”), other electronics manufacturers and automotive electronics suppliers.

Our goal is to be the technology leader and the most competitive supplier in terms of cost and performance in each of our major product lines. Accordingly, we invest in research and engineering projects intended to enhance our position as a leader in semiconductor assembly technology. We also remain focused on our cost structure through continuous improvement and optimization of operations. Cost reduction efforts are an important part of our normal ongoing operations and are intended to generate savings without compromising overall product quality and service.

28

The Company operates two reportable segments consisting of: Capital Equipment and Aftermarket Products and Services ("APS"). The Company has aggregated twelve operating segments as of June 27, 2020, with six operating segments within the Capital Equipment reportable segment and six operating segments within the APS reportable segment.

Our Capital Equipment segment engages in the manufacture and sale of ball bonders, wafer level bonders, wedge bonders, advanced packaging and electronic assembly solutions to semiconductor device manufacturers, IDMs, OSATs, other electronics manufacturers and automotive electronics suppliers. Our APS segment engages in the manufacture and sale of a variety of tools for a broad range of semiconductor packaging applications, spare parts, equipment repair, maintenance and servicing, training services, refurbishment and upgrades for our equipment.

Business Environment

The semiconductor business environment is highly volatile and is driven by internal dynamics, both cyclical and seasonal, in addition to macroeconomic forces. Over the long term, semiconductor consumption has historically grown, and is forecast to continue to grow. This growth is driven, in part, by regular advances in device performance and by price declines that result from improvements in manufacturing technology. In order to exploit these trends, semiconductor manufacturers, both IDMs and OSATs, periodically invest aggressively in latest generation capital equipment. This buying pattern often leads to periods of excess supply and reduced capital spending—the so-called semiconductor cycle. Within this broad semiconductor cycle there are also, generally weaker, seasonal effects that are specifically tied to annual, end-consumer purchasing patterns. Typically, semiconductor manufacturers prepare for heightened demand by adding or replacing equipment capacity by the end of the September quarter. Occasionally, this results in subsequent reductions in the December quarter. This annual seasonality can be overshadowed by effects of the broader semiconductor cycle. Macroeconomic factors also affect the industry, primarily through their effect on business and consumer demand for electronic devices, as well as other products that have significant electronic content such as automobiles, white goods, and telecommunication equipment. There can be no assurances regarding levels of demand for our products and we believe historic industry-wide volatility will persist.

In the Asia/Pacific region, our customer base has also become more geographically concentrated as a result of economic and industry conditions. Approximately 93.9% and 93.2% of our net revenue for the three months ended June 27, 2020 and June 29, 2019, respectively, was for shipments to customer locations outside of the U.S., primarily in the Asia/Pacific region. Approximately 53.3% and 49.0% of our net revenue for the three months ended June 27, 2020 and June 29, 2019, respectively, was for shipments to customers located in China, which is subject to risks and uncertainties related to the respective policies of the governments of China and the U.S.

Similarly, approximately 93.5% and 93.6% of our net revenue for the nine months ended June 27, 2020 and June 29, 2019, respectively, was for shipments to customer locations outside of the U.S., primarily in the Asia/Pacific region. Approximately 54.6% and 42.1% of our net revenue for the nine months ended June 27, 2020 and June 29, 2019, respectively, was for shipments to customers located in China.

The U.S. and several other countries have levied tariffs on certain goods and have introduced other trade restrictions, which, together with the impact of the COVID-19 pandemic discussed below, has resulted in substantial uncertainties in the semiconductor, LED, memory and automotive market with a resulting softening demand. While the Company anticipates long-term growth in semiconductor consumption, the adverse impacts on demand, which began in the fourth quarter of fiscal 2018, may continue through fiscal 2020 and beyond.

Our Capital Equipment segment is primarily affected by the industry's internal cyclical and seasonal dynamics in addition to broader macroeconomic factors that can positively or negatively affect our financial performance. The sales mix of IDM and OSAT customers in any period also impacts financial performance, as changes in this mix can affect our products' average selling prices and gross margins due to differences in volume purchases and machine configurations required by each customer type.

Our APS segment has historically been less volatile than our Capital Equipment segment. APS sales are more directly tied to semiconductor unit consumption rather than capacity requirements and production capability improvements. 

We continue to position our business to leverage our research and development leadership and innovation and to focus our efforts on mitigating volatility, improving profitability and ensuring longer-term growth. We remain focused on operational excellence, expanding our product offerings and managing our business efficiently throughout the business cycles. Our visibility into future demand is generally limited, forecasting is difficult, and we generally experience typical industry seasonality.

To limit potential adverse cyclical, seasonal and macroeconomic effects on our financial position, we have continued our efforts to maintain a strong balance sheet. As of June 27, 2020, our total cash, cash equivalents and short-term investments, net of short-term borrowings, were $515.8 million, a $16.5 million decrease from the prior fiscal year end. We believe our strong cash position will allow us to continue to invest in product development and pursue non-organic opportunities.

29

Key Events in Fiscal 2020

Trade Restriction and Emerging Regulation

On April 28, 2020, the U.S. Department of Commerce’s Bureau of Industry and Security (“BIS”) issued new rules that will require increased investigation of our customers’ end users in China. Further, on May 15, 2020, BIS announced new Export Administration Regulations (“EAR”) specifically applicable to Huawei Technologies Co., Ltd. and its affiliates. We have assessed the potential impact of the new BIS rules and EAR, and do not believe that they will have a material direct impact on our business, financial condition or results of operations. For additional information, please see Part II Item 1A. Risk Factors - We are subject to export restrictions that may limit our ability to sell to certain customers.

COVID-19 Pandemic

The COVID-19 pandemic has significantly impacted the global economy, disrupted global supply chains, lowered equity market valuations, created significant volatility and disruption in financial markets, and significantly increased unemployment levels. In addition, the pandemic resulted in temporary closures and failures of many businesses and the institution of social distancing and sheltering-in-place requirements in many jurisdictions. As these measures begin to be relaxed, in certain jurisdictions there has been a resurgence of illnesses, potentially leading to more severe restrictions in the future.

In response to the pandemic, we have temporarily closed certain offices in the United States, Europe and Asia as well as executed our Business Continuity Plan ("BCP"), which measures have disrupted how we operate our business. While we are currently operating at nearly full capacity in all of our manufacturing locations, work-from-home practices were instituted across every office worldwide, which have impacted our non-manufacturing productivity, including our research & development. At this point, our BCP has not included significant headcount reductions or changes in our overall liquidity position. As certain countries begin to relax the measures, we have restarted certain activities, such as our research & development, in accordance with local guidelines.

We have not experienced significant delays in customer deliveries, but our supply chain is strained in some cases as the availability of materials, logistics and freight options are challenging in many jurisdictions. Demand for many of our products was consistent with our expectations for our third quarter of fiscal 2020, but we are seeing a lower projected demand in the automotive end market, which particularly impacts near-term demand for our wedge bonders. We believe the semiconductor industry macroeconomics have not changed and we anticipate the industry’s long-term growth projections will normalize, but the sector is expected to see significant short-term volatility and potential disruption.

Various countries have announced measures, including government grants, tax changes and tax credits, among other types of relief, in response to the pandemic. For fiscal 2020, we have received a $3.2 million COVID-19 related grant from the Singapore government as well as other measures including rental rebates and social insurance exemption, which are not material to our operating results.

Based on our current evaluation, the pandemic has not had a material impact on our financial condition and operating results in fiscal 2020. We believe that our existing cash, cash equivalents, short-term investments, existing Facility Agreements, and anticipated cash flows from operations will be sufficient to meet our liquidity and capital requirements, notwithstanding the COVID-19 pandemic, for at least the next twelve months from the date of filing. However, as this is a highly dynamic situation, and it is still developing rapidly, there is uncertainty on our business, and our near- and long-term liquidity, financial condition and operating results could deteriorate.

For other information, please see our Quarterly Report on Form 10-Q for the fiscal quarter ended March 28, 2020 Part II Item 1A. Risk Factors - The effects of the COVID-19 pandemic could adversely affect our business, results of operations, and financial condition.

30

RESULTS OF OPERATIONS

The following tables reflect our income from operations for the three and nine months ended June 27, 2020 and June 29, 2019:

	Three months ended
(dollar amounts in thousands)	June 27, 2020		June 29, 2019		$ Change			% Change
Net revenue	$	150,450	$	127,109	$	23,341		18.4	%
Cost of sales	81,027		68,329		12,698			18.6	%
Gross profit	69,423		58,780		10,643			18.1	%
Selling, general and administrative	27,905		28,724		(819		)	(2.9	)%
Research and development	30,547		28,229		2,318			8.2	%
Operating expenses	58,452		56,953		1,499			2.6	%
Income from operations	$	10,971	$	1,827	$	9,144		500.5	%

	Nine months ended
(dollar amounts in thousands)	June 27, 2020		June 29, 2019		$ Change			% Change
Net revenue	$	445,488	$	400,225	$	45,263		11.3	%
Cost of sales	236,398		211,073		25,325			12.0	%
Gross profit	209,090		189,152		19,938			10.5	%
Selling, general and administrative	85,723		87,626		(1,903		)	(2.2	)%
Research and development	87,906		87,609		297			0.3	%
Operating expenses	173,629		175,235		(1,606		)	(0.9	)%
Income from operations	$	35,461	$	13,917	$	21,544		154.8	%

Net Revenue

Our net revenues for the three and nine months ended June 27, 2020 increased as compared to our net revenues for the three and nine months ended June 29, 2019. The increase in net revenue is primarily due to higher volume in both Capital Equipment and APS.

The following tables reflect net revenue by business segment for the three and nine months ended June 27, 2020 and June 29, 2019: 

	Three months ended
(dollar amounts in thousands)	June 27, 2020				June 29, 2019				$ Change		% Change
	Net Revenue		% of total net revenue		Net Revenue		% of total net revenue
Capital Equipment	$	111,436	74.1	%	$	89,860	70.7	%	$	21,576	24.0	%
APS	39,014		25.9	%	37,249		29.3	%	1,765		4.7	%
Total net revenue	$	150,450	100.0	%	$	127,109	100.0	%	$	23,341	18.4	%

	Nine months ended
(dollar amounts in thousands)	June 27, 2020				June 29, 2019				$ Change		% Change
	Net Revenue		% of total net revenue		Net Revenue		% of total net revenue
Capital Equipment	$	326,982	73.4	%	$	286,364	71.6	%	$	40,618	14.2	%
APS	118,506		26.6	%	113,861		28.4	%	4,645		4.1	%
Total net revenue	$	445,488	100.0	%	$	400,225	100.0	%	$	45,263	11.3	%

Capital Equipment

31

For the three months ended June 27, 2020, the higher Capital Equipment net revenue as compared to the prior year period was primarily driven by the growing demand in the LED end market for LED and mini-LED applications, and in the general semiconductor end market for consumer applications. This increased demand was partially offset by lower demand in automotive markets and unfavorable price variance due to less favorable customer and product mix. 

For the nine months ended June 27, 2020, the higher Capital Equipment net revenue as compared to the prior year period was primarily driven by growing demand in the general semiconductor market for consumer applications and telecommunication infrastructure renewal for 5G buildout and in the LED end market due to adoption of emerging mini-LED backlighting displays. These were partially offset by lower demand in the memory and automotive end markets and unfavorable price variance due to less favorable customer and product mix.

APS

For the three and nine months ended June 27, 2020, the higher APS net revenue as compared to the prior year period was primarily due to higher volume in spares and services. This was partially offset by a price reduction in our bonding tools business.

Gross Profit Margin

The following tables reflect gross profit margin as a percentage of net revenue by reportable segments for the three and nine months ended June 27, 2020 and June 29, 2019: 

	Three months ended				Basis Point
	June 27, 2020		June 29, 2019		Change
Capital Equipment	41.8	%	42.4	%	(60	)
APS	58.6	%	55.4	%	320
Total gross profit margin	46.1	%	46.2	%	(10	)

	Nine months ended				Basis Point
	June 27, 2020		June 29, 2019		Change
Capital Equipment	43.4	%	43.6	%	(20	)
APS	56.6	%	56.4	%	20
Total gross profit margin	46.9	%	47.3	%	(40	)

Capital Equipment

For the three months ended June 27, 2020, the lower Capital Equipment gross profit margin as compared to the prior year period was primarily driven by less favorable product mix. The less favorable product mix was due to higher sales of lower margin LED bonders.

For the nine months ended June 27, 2020, the Capital Equipment gross profit margin was generally consistent with the prior year period.

APS

For the three months ended June 27, 2020, the higher APS gross profit margin as compared to the prior year period was primarily driven by better absorption from higher production volume.

For the nine months ended June 27, 2020, the APS gross profit margin was generally consistent with the prior year period.

Income from Operations

For the three and nine months ended June 27, 2020, the higher income from operations as compared to the prior year period was primarily due to higher contribution from Capital Equipment as a result of increased Capital Equipment revenue, as discussed above.

The following tables reflect income from operations by business segment for the three and nine months ended June 27, 2020 and June 29, 2019:

32

	Three months ended
(dollar amounts in thousands)	June 27, 2020		June 29, 2019			$ Change		% Change
Capital Equipment	$	1,045	$	(6,449	)	$	7,494	116.2	%
APS	9,926		8,276			1,650		19.9	%
Total income from operations	$	10,971	$	1,827		$	9,144	500.5	%

	Nine months ended
(dollar amounts in thousands)	June 27, 2020		June 29, 2019			$ Change		% Change
Capital Equipment	$	7,815	$	(10,563	)	$	18,378	174.0	%
APS	27,646		24,480			3,166		12.9	%
Total income from operations	$	35,461	$	13,917		$	21,544	154.8	%

Capital Equipment

For the three and nine months ended June 27, 2020, the higher Capital Equipment income from operations as compared to the prior year period was primarily due to higher volume as explained under 'Net Revenue' above.

APS

For the three and nine months ended June 27, 2020, the higher APS income from operations as compared to the prior year period was primarily due to higher volume as explained under 'Net Revenue' above.

Operating Expenses

The following tables reflect operating expenses for the three and nine months ended June 27, 2020 and June 29, 2019:

	Three months ended
	June 27, 2020		June 29, 2019		$ Change			% Change
Selling, general & administrative	$	27,905	$	28,724	$	(819	)	(2.9	)%
Research & development	30,547		28,229		2,318			8.2	%
Total	$	58,452	$	56,953	$	1,499		2.6	%

	Nine months ended
	June 27, 2020		June 29, 2019		$ Change			% Change
Selling, general & administrative	$	85,723	$	87,626	$	(1,903	)	(2.2	)%
Research & development	87,906		87,609		297			0.3	%
Total	$	173,629	$	175,235	$	(1,606	)	(0.9	)%

Selling, General and Administrative (“SG&A”)

For the three months ended June 27, 2020, the lower SG&A expense as compared to the prior year period was primarily due to a $3.2 million COVID-19 related grant received from the Singapore government. This was partially offset by $1.4 million higher net unfavorable variance in foreign exchange and $0.9 million in higher staff costs related to an increase in incentive compensation as a result of the stronger current fiscal quarter performance.

For the nine months ended June 27, 2020, the lower SG&A expense as compared to the prior year period was primarily due to a $3.2 million COVID-19 related grant received from the Singapore government, a $1.4 million net favorable variance in foreign exchange and $0.4 million lower severance. These were partially offset by $1.4 million in higher staff costs related to an increase in incentive compensation as a result of the stronger performance in the current period, a $1.1 million higher net unfavorable change in doubtful debt accounts and $0.9 million lower restructuring expenses in the prior year period.

Research and Development (“R&D”)

For the three and nine months ended June 27, 2020, the higher R&D expenses as compared to the prior year period were primarily due to higher staff costs related to an increase in incentive compensation as a result of the stronger performance in the current period and higher spending on professional fees.

33

Interest Income and Expense

The following tables reflect interest income and interest expense for the three and nine months ended June 27, 2020 and June 29, 2019: 

	Three months ended
(dollar amounts in thousands)	June 27, 2020			June 29, 2019			$ Change			% Change
Interest income	$	1,374		$	3,956		$	(2,582	)	(65.3	)%
Interest expense	$	(446	)	$	(632	)	$	186		(29.4	)%

	Nine months ended
(dollar amounts in thousands)	June 27, 2020			June 29, 2019			$ Change			% Change
Interest income	$	6,888		$	11,647		$	(4,759	)	(40.9	)%
Interest expense	$	(1,690	)	$	(1,137	)	$	(553	)	48.6	%

Interest income

For the three and nine months ended June 27, 2020, the lower interest income as compared to the prior year period was primarily due to lower weighted average interest rate on cash, cash equivalents and short-term investments.

Interest expense

For the three months ended June 27, 2020, the lower interest expense as compared to prior year period was primarily due to lower weighted average interest rate on the short-term debt (Refer to Note 9 of Item 1) and absence of interest expense related to the financing obligation for our corporate headquarters. The financing obligation was derecognized pursuant to the transition guidance provided in ASC 842, which was adopted at the beginning of the current fiscal year.

For the nine months ended June 27, 2020, the higher interest expense as compared to prior year period was primarily due to higher average short-term debt and partially offset by lower interest rate on the short-term debt and absence of interest expense related to the financing obligation relating to our corporate headquarters as discussed above.

34

Provision for Income Taxes

The following table reflects the provision for income taxes and the effective tax rate for the three and nine months ended June 27, 2020 and June 29, 2019: 

	Three months ended									Nine months ended
(dollar amounts in thousands)	June 27, 2020			June 29, 2019			Change			June 27, 2020			June 29, 2019			Change
Provision for income taxes	$	690		$	3,864		$	(3,174	)	$	3,985		$	19,106		$	(15,121	)
Effective tax rate	5.8		%	75.0		%	(69.2		)%	9.8		%	78.2		%	(68.4		)%

Please refer to Note 13 of Item 1 for discussion on the provision for income taxes and the effective tax rate for the three and nine months ended June 27, 2020 as compared to the prior year period.

LIQUIDITY AND CAPITAL RESOURCES

The following table reflects total cash, cash equivalents, and short-term investments as of June 27, 2020 and September 28, 2019:

	As of
(dollar amounts in thousands)	June 27, 2020			September 28, 2019			$ Change
Cash and cash equivalents	$	321,775		$	364,184		$	(42,409	)
Short-term investments	194,000			229,000			(35,000		)
Total cash, cash equivalents, and short-term investments	$	515,775		$	593,184		$	(77,409	)
Percentage of total assets	50.1		%	54.9		%

The following table reflects a summary of the Consolidated Condensed Statement of Cash Flow information for the nine months ended June 27, 2020 and June 29, 2019:

	Nine months ended
(in thousands)	June 27, 2020			June 29, 2019
Net cash provided by operating activities	$	62,681		$	83,181
Net cash provided by investing activities	25,863			30,374
Net cash used in financing activities	(130,618		)	(38,751		)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(335		)	60
Changes in cash, cash equivalents and restricted cash	$	(42,409	)	$	74,864
Cash, cash equivalents and restricted cash, beginning of period	364,184			321,148
Cash, cash equivalents and restricted cash, end of period	$	321,775		$	396,012

Nine months ended June 27, 2020

Net cash provided by operating activities was primarily due to net income of $36.5 million and non-cash adjustments to net income of $31.8 million and partially offset by a decrease in net change in operating assets and liabilities of $5.7 million. The decrease in net change in operating assets and liabilities was primarily driven by an increase in inventory of $28.0 million, and a decrease in income tax payable of $5.4 million. This was partially offset by an increase in accounts payable, accrued expenses and other current liabilities of $25.9 million, and a decrease in prepaid expenses and other current assets of $1.7 million .

The increase in inventory was due to higher manufacturing activities during the third quarter of fiscal 2020 as compared to the fourth quarter of fiscal 2019 in anticipation of higher demand in subsequent periods. The decrease in income tax payable was mainly due to payment. The higher accounts payable, accrued expenses and other current liabilities was primarily due to higher purchases, and higher accruals on incentive compensation and other bonuses in the third quarter of fiscal 2020.

Net cash provided by investing activities was due to net redemption of short-term investments of $35.0 million to repay the short-term debt. This was partially offset by capital expenditures of $7.8 million and an equity investment of $1.3 million.

35

Net cash used in financing activities was primarily due to a net repayment of short-term debt of $60.9 million, common stock repurchases of $46.9 million and dividend payments of $22.8 million.

Nine months ended June 29, 2019

Net cash provided by operating activities was primarily due to the increase in net change in operating assets and liabilities of $47.9 million, non-cash adjustments to net income of $30.1 million and net income of $5.2 million. The increase in net change in operating assets and liabilities was primarily driven by a decrease in accounts and notes receivable of $92.7 million related to the lower sales and a decrease in inventory of $16.0 million. This was partially offset by a decrease in accounts payable, accrued expenses and other current liabilities of $48.1 million, also related to the lower sales, an increase in prepaid expenses and other assets of $10.6 million, and a decrease in income tax payable of $3.7 million.

The decrease in accounts receivable was due to higher sales in the fourth quarter of fiscal 2018 as compared to the third quarter of fiscal 2019 as well as timing of collections. The decrease in inventory was due to decreased manufacturing activities in third quarter of fiscal 2019 as compared to the fourth quarter of fiscal 2018 in response to lower sales levels in fiscal 2019. The lower accounts payable, accrued expenses and other current liabilities were primarily due to lower accruals on incentive compensation and other bonuses as a result of payment made in fiscal 2019 and lower purchases due to lower manufacturing activities. The decrease in income tax payable was mainly due to payment of tax during fiscal 2019.

Net cash provided by investing activities was due to net redemption of short-term investments of $45.0 million. This was partially offset by capital expenditures of $9.7 million and an equity investment of $5.0 million in one of our collaborative partners.

Net cash used in financing activities was primarily due to common stock repurchases of $85.5 million and dividend payment of $23.9 million. These were partially offset by an overdraft of $71.2 million.

Fiscal 2020 Liquidity and Capital Resource Outlook

We expect our aggregate fiscal 2020 capital expenditures to be between $12.0 million and $14.0 million, of which approximately $8.6 million has been incurred through the third quarter. Expenditures are anticipated to be primarily used for R&D projects, enhancements to our manufacturing operations in Asia, improvements to our information technology infrastructure and leasehold improvements for our facilities. Our ability to fund these requirements will depend, in part, on our future cash flows, which are determined by our future operating performance and, therefore, subject to prevailing global macroeconomic conditions, including the impact from the COVID-19 pandemic, financial, business and other factors, some of which are beyond our control.

As of June 27, 2020 and September 28, 2019, approximately $457.3 million and $591.3 million of cash, cash equivalents, and short-term investments were held by the Company's foreign subsidiaries, respectively, and are expected to be available for use in the U.S. without incurring additional income tax.

The Company’s international operations and capital requirements are anticipated to be funded primarily by cash generated by foreign operating activities and cash held by foreign subsidiaries. Most of the Company's operations and liquidity needs are outside the U.S. The Company’s U.S. operations and capital requirements are anticipated to be funded primarily by cash generated from U.S. operating activities, and by our existing Facility Agreements with MUFG Bank, Ltd. In the future, the Company may repatriate additional cash held by foreign subsidiaries that has already been subject to U.S. income taxes. We believe these sources of cash and liquidity are sufficient to meet our business needs in the U.S. for the foreseeable future including funding of U.S. operations, capital expenditures, repayment of outstanding balances under the Facility Agreements, the dividend program, and the share repurchase program as approved by the Board of Directors.

We believe that our existing cash, cash equivalents, short-term investments, existing Facility Agreements, and anticipated cash flows from operations will be sufficient to meet our liquidity and capital requirements, notwithstanding the COVID-19 pandemic, for at least the next twelve months from the date of filing. Our liquidity is affected by many factors, some based on normal operations of our business and others related to global economic conditions and industry uncertainties, which we cannot predict. We also cannot predict economic conditions or industry downturns or the timing, strength or duration of recoveries. We intend to continue to use our cash for working capital needs and for general corporate purposes.

In this unprecedented environment, as a result of the COVID-19 pandemic or for other reasons, we may seek, as we believe appropriate, additional debt or equity financing that would provide capital for general corporate purposes, working capital funding, additional liquidity needs or to fund future growth opportunities, including possible acquisitions. The timing and amount of potential capital requirements cannot be determined at this time and will depend on a number of factors, including the actual and projected demand for our products, semiconductor and semiconductor capital equipment industry conditions, competitive factors, and the condition of financial markets.

36

Share Repurchase Program

On August 15, 2017, the Company’s Board of Directors authorized a program (the "Program") to repurchase up to $100 million in total of the Company’s common stock on or before August 1, 2020. In 2018 and 2019, the Board of Directors increased the share repurchase authorization under the Program to $200 million and $300 million, respectively. The Company has entered into a written trading plan under Rule 10b5-1 of the Exchange Act to facilitate repurchases under the Program. The Program may be suspended or discontinued at any time and is funded using the Company's available cash, cash equivalents and short-term investments. Under the Program, shares may be repurchased through open market and/or privately negotiated transactions at prices deemed appropriate by management. The timing and amount of repurchase transactions under the Program depend on market conditions as well as corporate and regulatory considerations. During the three and nine months ended June 27, 2020, the Company repurchased a total of 1.0 million and 2.1 million shares of common stock under the Program at a cost of $22.4 million and $46.2 million, respectively. As of June 27, 2020, our remaining stock repurchase authorization under the Program was approximately $50.9 million.

On July 3, 2020, the Board of Directors increased the share repurchase authorization under the Company’s existing share repurchase program by an additional $100 million to $400 million, and extended its duration through August 1, 2022.

Dividends

On May 29, 2020, February 20, 2020 and December 12, 2019, the Board of Directors declared a quarterly dividend of $0.12 per share of common stock. Dividends paid during the three and nine months ended June 27, 2020 totaled $7.6 million and $22.8 million, respectively. The declaration of any future cash dividend is at the discretion of the Board of Directors and will depend on the Company's financial condition, results of operations, capital requirements, business conditions and other factors, as well as a determination that such dividends are in the best interests of the Company's shareholders.

Other Obligations and Contingent Payments

In accordance with GAAP, certain obligations and commitments are not required to be included in the Consolidated Condensed Balance Sheets and Statements of Operations. These obligations and commitments, while entered into in the normal course of business, may have a material impact on our liquidity and are disclosed in the table below.

As of June 27, 2020, the Company has deferred tax liabilities of $34.5 million and unrecognized tax benefits within the income tax payable for uncertain tax positions of $12.8 million, inclusive of accrued interest on uncertain tax positions of $1.5 million, substantially all of which would affect our effective tax rate in the future, if recognized. It is reasonably possible that the amount of the unrecognized tax benefit with respect to certain unrecognized tax positions will increase or decrease during the next 12 months due to the expected lapse of statutes of limitation and / or settlements of tax examinations. These amounts are not included in the table below because given the number of years and numerous matters that remain subject to examination in various tax jurisdictions, we cannot practicably estimate the timing or financial outcomes of these examinations. When estimating its tax positions, the Company considers and evaluates numerous complex areas of taxation, such as transfer pricing methodologies, which may require periodic adjustments and which may not reflect the final tax liabilities.

The following table presents certain payments due by the Company under contractual obligations with minimum firm commitments as of June 27, 2020:

			Payments due in
(in thousands)	Total		Less than 1 year		1 - 3 years		3 - 5 years		More than 5 years
Inventory purchase obligations (1)	$	125,803	$	125,803	$	—	$	—	$	—
U.S. one-time transition tax payable (2) (reflected on our Consolidated Condensed Balance Sheets)	67,161		5,676		12,944		28,316		20,225
Asset retirement obligations (3) (reflected on our Consolidated Condensed Balance Sheets)	1,728		291		159		1,143		135
Total	$	194,692	$	131,770	$	13,103	$	29,459	$	20,360

(1) We order inventory components in the normal course of our business. A portion of these orders are non-cancellable and a portion may have varying penalties and charges in the event of cancellation.

(2) Associated with the U.S. one-time transition tax on certain earnings and profits of our foreign subsidiaries in relation to the TCJA.

37

(3) Asset retirement obligations are associated with commitments to return the property to its original condition upon lease termination at various sites.

Off-Balance Sheet Arrangements

Bank Guarantees

On November 22, 2013, the Company obtained a $5.0 million credit facility with Citibank in connection with the issuance of bank guarantees for operational purposes. As of June 27, 2020, the outstanding amount under this facility was $3.2 million.

Credit facilities

On February 15, 2019, the Company entered into a Facility Letter and Overdraft Agreement (collectively, the “Facility Agreements”) with MUFG Bank, Ltd., Singapore Branch (the “Bank”). The Facility Agreements provide the Company with an overdraft line of credit facility of up to $150.0 million (the “Overdraft Facility”) for general corporate purposes. Amounts outstanding under the Overdraft Facility, including interest, are payable upon thirty days written demand by the Bank. Interest on the Overdraft Facility is calculated on a daily basis, and the applicable interest rate is calculated at the overnight U.S. Dollar LIBOR rate plus a margin of 1.5% per annum. The Overdraft Facility is an unsecured facility per the terms of the Facility Agreements. The Facility Agreements contain customary non-financial covenants, including, without limitation, covenants that restrict the Company’s ability to sell or dispose of its assets, cease owning at least 51% of one of its subsidiaries (the "Subsidiary") or encumber its assets with material security interests (including any pledge of monies in the Subsidiary’s cash deposit account with the Bank). The Facility Agreements also contain typical events of default, including, without limitation, non-payment of financial obligations when due, cross defaults to other material indebtedness of the Company, and breach of a representation or warranty under the Facility Agreements. As of June 27, 2020, there were no outstanding amounts under the Overdraft Facility, representing a $115.6 million decrease from the quarter ended March 28, 2020.

As of June 27, 2020, we did not have any other off-balance sheet arrangements, such as contingent interests or obligations associated with variable interest entities.

Item 3. - QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Interest Rate Risk

Our available-for-sale securities, if applicable, may consist of short-term investments in highly rated debt instruments of the U.S. Government and its agencies, financial institutions, and corporations. We continually monitor our exposure to changes in interest rates and credit ratings of issuers with respect to any available-for-sale securities and target an average life to maturity of less than 18 months. Accordingly, we believe that the effects on us of changes in interest rates and credit ratings of issuers are limited and would not have a material impact on our financial condition or results of operations.

Foreign Currency Risk

Our international operations are exposed to changes in foreign currency exchange rates due to transactions denominated in currencies other than the location's functional currency. Our international operations are also exposed to foreign currency fluctuations that impact the remeasurement of net monetary assets of those operations whose functional currency, the U.S. dollar, differs from their respective local currencies, most notably in Israel, Singapore and Switzerland. In addition to net monetary remeasurement, we have exposures related to the translation of subsidiary financial statements from their functional currency, the local currency, into its reporting currency, the U.S. dollar, most notably in the Netherlands, China, Taiwan, Japan and Germany. Our U.S. operations also have foreign currency exposure due to net monetary assets denominated in currencies other than the U.S. dollar.

Based on our foreign currency exposure as of June 27, 2020, a 10.0% fluctuation could impact our financial position, results of operations or cash flows by $2.0 to $3.0 million. Our attempts to hedge against these risks may not be successful and may result in a material adverse impact on our financial results and cash flow.

We enter into foreign exchange forward contracts to hedge a portion of our forecasted foreign currency-denominated expenses in the normal course of business and, accordingly, they are not speculative in nature. These instruments generally mature within twelve months. We have foreign exchange forward contracts with a notional amount of $37.4 million outstanding as of June 27, 2020.

38

Item 4. - CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of June 27, 2020. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that, as of June 27, 2020 our disclosure controls and procedures were effective in providing reasonable assurance that the information required to be disclosed by us in reports filed under the Securities Exchange Act of 1934, as amended, is (i) recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms and (ii) accumulated and communicated to our management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding disclosure.

Changes in Internal Control Over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rule 13a-15(f). Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP.

In connection with the evaluation by our management, including with the participation of our Chief Executive Officer and Chief Financial Officer, of our internal control over financial reporting, no changes during the three months ended June 27, 2020 were identified to have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

39

PART II. - OTHER INFORMATION 

Item 1. - LEGAL PROCEEDINGS

From time to time, we may be a plaintiff or defendant in cases arising out of our business. We cannot be assured of the results of any pending or future litigation, but we do not believe resolution of these matters will have a material adverse effect on our business, financial condition or operating results. There are currently no material pending legal proceedings, other than ordinary routine litigation incidental to our business, to which we or any of our subsidiaries is a party or of which any of our property is the subject.

Item 1A. - RISK FACTORS

Certain Risks Related to Our Business

The following risk factor should be considered in conjunction with the other risk factors disclosed under Item 1A. Risk Factors disclosed in Part I of the Annual Report and our Quarterly Reports on Form 10-Q filed thereafter. These factors could materially and adversely affect the company’s business, financial condition or results of operations and cause reputational harm, and should be carefully considered in evaluating the Company and its business, in addition to other information presented elsewhere in this report.

We are subject to export restrictions that may limit our ability to sell to certain customers.

Though the majority of our manufacturing activities take place outside of the U.S., certain of our advanced packaging products are subject to the U.S. Export Administration Regulations (“EAR”) because they are based on U.S. technology or contain more than a de minimis amount of controlled U.S. content. The EAR require licenses for, and sometimes prohibit, the export of certain products. The Commerce Control List (“CCL”) sets forth the types of goods and services controlled by the EAR, including civilian science, technology, and engineering dual use items. For products listed on the CCL, a license may be required as a condition to export depending on the end destination, end use or end user and any applicable license exceptions.

On April 28, 2020, the U.S. Department of Commerce Bureau of Industry and Security (“BIS”) issued two new final rules amending the EAR. Among other things, these rules (i) remove license exceptions regarding certain national security-controlled items for civil end uses in countries that are of national security concern, and (ii) expand license requirements for products with military end uses in China, Russia or Venezuela. We have assessed the potential impact of these new rules, and concluded that they are not expected to have a material impact on our business, financial condition or results of operations.

On May 15, 2020, the BIS amended the EAR to expand controls on certain foreign products based on U.S. technology and sold to Huawei Technologies Co., Ltd. or its affiliates (collectively, “Huawei”) and certain other companies. This amendment impacts some of our advanced packaging products, which are based on U.S. technology and are within the scope of the expanded EAR controls on Huawei. Therefore, these products cannot be sold to Huawei, and are subject to certain end-use restrictions. We do not believe that this amendment to the EAR will have a material direct impact on our business, financial condition or results of operations, but it could have indirect impacts, including increasing tensions in U.S. and Chinese trade relations, potentially leading to negative sentiments towards U.S.-based companies among Chinese consumers. Approximately 46.7% of our net revenue for fiscal 2019 was for shipments to customers located in China. Additionally, some end users may prefer to avoid the U.S. supply chain to avoid the application of these regulations.

Future changes in, and responses to, U.S. trade policy could reduce the competitiveness of our products and cause our sales to decline, and therefore could have a material adverse effect on our business, financial condition or results of operations.

40

Item 2. - UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

The following table summarizes the repurchases of common stock during the three months ended June 27, 2020 (in millions, except number of shares, which are reflected in thousands, and per share amounts):

Period	Total Number of Shares Repurchased	Average Price Paid Per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs (1)
March 29, 2020 to April 25, 2020	495	$	22.06	495	$	62.3
April 26, 2020 to May 30, 2020	304	$	22.32	304	$	55.6
May 31, 2020 to June 27, 2020	205	$	22.68	205	$	50.9
For the three months ended June 27, 2020	1,004			1,004

(1) On August 15, 2017, the Company's Board of Directors authorized a program (the "Program") to repurchase up to $100 million in total of the Company's common stock on or before August 1, 2020. In 2018 and 2019, the Board of Directors increased the share repurchase authorization under the Program to $200 million and $300 million, respectively. On July 3, 2020, the Board of Directors increased the share repurchase authorization under the Company’s existing share repurchase program by an additional $100 million to $400 million, and extended its duration through August 1, 2022. The Company may repurchase shares of its common stock through open market and privately negotiated transactions at prices deemed appropriate by management. The Company has entered into a written trading plan under Rule 10b5-1 of the Exchange Act to facilitate repurchases under the Program. The Program may be suspended or discontinued at any time and will be funded using the Company's available cash, cash equivalents and short-term investments. The timing and amount of repurchase transactions under the Program depend on market conditions as well as corporate and regulatory considerations.

41

Item 6. -     EXHIBITS

Exhibit No.	Description
3.1	The Company's Amended and Restated Articles of Incorporation, dated December 5, 2007, are incorporated herein by reference to Exhibit 3(i) to the Company's Annual Report on Form 10-K for the fiscal year ended September 29, 2007, SEC file number 000-00121.
3.2	The Company's Amended and Restated By-Laws, dated October 22, 2015, are incorporated herein by reference to Exhibit 3(ii) to the Company's Current Report on Form 8-K dated October 22, 2015, SEC file number 000-00121.
31.1	Certification of Fusen Chen, Chief Executive Officer of Kulicke and Soffa Industries, Inc., pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act as adopted pursuant to section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification of Lester Wong, Chief Financial Officer of Kulicke and Soffa Industries, Inc., pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act as adopted pursuant to section 302 of the Sarbanes-Oxley Act of 2002.
32.1*	Certification of Fusen Chen, Chief Executive Officer of Kulicke and Soffa Industries, Inc., pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2*	Certification of Lester Wong, Chief Financial Officer of Kulicke and Soffa Industries, Inc., pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS	Inline XBRL Instance Document.
101.SCH	Inline XBRL Taxonomy Extension Schema Document.
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101.INS).
*	This exhibit shall not be deemed "filed" for purposes of Section 18 of the Exchange Act or otherwise subject to the liability of that Section. Such exhibit shall not be deemed incorporated into any filing under the Securities Act or the Exchange Act.

42

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	KULICKE AND SOFFA INDUSTRIES, INC.
Date: July 30, 2020	By:	/s/ LESTER WONG
		Lester Wong
		Senior Vice President and Chief Financial Officer

43

EXHIBIT INDEX

Exhibit No.	Description
3.1	The Company's Amended and Restated Articles of Incorporation, dated December 5, 2007, are incorporated herein by reference to Exhibit 3(i) to the Company's Annual Report on Form 10-K for the fiscal year ended September 29, 2007, SEC file number 000-00121.
3.2	The Company's Amended and Restated By-Laws, dated October 22, 2015, are incorporated herein by reference to Exhibit 3(ii) to the Company's Current Report on Form 8-K dated October 22, 2015, SEC file number 000-00121.
31.1	Certification of Fusen Chen, Chief Executive Officer of Kulicke and Soffa Industries, Inc., pursuant to Rule 13a-14(a) or Rule15d-14(a) of the Exchange Act as adopted pursuant to section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification of Lester Wong, Chief Financial Officer of Kulicke and Soffa Industries, Inc., pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act as adopted pursuant to section 302 of the Sarbanes-Oxley Act of 2002.
32.1*	Certification of Fusen Chen, Chief Executive Officer of Kulicke and Soffa Industries, Inc., pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2*	Certification of Lester Wong, Chief Financial Officer of Kulicke and Soffa Industries, Inc., pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS	Inline XBRL Instance Document.
101.SCH	Inline XBRL Taxonomy Extension Schema Document.
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101.INS).
*	This exhibit shall not be deemed "filed" for purposes of Section 18 of the Exchange Act or otherwise subject to the liability of that Section. Such exhibit shall not be deemed incorporated into any filing under the Securities Act or the Exchange Act.

44

EX-31.1

Exhibit 31.1

CERTIFICATION

I, Fusen Chen, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Kulicke and Soffa Industries, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: July 30, 2020	By:	/s/ FUSEN CHEN
		Fusen Chen
		President and Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION

I, Lester Wong, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Kulicke and Soffa Industries, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: July 30, 2020	By:	/s/ LESTER WONG
		Lester Wong
		Senior Vice President and Chief Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Fusen Chen, President and Chief Executive Officer of Kulicke and Soffa Industries, Inc., do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

1. the Quarterly Report on Form 10-Q of Kulicke and Soffa Industries, Inc. for the period ended June 27, 2020 (the “June 27, 2020 Form 10-Q”), as filed with the Securities and Exchange Commission, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

2. the information contained in the June 27, 2020 Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Kulicke and Soffa Industries, Inc.

Date: July 30, 2020	By:	/s/ FUSEN CHEN
		Fusen Chen
		President and Chief Executive Officer

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Lester Wong, Senior Vice President and Chief Financial Officer of Kulicke and Soffa Industries, Inc., do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

1. the Quarterly Report on Form 10-Q of Kulicke and Soffa Industries, Inc. for the period ended June 27, 2020 (the “June 27, 2020 Form 10-Q”), as filed with the Securities and Exchange Commission, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

2. the information contained in the June 27, 2020 Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Kulicke and Soffa Industries, Inc.

Date: July 30, 2020	By:	/s/ LESTER WONG
		Lester Wong
		Senior Vice President and Chief Financial Officer

XML

DOCUMENT AND ENTITY INFORMATION - shares	9 Months Ended
	Jun. 27, 2020	Jul. 24, 2020
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	0-121
Entity Registrant Name	KULICKE & SOFFA INDUSTRIES INC
Entity Central Index Key	0000056978
Amendment Flag	false
Entity Incorporation, State or Country Code	PA
Entity Tax Identification Number	23-1498399
Entity Address, Address Line One	23A Serangoon North Avenue 5
Entity Address, Address Line Two	#01-01
Entity Address, Address Line Three	K&S Corporate Headquarters
Entity Address, City or Town	Singapore
Entity Address, Country	SG
Entity Address, Postal Zip Code	554369
City Area Code	215
Local Phone Number	784-6000
Title of 12(b) Security	Common Stock, Without Par Value
Trading Symbol	KLIC
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Current Fiscal Year End Date	--10-03
Entity Filer Category	Large Accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	false
Document Period End Date	Jun. 27, 2020
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2020
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		61,840,109

XML

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands		Jun. 27, 2020	Sep. 28, 2019
Current assets:
Cash and cash equivalents		$ 321,775	$ 364,184
Short-term investments	[1]	194,000	229,000
Accounts and other receivable, net of allowance for doubtful accounts of $1,306 and $597, respectively		195,489	195,830
Inventories, net		114,194	89,308
Prepaid expenses and other current assets		13,735	15,429
Total current assets		839,193	893,751
Property, plant and equipment, net		55,826	72,370
Operating right-of-use assets		22,192	0
Goodwill		56,053	55,691
Intangible assets, net		38,207	42,651
Deferred tax assets		8,515	6,409
Equity investments		7,367	6,250
Other assets		2,112	2,494
TOTAL ASSETS		1,029,465	1,079,616
Current liabilities:
Short-term debt		0	60,904
Accounts payable		49,659	36,711
Less: Current portion		5,471	0
Income tax payable		13,050	12,494
Accrued expenses and other current liabilities		74,624	64,533
Total current liabilities		142,804	174,642
Financing obligation		0	14,207
Deferred tax liabilities		34,508	32,054
Income tax payable		74,307	80,290
Long-term portion of lease obligations		18,124	0
Other liabilities		10,078	9,360
TOTAL LIABILITIES		279,821	310,553
Commitments and contingent liabilities (Note 15)
SHAREHOLDERS' EQUITY:
Preferred stock, without par value: Authorized 5,000 shares; issued - none		0	0
Common stock, without par value: Authorized 200,000 shares; issued 85,364 and 85,364, respectively; outstanding 61,925 and 63,172 shares, respectively		536,487	533,590
Treasury stock, at cost, 23,439 and 22,192 shares, respectively		(387,302)	(349,212)
Retained earnings		607,733	594,625
Accumulated other comprehensive loss		(7,274)	(9,940)
TOTAL SHAREHOLDERS' EQUITY		749,644	769,063
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY		$ 1,029,465	$ 1,079,616

[1] All short-term investments were classified as available-for-sale and were measured at fair value based on level one measurement, or quoted market prices, as defined by ASC 820. The Company did not recognize any realized gains or losses on the sale of investments during the three and nine months ended June 27, 2020 and June 29, 2019.

XML

CONSOLIDATED CONDENSED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Jun. 27, 2020	Sep. 28, 2019
Consolidated Balance Sheets Parenthetical [Abstract]
Allowance for doubtful accounts and notes receivable	$ 1,306	$ 597
Preferred stock, without par value (usd per share)	$ 0	$ 0
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Common stock, no par value (usd per share)	$ 0	$ 0
Common stock, shares authorized	200,000,000	200,000,000
Common stock, shares issued	85,364,000	85,364,000
Common stock, shares outstanding	61,925,000	63,172,000
Treasury stock, shares	23,439,000	22,192,000

XML

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Jun. 27, 2020	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019
Revenues	$ 150,450	$ 127,109	$ 445,488	$ 400,225
Cost of sales	81,027	68,329	236,398	211,073
Gross profit	69,423	58,780	209,090	189,152
Selling, general and administrative	27,905	28,724	85,723	87,626
Research and development	30,547	28,229	87,906	87,609
Operating expenses	58,452	56,953	173,629	175,235
Income from operations	10,971	1,827	35,461	13,917
Interest income	1,374	3,956	6,888	11,647
Interest expense	(446)	(632)	(1,690)	(1,137)
Income before income taxes	11,899	5,151	40,659	24,427
Provision for income taxes	690	3,864	3,985	19,106
Share of results of equity-method investee, net of tax	58	0	158	72
Net income	$ 11,151	$ 1,287	$ 36,516	$ 5,249
Net income per share:
Basic (in dollars per share)	$ 0.18	$ 0.02	$ 0.58	$ 0.08
Diluted (in dollars per share)	$ 0.18	$ 0.02	$ 0.57	$ 0.08
Weighted average shares outstanding:
Basic (in shares)	62,313	64,683	63,200	65,914
Diluted (in shares)	62,833	65,431	63,755	66,597

XML

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jun. 27, 2020	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019
Statement of Comprehensive Income [Abstract]
Net income	$ 11,151	$ 1,287	$ 36,516	$ 5,249
Other comprehensive income/(loss):
Foreign currency translation adjustment	745	(42)	2,424	(1,430)
Unrecognized actuarial loss on pension plan, net of tax	(5)	(31)	(71)	(9)
Foreign currency translation and pension plan, net of tax	740	(73)	2,353	(1,439)
Derivatives designated as hedging instruments:
Unrealized gain/(loss) on derivative instruments, net of tax	1,034	(49)	(340)	39
Reclassification adjustment for gain on derivative instruments recognized, net of tax	384	33	653	1,165
Net increase/(decrease) from derivatives designated as hedging instruments, net of tax	1,418	(16)	313	1,204
Total other comprehensive gain/(loss)	2,158	(89)	2,666	(235)
Comprehensive income	$ 13,309	$ 1,198	$ 39,182	$ 5,014

XML

CONSOLIDATED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Treasury Stock	Retained Earnings	Accumulated Other Comprehensive Loss
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cumulative effect of accounting changes	$ 534			$ 534
Beginning balance at Sep. 29, 2018	880,207	$ 519,244	$ (248,664)	613,529	$ (3,902)
Beginning balance (shares) at Sep. 29, 2018		67,143
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of stock for services rendered (shares)		8
Issuance of stock for services rendered	195	$ 195
Repurchase of common stock (shares)		(1,233)
Repurchase of common stock	(25,485)		(25,485)
Issuance of shares for market-based restricted stock and time-based restricted stock (shares)		642
Issuance of shares for equity-based compensation	0
Equity-based compensation	3,678	$ 3,678
Cash dividend declared	(8,055)			(8,055)
Net income	7,517			7,517
Other comprehensive income	(182)				(182)
Total comprehensive income	7,335			7,517	(182)
Ending balance (shares) at Dec. 29, 2018		66,560
Ending balance at Dec. 29, 2018	858,409	$ 523,117	(274,149)	613,525	(4,084)
Beginning balance at Sep. 29, 2018	880,207	$ 519,244	(248,664)	613,529	(3,902)
Beginning balance (shares) at Sep. 29, 2018		67,143
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	5,249
Other comprehensive income	(235)
Total comprehensive income	5,014
Ending balance (shares) at Jun. 29, 2019		63,837
Ending balance at Jun. 29, 2019	787,435	$ 530,016	(334,248)	595,803	(4,136)
Beginning balance at Dec. 29, 2018	858,409	$ 523,117	(274,149)	613,525	(4,084)
Beginning balance (shares) at Dec. 29, 2018		66,560
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of stock for services rendered (shares)		10
Issuance of stock for services rendered	195	$ 195
Repurchase of common stock (shares)		(1,225)
Repurchase of common stock	(26,922)		(26,922)
Issuance of shares for market-based restricted stock and time-based restricted stock (shares)		4
Issuance of shares for equity-based compensation	0
Equity-based compensation	3,107	$ 3,107
Cash dividend declared	(8,057)			(8,057)
Net income	(3,555)			(3,555)
Other comprehensive income	37				37
Total comprehensive income	(3,518)			(3,555)	37
Ending balance (shares) at Mar. 30, 2019		65,349
Ending balance at Mar. 30, 2019	823,214	$ 526,419	(301,071)	601,913	(4,047)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of stock for services rendered (shares)		10
Issuance of stock for services rendered	222	$ 222
Repurchase of common stock (shares)		(1,538)
Repurchase of common stock	(33,177)		(33,177)
Issuance of shares for market-based restricted stock and time-based restricted stock (shares)		16
Issuance of shares for equity-based compensation	0
Equity-based compensation	3,375	$ 3,375
Cash dividend declared				(7,397)
Net income	1,287			1,287
Other comprehensive income	(89)				(89)
Total comprehensive income	1,198			1,287	(89)
Ending balance (shares) at Jun. 29, 2019		63,837
Ending balance at Jun. 29, 2019	787,435	$ 530,016	(334,248)	595,803	(4,136)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cumulative effect of accounting changes	(769)			(769)
Beginning balance at Sep. 28, 2019	769,063	$ 533,590	(349,212)	594,625	(9,940)
Beginning balance (shares) at Sep. 28, 2019		63,173
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of stock for services rendered (shares)		9
Issuance of stock for services rendered	222	$ 131	91
Repurchase of common stock (shares)		(224)
Repurchase of common stock	(5,369)		(5,369)
Issuance of shares for market-based restricted stock and time-based restricted stock (shares)		800
Stock Issued During Period, Value, Treasury Stock Reissued		$ (7,653)	7,653
Issuance of shares for equity-based compensation	0
Equity-based compensation	3,387	$ 3,387
Cash dividend declared	(7,651)			(7,651)
Net income	13,477			13,477
Other comprehensive income	3,293				3,293
Total comprehensive income	16,770			13,477	3,293
Ending balance (shares) at Dec. 28, 2019		63,758
Ending balance at Dec. 28, 2019	775,653	$ 529,455	(346,837)	599,682	(6,647)
Beginning balance at Sep. 28, 2019	$ 769,063	$ 533,590	(349,212)	594,625	(9,940)
Beginning balance (shares) at Sep. 28, 2019		63,173
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchase of common stock (shares)	(2,100)
Repurchase of common stock	$ (46,200)
Net income	36,516
Other comprehensive income	2,666
Total comprehensive income	39,182
Ending balance (shares) at Jun. 27, 2020		61,925
Ending balance at Jun. 27, 2020	749,644	$ 536,487	(387,302)	607,733	(7,274)
Beginning balance at Dec. 28, 2019	775,653	$ 529,455	(346,837)	599,682	(6,647)
Beginning balance (shares) at Dec. 28, 2019		63,758
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of stock for services rendered (shares)		8
Issuance of stock for services rendered	221	$ 142	79
Repurchase of common stock (shares)		(872)
Repurchase of common stock	(18,522)		(18,522)
Issuance of shares for market-based restricted stock and time-based restricted stock (shares)		19
Stock Issued During Period, Value, Treasury Stock Reissued		$ (185)	185
Issuance of shares for equity-based compensation	0
Equity-based compensation	3,500	$ 3,500
Cash dividend declared	(7,557)			(7,557)
Net income	11,888			11,888
Other comprehensive income	(2,785)				(2,785)
Total comprehensive income	9,103			11,888	(2,785)
Ending balance (shares) at Mar. 28, 2020		62,913
Ending balance at Mar. 28, 2020	762,398	$ 532,912	(365,095)	604,013	(9,432)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of stock for services rendered (shares)		9
Issuance of stock for services rendered	$ 186	$ 102	84
Repurchase of common stock (shares)	(1,000)	(1,004)
Repurchase of common stock	$ (22,358)		(22,358)
Issuance of shares for market-based restricted stock and time-based restricted stock (shares)		7
Stock Issued During Period, Value, Treasury Stock Reissued		$ (67)	67
Issuance of shares for equity-based compensation	0
Equity-based compensation	3,540	$ 3,540
Cash dividend declared	(7,431)			(7,431)
Net income	11,151			11,151
Other comprehensive income	2,158				2,158
Total comprehensive income	13,309			11,151	2,158
Ending balance (shares) at Jun. 27, 2020		61,925
Ending balance at Jun. 27, 2020	$ 749,644	$ 536,487	$ (387,302)	$ 607,733	$ (7,274)

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Jun. 27, 2020	Jun. 29, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 36,516	$ 5,249
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	14,597	15,001
Equity-based compensation and employee benefits	11,056	10,772
Adjustment for doubtful accounts	709	(385)
Adjustment for inventory valuation	3,197	2,059
Deferred income taxes	360	2,450
Loss/(gain) on disposal of property, plant and equipment	860	(19)
Unrealized foreign currency translation	909	117
Share of results of equity-method investee	158	72
Changes in operating assets and liabilities:
Accounts and other receivable	(122)	92,696
Inventories	(28,013)	15,960
Prepaid expenses and other current assets	1,697	(10,623)
Accounts payable, accrued expenses and other current liabilities	25,903	(48,148)
Income tax payable	(5,428)	(3,655)
Other, net	282	1,635
Net cash provided by operating activities	62,681	83,181
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property, plant and equipment	(7,849)	(9,665)
Proceeds from sales of property, plant and equipment	0	39
Purchase of equity investments	(1,288)	(5,000)
Purchase of short-term investments	(234,000)	(489,000)
Maturity of short-term investments	269,000	534,000
Net cash provided by investing activities	25,863	30,374
CASH FLOWS FROM FINANCING ACTIVITIES:
Payment on debts	(147,143)	(574)
Payment for finance lease	(67)	0
Repurchase of common stock	(46,851)	(85,469)
Common stock cash dividends paid	(22,796)	(23,902)
Proceeds from short-term debt	86,239	71,194
Net cash used in financing activities	(130,618)	(38,751)
Effect of exchange rate changes on cash and cash equivalents	(335)	60
Changes in cash, cash equivalents and restricted cash	(42,409)	74,864
Cash, cash equivalents and restricted cash at beginning of period	364,184	321,148
Cash, cash equivalents and restricted cash at end of period	321,775	396,012
CASH PAID FOR:
Interest Paid, Excluding Capitalized Interest, Operating Activities	1,690	747
Income taxes, net of refunds	$ 10,088	$ 21,373

XML

BASIS OF PRESENTATION

9 Months Ended

Jun. 27, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

BASIS OF PRESENTATION

BASIS OF PRESENTATION

These consolidated condensed financial statements include the accounts of Kulicke and Soffa Industries, Inc. and its subsidiaries (the “Company”), with appropriate elimination of intercompany balances and transactions.

The interim consolidated condensed financial statements are unaudited and, in management's opinion, include all adjustments (consisting only of normal and recurring adjustments) necessary for a fair statement of results for these interim periods. The interim consolidated condensed financial statements do not include all of the information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and should be read in conjunction with the consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended September 28, 2019, filed with the Securities and Exchange Commission, which includes Consolidated Balance Sheets as of September 28, 2019 and September 29, 2018, and the related Consolidated Statements of Operations, Statements of Other Comprehensive Income, Changes in Shareholders' Equity and Cash Flows for each of the years in the three-year period ended September 28, 2019. The results of operations for any interim period are not necessarily indicative of the results of operations for any other interim period or for a full year.

Fiscal Year    

Each of the Company's first three fiscal quarters end on the Saturday that is 13 weeks after the end of the immediately preceding fiscal quarter. The fourth quarter of each fiscal year ends on the Saturday closest to September 30. Fiscal 2020 quarters end on December 28, 2019, March 28, 2020, June 27, 2020 and October 3, 2020. In fiscal years consisting of 53 weeks, the fourth quarter will consist of 14 weeks. Fiscal 2019 quarters ended on December 29, 2018, March 30, 2019, June 29, 2019 and September 28, 2019.

Nature of Business

The Company designs, manufactures and sells capital equipment and tools as well as services, maintains, repairs and upgrades equipment, all used to assemble semiconductor devices. The Company's operating results depend upon the capital and operating expenditures of semiconductor device manufacturers, integrated device manufacturers, outsourced semiconductor assembly and test providers (“OSATs”), and other electronics manufacturers including automotive electronics suppliers, worldwide which, in turn, depend on the current and anticipated market demand for semiconductors and products utilizing semiconductors. The semiconductor industry is highly volatile and experiences downturns and slowdowns which can have a severe negative effect on the semiconductor industry's demand for semiconductor capital equipment, including assembly equipment manufactured and sold by the Company and, to a lesser extent, tools, including those sold by the Company. These downturns and slowdowns have in the past adversely affected the Company's operating results. The Company believes such volatility will continue to characterize the industry and the Company's operations in the future.

Use of Estimates

The preparation of consolidated condensed financial statements requires management to make assumptions, estimates and judgments that affect the reported amounts of assets and liabilities, net revenue and expenses during the reporting periods, and disclosures of contingent assets and liabilities as of the date of the consolidated condensed financial statements. On an ongoing basis, management evaluates estimates, including but not limited to, those related to accounts receivable, reserves for excess and obsolete inventory, carrying value and lives of fixed assets, goodwill and intangible assets, the valuation estimates and assessment of impairment and observable price adjustments, income taxes, equity-based compensation expense, and warranties. Management bases its estimates on historical experience and on various other assumptions believed to be reasonable. As a result, management makes judgments regarding the carrying values of the Company's assets and liabilities that are not readily apparent from other sources. Authoritative pronouncements, historical experience and assumptions also are used as the basis for making estimates, and on an ongoing basis, management evaluates these estimates. Actual results may differ from these estimates.

Due to the Coronavirus (“COVID-19”) pandemic, there has been uncertainty and disruption in the global economy and financial markets. The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of June 27, 2020. While there was not a material impact to our consolidated financial statements as of and for the quarter ended June 27, 2020, these estimates may change, as new events occur and additional information is obtained, as well as other factors related to COVID-19 that could result in material impacts to our consolidated financial statements in future reporting periods.

Vulnerability to Certain Concentrations

Financial instruments which may subject the Company to concentrations of credit risk as of June 27, 2020 and September 28, 2019 consisted primarily of trade receivables. The Company manages credit risk associated with investments by investing its excess cash in highly rated debt instruments of the U.S. government and its agencies, financial institutions, and corporations. The Company has established investment guidelines relative to diversification and maturities designed to maintain safety and liquidity. These guidelines are periodically reviewed and modified as appropriate. The Company does not have any exposure to sub-prime financial instruments or auction rate securities.

The Company's trade receivables result primarily from the sale of semiconductor equipment, related accessories and replacement parts, and tools to a relatively small number of large manufacturers in a highly concentrated industry. Write-offs of uncollectible accounts have historically not been significant. The Company actively monitors its customers' financial strength to reduce the risk of loss, including as a result of COVID-19.

The Company's products are complex and require raw materials, components and subassemblies having a high degree of reliability, accuracy and performance. The Company relies on subcontractors to manufacture many of these components and subassemblies and it relies on sole source suppliers for some important components and raw material inventory.

Foreign Currency Translation and Remeasurement

The majority of the Company's business is transacted in U.S. dollars; however, the functional currencies of some of the Company's subsidiaries are their local currencies. In accordance with ASC No. 830, Foreign Currency Matters (“ASC 830”), for a subsidiary of the Company that has a functional currency other than the U.S. dollar, gains and losses resulting from the translation of the functional currency into U.S. dollars for financial statement presentation are not included in determining net income, but are accumulated in the cumulative translation adjustment account as a separate component of shareholders' equity (accumulated other comprehensive income). The tax effect of currency translation adjustments related to unremitted foreign earnings no longer deemed to be indefinitely reinvested outside the U.S. is reflected in the determination of the Company’s net income or other comprehensive income (“OCI”). Gains and losses resulting from foreign currency transactions are included in the determination of net income.

The Company's operations are exposed to changes in foreign currency exchange rates due to transactions denominated in currencies other than the location's functional currency. The Company is also exposed to foreign currency fluctuations that impact the remeasurement of net monetary assets of those operations whose functional currency, the U.S. dollar, differs from their respective local currencies, most notably in Israel, Singapore and Switzerland. In addition to net monetary remeasurement, the Company has exposures related to the translation of subsidiary financial statements from their functional currency, the local currency, into its reporting currency, the U.S. dollar, most notably in the Netherlands, China, Taiwan, Japan and Germany. The Company's U.S. operations also have foreign currency exposure due to net monetary assets denominated in currencies other than the U.S. dollar.

Derivative Financial Instruments

The Company’s primary objective for holding derivative financial instruments is to manage the fluctuation in foreign exchange rates and accordingly is not speculative in nature. The Company’s international operations are exposed to changes in foreign exchange rates as described above. The Company has established a program to monitor the forecasted transaction currency risk to protect against foreign exchange rate volatility. Generally, the Company uses foreign exchange forward contracts in these hedging programs. These instruments, which have maturities of up to twelve months, are recorded at fair value and are included in prepaid expenses and other current assets, or accrued expenses and other current liabilities.

Our accounting policy for derivative financial instruments is based on whether they meet the criteria for designation as a cash flow hedge. A designated hedge with exposure to variability in the functional currency equivalent of the future foreign currency cash flows of a forecasted transaction is referred to as a cash flow hedge. The criteria for designating a derivative as a cash flow hedge include the assessment of the instrument’s effectiveness in risk reduction, matching of the derivative instrument to its underlying transaction, and the assessment of the probability that the underlying transaction will occur. For derivatives with cash flow hedge accounting designation, we report the after-tax gain / (loss) from the effective portion of the hedge as a component of accumulated other comprehensive income / (loss) and reclassify it into earnings in the same period in which the hedged transaction affects earnings and in the same line item on the Consolidated Condensed Statement of Operations as the impact of the hedged transaction. Derivatives that we designate as cash flow hedges are classified in the Consolidated Condensed Statement of Cash Flows in the same section as the underlying item, primarily within cash flows from operating activities.

The hedge effectiveness of these derivative instruments is evaluated by comparing the cumulative change in the fair value of the hedge contract with the cumulative change in the fair value of the forecasted cash flows of the hedged item.

If a cash flow hedge is discontinued because it is no longer probable that the original hedged transaction will occur as previously anticipated, the cumulative unrealized gain or loss on the related derivative is reclassified from accumulated other comprehensive income / (loss) into earnings. Subsequent gain / (loss) on the related derivative instrument is recognized into earnings in each period until the instrument matures, is terminated, is re-designated as a qualified cash flow hedge, or is sold. Ineffective portions of cash flow hedges, as well as amounts excluded from the assessment of effectiveness, are recognized in earnings.

Cash Equivalents

The Company considers all highly liquid investments with original maturities of three months or less when purchased to be cash equivalents. Cash equivalents are measured at fair value based on level one measurement, or quoted market prices, as defined by ASC No. 820, Fair Value Measurements and Disclosures.

Equity Investments

The Company invests in equity securities in companies to promote business and strategic objectives. Equity investments are measured and recorded as follows:

• Equity method investments are equity securities in investees that provide the Company with the ability to exercise significant influence in which it lacks a controlling financial interest. Our proportionate share of the income or loss is recognized on a one-quarter lag and is recorded as share of results of equity-method investee, net of tax.

• Non-marketable equity securities are equity securities without readily determinable fair value that are measured and recorded using a measurement alternative that measures the securities at cost minus impairment, if any, plus or minus changes resulting from qualifying observable price changes.

Allowance for Doubtful Accounts

The Company maintains allowances for doubtful accounts for estimated losses resulting from its customers' failure to make required payments. If the financial condition of the Company's customers were to deteriorate, resulting in an impairment of their ability to make payments, including as a result of COVID-19, additional allowances may be required. If global or regional economic conditions deteriorate or political conditions were to change in some of the countries where the Company does business, including as a result of COVID-19, it could have a significant impact on the results of operations, and the Company's ability to realize the full value of its accounts receivable.

Inventories

Inventories are stated at the lower of cost (on a first-in first-out basis) or net realizable value. The Company generally provides reserves for obsolete inventory and for inventory considered to be in excess of demand. Demand is generally defined as 18 months forecasted future consumption for equipment, 24 months forecasted future consumption for spare parts, and 12 months forecasted future consumption for tools. Forecasted consumption is based upon internal projections, historical sales volumes, customer order activity and a review of consumable inventory levels at customers' facilities. The Company communicates forecasts of its future consumption to its suppliers and adjusts commitments to those suppliers accordingly. If required, the Company reserves the difference between the carrying value of its inventory and the lower of cost or net realizable value, based upon projections about future consumption, and market conditions. If actual market conditions are less favorable than projections, additional inventory reserves may be required.

Inventory reserve provision for certain subsidiaries is determined based on management's estimate of future consumption for equipment and spare parts. This estimate is based on historical sales volumes, internal projections and market developments and trends.

Property, Plant and Equipment

Property, plant and equipment are carried at cost. The cost of additions and those improvements which increase the capacity or lengthen the useful lives of assets are capitalized, while repair and maintenance costs are expensed as incurred. Depreciation and amortization are provided on a straight-line basis over the estimated useful lives as follows: buildings 25 years; machinery, equipment, furniture and fittings 3 to 10 years; toolings 1 year; and leasehold improvements are based on the shorter of the life of lease or life of asset. Purchased computer software costs related to business and financial systems are amortized over a five-year period on a straight-line basis. Land is not depreciated.

Valuation of Long-Lived Assets

In accordance with ASC No. 360, Property, Plant & Equipment ("ASC 360"), the Company's property, plant and equipment is tested for impairment based on undiscounted cash flows when triggering events occur, and if impaired, written-down to fair value

based on either discounted cash flows or appraised values. ASC 360 also provides a single accounting model for long-lived assets to be disposed of by sale and establishes additional criteria that would have to be met to classify an asset as held for sale. The carrying amount of an asset or asset group is not recoverable to the extent it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset or asset group. Estimates of future cash flows used to test the recoverability of a long-lived asset or asset group must incorporate the entity's own assumptions about its use of the asset or asset group and must factor in all available evidence.

ASC 360 requires that long-lived assets be tested for recoverability whenever events or changes in circumstances indicate that their carrying amount may not be recoverable. Such events include significant under-performance relative to historical internal forecasts or projected future operating results; significant changes in the manner of use of the assets; significant negative industry or economic trends; or significant changes in market capitalization. During the three and nine months ended June 27, 2020, no "triggering" events occurred.

Accounting for Impairment of Goodwill

ASC No. 350, Intangibles-Goodwill and Other ("ASC 350") requires goodwill and other intangible assets with indefinite lives to be reviewed for impairment annually, or more frequently if circumstances indicate a possible impairment. We assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. If, after assessing the qualitative factors, a company determines that it is not more likely than not that the fair value of a reporting unit is less than its carrying value, then performing the impairment test is unnecessary. However, if a company concludes otherwise, then it is required to perform the goodwill impairment test. Following the Company's early adoption of ASU 2017-04, Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment in the third quarter of fiscal 2017, the requirement to perform a hypothetical purchase price allocation to measure goodwill impairment (i.e. step 2 of the goodwill impairment test) was eliminated. Accordingly, the Company's impairment test is performed by comparing the fair value of a reporting unit with its carrying value, and determining if the carrying amount exceeds its fair value.

As part of the annual evaluation, the Company performs an impairment test of its goodwill in the fourth quarter of each fiscal year to coincide with the completion of its annual forecasting and refreshing of its business outlook processes. On an ongoing basis, the Company monitors if a “triggering” event has occurred that may have the effect of reducing the fair value of a reporting unit below its respective carrying value. Adverse changes in expected operating results and/or unfavorable changes in other economic factors used to estimate fair values could result in a non-cash impairment charge in the future.

Impairment assessments inherently involve judgment as to the assumptions made about the expected future cash flows and the impact of market conditions on those assumptions. Future events and changing market conditions may impact the assumptions as to prices, costs, growth rates or other factors that may result in changes in the estimates of future cash flows. Although the Company believes the assumptions that it has used in testing for impairment are reasonable, significant changes in any one of the assumptions could produce a significantly different result. Indicators of potential impairment may lead the Company to perform interim goodwill impairment assessments, including significant and unforeseen customer losses, a significant adverse change in legal factors or in the business climate, a significant adverse action or assessment by a regulator, a significant stock price decline or unanticipated competition.

For further information on goodwill and other intangible assets, see Note 3 below.

Revenue Recognition

In accordance with ASC No. 606, Revenue from Contracts with Customers, the Company recognizes revenue when we satisfy performance obligations as evidenced by the transfer of control of our products or services to customers. In general, the Company generates revenue from product sales, either directly to customers or to distributors. In determining whether a contract exists, we evaluate the terms of the agreement, the relationship with the customer or distributor and their ability to pay.

The Company recognizes revenue from sales of our products, including sales to our distributors, at a point in time, generally upon shipment or delivery to the customer or distributor, depending upon the terms of the sales order. Control is considered transferred when title and risk of loss pass, when the customer becomes obligated to pay and, where applicable, when the customer has accepted the products or upon expiration of the acceptance period. For sales to distributors, payment is due on our standard commercial terms and is not contingent upon resale of the products.

Our business is subject to contingencies related to customer orders, including:

• Right of Return: A large portion of our revenue comes from the sale of equipment used in the semiconductor assembly process. Other product sales relate to consumable products, which are sold in high-volume quantities, and are generally

maintained at low stock levels at customer's facility. Customer returns have historically represented a very small percentage of customer sales on an annual basis.

• Warranties: Our equipment is generally shipped with a one-year warranty against manufacturing defects. We establish reserves for estimated warranty expense when revenue for the related equipment is recognized. The reserve for estimated warranty expense is based upon historical experience and management's estimate of future expenses, including product parts replacement, freight charges and labor costs expected to be incurred to correct product failures during the warranty period.

• Conditions of Acceptance: Sales of our consumable products generally do not have customer acceptance terms. In certain cases, sales of our equipment have customer acceptance clauses which may require the equipment to perform in accordance with customer specifications or when installed at the customer's facility. In such cases, if the terms of acceptance are satisfied at our facility prior to shipment, the revenue for the equipment will be recognized upon shipment. If the terms of acceptance are satisfied at our customers' facilities, the revenue for the equipment will not be recognized until acceptance, which is typically obtained after installation and testing, is received from the customer.

Service revenue is generally recognized over time as the services are performed. For the three and nine months ended June 27, 2020, and June 29, 2019, the service revenue is not material.

The Company measures revenue based on the amount of consideration we expect to be entitled to in exchange for products or services. Any variable consideration such as sales incentives are recognized as a reduction of net revenue at the time of revenue recognition.

The length of time between invoicing and payment is not significant under our payment terms. In instances where the timing of revenue recognition differs from the timing of invoicing, we have determined our contracts generally do not include a significant financing component.

Shipping and handling costs billed to customers are recognized in net revenue. Shipping and handling costs paid by the Company are included in cost of sales.

Research and Development

The Company charges research and development costs associated with the development of new products to expense when incurred. In certain circumstances, pre-production machines that the Company intends to sell are carried as inventory until sold.

Income Taxes

In accordance with ASC No. 740, Income Taxes, deferred income taxes are determined using the balance sheet method. The Company records a valuation allowance to reduce its deferred tax assets to the amount expected, on a more likely than not basis, to be realized. While the Company has considered future taxable income and ongoing tax planning strategies in assessing the need for the valuation allowance, if it were to determine that it would be able to realize its deferred tax assets in the future in excess of its net recorded amount, an adjustment to deferred tax assets would increase income in the period when such determination is made. Likewise, should the Company determine it would not be able to realize all or part of its deferred tax assets in the future, an adjustment to deferred tax assets would decrease income in the period when such determination is made.

The Company determines the amount of unrecognized tax benefit with respect to uncertain tax positions taken or expected to be

taken on its income tax returns in accordance with ASC No. 740 Topic 10, Income Taxes, General (“ASC 740.10”). Under ASC 740.10, the Company utilizes a two-step approach for evaluating uncertain tax positions. Step one, or recognition, requires a company to determine if the weight of available evidence indicates a tax position is more likely than not to be sustained upon examination solely based on its technical merit. Step two, or measurement, is based on the largest amount of benefit, which is more likely than not to be realized on settlement with the taxing authority, including resolution of related appeals or litigation processes, if any.

Equity-Based Compensation

The Company accounts for equity-based compensation under the provisions of ASC No. 718, Compensation - Stock Compensation (“ASC 718”). ASC 718 requires the recognition of the fair value of the equity-based compensation in net income. Compensation expense associated with Relative TSR Performance Share Units is determined using a Monte-Carlo valuation model, and compensation expense associated with time-based and Special/Growth Performance Share Units is determined based on the number of shares granted and the fair value on the date of grant. See Note 10 for a summary of the terms of these performance-based awards. The fair value of the Company's stock option awards is estimated using a Black-Scholes option valuation model. The fair

value of equity-based awards is amortized over the vesting period of the award and the Company elected to use the straight-line method for awards granted after the adoption of ASC 718.

Earnings per Share

Earnings per share (“EPS”) are calculated in accordance with ASC No. 260, Earnings per Share. Basic EPS include only the weighted average number of common shares outstanding during the period. Diluted EPS include the weighted average number of common shares and the dilutive effect of stock options, restricted stock awards, performance share units and restricted share units outstanding during the period, when such instruments are dilutive.

Accounting for Business Acquisitions

The Company accounts for business acquisitions in accordance with ASC No. 805, Business Combinations. The fair value of the net assets acquired and the results of operations of the acquired businesses are included in the Unaudited Consolidated Condensed Financial Statements from the acquisition date forward. The Company is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and results of operations during the reporting period. Estimates are used in accounting for, among other things, the fair value of acquired net operating assets, property, plant and equipment, deferred revenue, intangible assets and related deferred income taxes, useful lives of property, plant and equipment, and amortizable lives of acquired intangible assets. Any excess of the purchase consideration over the identified fair value of the assets and liabilities acquired is recognized as goodwill. The valuation of these tangible and identifiable intangible assets and liabilities is subject to further management review and may change materially between the preliminary allocation and end of the purchase price allocation period.

Restructuring Charges

Restructuring charges may consist of voluntary or involuntary severance-related charges, asset-related charges and other costs due to exit activities. We recognize voluntary termination benefits when an employee accepts the offered benefit arrangement. We recognize involuntary severance-related charges depending on whether the termination benefits are provided under an ongoing benefit arrangement or under a one-time benefit arrangement. If the former, we recognize the charges once they are probable and the amounts are estimable. If the latter, we recognize the charges once the benefits have been communicated to employees.

Recent Accounting Pronouncements

Leases

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which requires the recognition of lease assets and lease liabilities by lessees for those leases classified as operating leases under current GAAP.

Subsequently in July 2018, the FASB issued ASU 2018-11, Leases (Topic 842): Targeted Improvements, which provides additional information concerning the new leases standard in ASU 2016-02, Leases (Topic 842). The targeted improvements provide entities with additional and optional transition methods.

In November 2018, the FASB issued ASU 2018-20, Leases (Topic 842): Narrow-Scope Improvements for Lessors. This ASU provides guidance in several areas, including the accounting policy election for sales taxes and other similar taxes collected from lessees, accounting for certain lessor costs and accounting for variable payments for contracts with lease and nonlease components.

We adopted these ASUs utilizing the modified retrospective transition method through a cumulative-effect adjustment at the beginning of the first quarter of fiscal 2020. In addition, we elected the package of practical expedients permitted under the transition guidance that allowed us to apply prior conclusions related to lease definition, classification and initial direct costs. Additionally, the lease previously identified as build-to-suit leasing arrangement under legacy lease accounting (ASC 840), was derecognized pursuant to the transition guidance provided for build-to-suit leases in ASC 842 (see Note 9 below). Accordingly, the lease has been reassessed as an operating lease as of the adoption date under ASC 842, and is included on the Consolidated Condensed Balance Sheets. The adoption of these ASUs has resulted in an increase of approximately $23.8 million in operating lease liabilities and $22.2 million in right-of-use assets, decrease of approximately $14.5 million in financing obligation, decrease of approximately $15.3 million in property, plant and equipment, and an adjustment of $0.8 million to retained earnings after income tax effects on our Consolidated Condensed Balance Sheets.

Financial Instruments

In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. This ASU replaces the impairment methodology in current GAAP, which delays recognition of credit losses until it is probable a loss has been incurred, with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. This ASU will be effective for us

beginning in our first quarter of fiscal 2021. We are currently evaluating the impact of the adoption of this ASU on our consolidated condensed financial statements.

Derivatives and Hedging

In August 2017, the FASB issued ASU 2017-12, Targeted Improvements to Accounting for Hedging Activities (Topic 815). The new guidance expands and refines hedge accounting for both financial and non-financial risks. The new guidance also modifies disclosure requirements for hedging activities. We adopted this ASU as of the beginning of the first quarter of 2020. The adoption of this ASU did not have a material impact on our consolidated condensed financial statements.

Collaborative Arrangements

In November 2018, the FASB issued ASU 2018-18, Collaborative Arrangements (Topic 808). This ASU clarifies that certain transactions between collaborative arrangement participants should be accounted for as revenue when the collaborative arrangement participant is a customer in the context of a unit of account and precludes recognizing as revenue consideration received from a collaborative arrangement participant if the participant is not a customer. This ASU will be effective for us in the first quarter of 2021 with early adoption permitted. This ASU requires retrospective adoption to the date we adopted ASC 606 by recognizing a cumulative-effect adjustment to the opening balance of retained earnings of the earliest annual period presented. We are currently evaluating the timing and the effects of the adoption of this ASU on our consolidated condensed financial statements.

Income Taxes

In February 2018, the FASB issued ASU 2018-02, Income Statement - Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects From Accumulated Other Comprehensive Income, which allows for a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the U.S. Tax Cuts and Jobs Act (the “TCJA”) and requires entities to provide certain disclosures regarding these stranded tax effects, if any. We adopted this ASU in the first quarter of 2020. The adoption did not have a material impact on our consolidated condensed financial statements.

In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740). The amendments in this ASU simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740 and clarify and amend existing guidance. This ASU will be effective for us in the first quarter of 2022 with early adoption permitted. We are currently evaluating the timing and the effects of the adoption of this ASU on our consolidated condensed financial statements.

XML

BALANCE SHEET COMPONENTS

9 Months Ended

Jun. 27, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

BALANCE SHEET COMPONENTS

BALANCE SHEET COMPONENTS

The following tables reflect the components of significant balance sheet accounts as of June 27, 2020 and September 28, 2019:

	As of
(in thousands)	June 27, 2020			September 28, 2019
Short-term investments, available-for-sale(1)	$	194,000		$	229,000
Inventories, net:
Raw materials and supplies	$	63,878		$	52,853
Work in process	41,757			32,026
Finished goods	39,663			33,742
	145,298			118,621
Inventory reserves	(31,104		)	(29,313		)
	$	114,194		$	89,308
Property, plant and equipment, net:
Land	$	2,182		$	2,182
Buildings and building improvements	22,542			41,961
Leasehold improvements	22,812			24,441
Data processing equipment and software	37,760			36,302
Machinery, equipment, furniture and fixtures	76,589			71,465
Construction in progress	6,578			6,512
	168,463			182,863
Accumulated depreciation	(112,637		)	(110,493		)
	$	55,826		$	72,370
Accrued expenses and other current liabilities:
Accrued customer obligations (2)	$	25,322		$	26,292
Wages and benefits	31,074			18,188
Dividend payable	7,431			7,582
Commissions and professional fees	2,486			2,024
Deferred rent	—			1,721
Severance	494			1,500
Other	7,817			7,226
	$	74,624		$	64,533

(1) All short-term investments were classified as available-for-sale and were measured at fair value based on level one measurement, or quoted market prices, as defined by ASC 820. The Company did not recognize any realized gains or losses on the sale of investments during the three and nine months ended June 27, 2020 and June 29, 2019.

(2)

Represents customer advance payments, customer credit program, accrued warranty expense and accrued retrofit obligations.

XML

GOODWILL AND INTANGIBLE ASSETS

9 Months Ended

Jun. 27, 2020

Goodwill and Intangible Assets Disclosure [Abstract]

GOODWILL AND INTANGIBLE ASSETS

GOODWILL AND INTANGIBLE ASSETS

Goodwill

Intangible assets classified as goodwill are not amortized. The goodwill established in connection with our acquisitions represents the estimated future economic benefits arising from the assets we acquired that did not qualify to be identified and recognized individually. The goodwill also includes the value of expected future cash flows from the acquisitions, expected synergies with our other affiliates and other unidentifiable intangible assets. The Company performs an annual impairment test of its goodwill

during the fourth quarter of each fiscal year, which coincides with the completion of its annual forecasting and refreshing of business outlook process.

The Company performed its annual impairment test in the fourth quarter of fiscal 2019 and concluded that no impairment charge was required. Any future adverse changes in expected operating results and/or unfavorable changes in other economic factors used to estimate fair values could result in a noncash impairment in the future.

During the three and nine months ended June 27, 2020, the Company reviewed qualitative factors to ascertain if a "triggering" event may have taken place that may have the effect of reducing the fair value of the reporting unit below its carrying value and concluded that no triggering event had occurred. While we have concluded that a triggering event did not occur during the quarter ended June 27, 2020, a prolonged COVID-19 pandemic could impact the results of operations due to changes to assumptions utilized in the determination of the estimated fair values of the reporting units that could be significant enough to trigger an impairment. Net sales and earnings growth rates could be negatively impacted by reductions or changes in demand for our products. The discount rate utilized in our valuation model could also be impacted by changes in the underlying interest rates and risk premiums included in the determination of the cost of capital.

The following table summarizes the Company's recorded goodwill by reporting segments as of June 27, 2020 and September 28, 2019:

	As of
(in thousands)	June 27, 2020		September 28, 2019
Capital Equipment	$	29,765	$	29,480
Aftermarket Products and Services ("APS")	26,288		26,211
Total goodwill	$	56,053	$	55,691

Intangible Assets

Intangible assets with determinable lives are amortized over their estimated useful lives. The Company's intangible assets consist primarily of developed technology, customer relationships and trade and brand names.

The following table reflects net intangible assets as of June 27, 2020 and September 28, 2019: 

	As of						Average estimated
(dollar amounts in thousands)	June 27, 2020			September 28, 2019			useful lives (in years)
Developed technology	$	88,591		$	87,209		7.0 to 15.0
Accumulated amortization	(52,327		)	(48,718		)
Net developed technology	$	36,264		$	38,491
Customer relationships	$	35,586		$	35,180		5.0 to 6.0
Accumulated amortization	(34,218		)	(31,862		)
Net customer relationships	$	1,368		$	3,318
Trade and brand names	$	7,285		$	7,219		7.0 to 8.0
Accumulated amortization	(6,710		)	(6,377		)
Net trade and brand names	$	575		$	842
Other intangible assets	$	2,500		$	2,500		1.9
Accumulated amortization	(2,500		)	(2,500		)
Net other intangible assets	$	—		$	—
Net intangible assets	$	38,207		$	42,651

The following table reflects estimated annual amortization expense related to intangible assets as of June 27, 2020:

	As of
(in thousands)	June 27, 2020
Remaining fiscal 2020	$	1,845
Fiscal 2021	5,346
Fiscal 2022	4,380
Fiscal 2023	4,284
Fiscal 2024	4,284
Thereafter	18,068
Total amortization expense	$	38,207

XML

CASH, CASH EQUIVALENTS, RESTRICTED CASH AND SHORT-TERM INVESTMENTS

9 Months Ended

Jun. 27, 2020

Cash and Cash Equivalents [Abstract]

CASH AND CASH EQUIVALENTS

CASH, CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS

Cash equivalents consist of instruments with remaining maturities of three months or less at the date of purchase. In general, these investments are free of trading restrictions.

Cash, cash equivalents, and short-term investments consisted of the following as of June 27, 2020:

(in thousands)	Amortized Cost		Unrealized Gains		Unrealized Losses		Estimated Fair Value
Current assets:
Cash	$	165,213	$	—	$	—	$	165,213
Cash equivalents:
Money market funds (1)	126,555		—		—		126,555
Time deposits (2)	30,007		—		—		30,007
Total cash and cash equivalents	$	321,775	$	—	$	—	$	321,775
Short-term investments (2):
Time deposits	95,000		—		—		95,000
Deposits (3)	99,000		—		—		99,000
Total short-term investments	$	194,000	$	—	$	—	$	194,000
Total cash, cash equivalents and short-term investments	$	515,775	$	—	$	—	$	515,775

(1) The fair value was determined using unadjusted prices in active, accessible markets for identical assets, and as such they were classified as Level 1 assets in the fair value hierarchy.

(2) Fair value approximates cost basis.

(3) Represents deposits that require a notice period of three months for withdrawal.

Cash, cash equivalents and short-term investments consisted of the following as of September 28, 2019:

(in thousands)	Amortized Cost		Unrealized Gains		Unrealized Losses		Estimated Fair Value
Current assets:
Cash	$	201,005	$	—	$	—	$	201,005
Cash equivalents:
Money market funds (1)	163,172		—		—		163,172
Time deposits (2)	7		—		—		7
Total cash and cash equivalents	$	364,184	$	—	$	—	$	364,184
Short-term investments (2):
Time deposits	130,000		—		—		130,000
Deposits (3)	99,000		—		—		99,000
Total short-term investments	$	229,000	$	—	$	—	$	229,000
Total cash, cash equivalents and short-term investments	$	593,184	$	—	$	—	$	593,184

(1) The fair value was determined using unadjusted prices in active, accessible markets for identical assets, and as such they were classified as Level 1 assets in the fair value hierarchy.

(2) Fair value approximates cost basis.

(3)

Represents deposits that require a notice period of three months for withdrawal.

XML

EQUITY INVESTMENTS

9 Months Ended

Jun. 27, 2020

Equity Method Investments [Abstract]

EQUITY INVESTMENTS

EQUITY INVESTMENTS

Equity investments consisted of the following as of June 27, 2020 and September 28, 2019:

	As of
(in thousands)	June 27, 2020		September 28, 2019
Non-marketable equity securities (1)	$	6,275	$	5,000
Equity method investments	1,092		1,250
Total equity investments	$	7,367	$	6,250

(1)

On January 30, 2019, the Company made a $5.0 million investment in one of our collaborative partners, over which the Company does not have significant influence. During the three and nine months ended June 27, 2020, there was no impairment or adjustment to the observable price.

XML

FAIR VALUE MEASUREMENTS

9 Months Ended

Jun. 27, 2020

Fair Value Disclosures [Abstract]

FAIR VALUE MEASURMENTS

FAIR VALUE MEASUREMENTS

Accounting standards establish three levels of inputs that may be used to measure fair value: quoted prices in active markets for identical assets or liabilities (referred to as Level 1), inputs other than Level 1 that are observable for the asset or liability either directly or indirectly (referred to as Level 2) and unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities (referred to as Level 3).

Assets and Liabilities Measured and Recorded at Fair Value on a Recurring Basis 

We measure certain financial assets and liabilities at fair value on a recurring basis. There were no transfers between fair value measurement levels during the three and nine months ended June 27, 2020.

Fair Value Measurements on a Nonrecurring Basis

Our non-financial assets such as intangible assets and property, plant and equipment are carried at cost unless impairment is deemed to have occurred. Our equity method investments are recorded at fair value only if an impairment is recognized.

Fair Value of Financial Instruments

Amounts reported as accounts receivables, prepaid expenses and other current assets, accounts payable and accrued expenses approximate fair value.

XML

DERIVATIVES FINANCIAL INSTRUMENTS (Notes)

9 Months Ended

Jun. 27, 2020

Derivative Instruments and Hedging Activities Disclosure [Abstract]

DERIVATIVES FINANCIAL INSTRUMENTS

DERIVATIVE FINANCIAL INSTRUMENTS

The Company’s international operations are exposed to changes in foreign exchange rates due to transactions denominated in currencies other than U.S. dollars. Most of the Company’s revenue and cost of materials are transacted in U.S. dollars. However, a significant amount of the Company’s operating expenses is denominated in local currencies, primarily in Singapore.

The foreign currency exposure of our operating expenses is generally hedged with foreign exchange forward contracts. The Company’s foreign exchange risk management programs include using foreign exchange forward contracts with cash flow hedge accounting designation to hedge exposures to the variability in the U.S. dollar equivalent of forecasted non-U.S. dollar-denominated operating expenses. These instruments generally mature within twelve months. For these derivatives, we report the after-tax gain or loss from the effective portion of the hedge as a component of accumulated other comprehensive income (loss), and we reclassify it into earnings in the same period or periods in which the hedged transaction affects earnings and in the same line item on the Consolidated Condensed Statements of Operations as the impact of the hedged transaction.

The fair value of derivative instruments on our Consolidated Condensed Balance Sheet as of June 27, 2020 and September 28, 2019 was as follows:

	As of
	June 27, 2020					September 28, 2019
(in thousands)	Notional Amount		Fair Value (Liability) Derivatives(1)			Notional Amount		Fair Value (Liability) Derivatives(1)
Derivatives designated as hedging instruments:
Foreign exchange forward contracts (2)	$	37,383	$	(284	)	$	33,834	$	(597	)
Total derivatives	$	37,383	$	(284	)	$	33,834	$	(597	)

(1) The fair value of derivative liabilities is measured using level 2 fair value inputs and is included in accrued expenses and other current liabilities on our Consolidated Condensed Balance Sheet.

(2) Hedged amounts expected to be recognized to income within the next twelve months.

The effects of derivative instruments designated as cash flow hedges in our Consolidated Condensed Statements of Comprehensive Income for the three and nine months ended June 27, 2020 and June 29, 2019 are as follows:

	Three months ended						Nine months ended
(in thousands)	June 27, 2020			June 29, 2019			June 27, 2020			June 29, 2019
Foreign exchange forward contract in cash flow hedging relationships:
Net gain/(loss) recognized in OCI, net of tax (1)	$	1,034		$	(49	)	$	(340	)	$	39
Net loss reclassified from accumulated OCI into income, net of tax(2)	$	(384	)	$	(33	)	$	(653	)	$	(1,165	)

(1) Net change in the fair value of the effective portion classified in OCI.

(2)

Effective portion classified as selling, general and administrative expense.

XML

LEASES

9 Months Ended

Jun. 27, 2020

Leases [Abstract]

Leases

LEASES

We have entered into various non-cancellable operating and finance lease agreements for certain of our offices, manufacturing, technology, sales support and service centers, equipment, and vehicles. We determine if an arrangement is a lease, or contains a lease, at inception and record the leases in our financial statements upon lease commencement, which is the date when the underlying asset is made available for use by the lessor. Our lease terms may include one or more options to extend the lease terms, for periods from one year to 20 years, when it is reasonably certain that we will exercise that option. As of June 27, 2020, one option to extend

the lease was recognized as a right-of-use ("ROU") asset, and a lease liability. We have lease agreements with lease and non-lease components, and non-lease components are accounted for separately and not included in our leased assets and corresponding liabilities. We have elected not to present short-term leases on the Consolidated Condensed Balance Sheet as these leases have a lease term of 12 months or less at lease inception.

Operating leases are included in operating ROU assets, current operating lease liabilities and non current operating lease liabilities, and finance leases are in included in property, plant and equipment, accrued expenses and other current liabilities, and other liabilities on the Consolidated Condensed Balance Sheet. As of June 27, 2020, our finance leases are not material.

The following table shows the components of lease expense:

	Three months ended			Nine months ended
(in thousands)	June 27, 2020			June 27, 2020
Operating lease expense  (1)	$	(1,646	)	$	(5,030	)

(1) Operating lease expense includes short-term lease expense, which is immaterial for the three and nine months ended June 27, 2020.

The following table shows the cash flows arising from lease transactions. Cash payments related to short-term leases are not included in the measurement of operating and finance lease liabilities, and, as such, are excluded from the amounts below:

	Nine months ended
(in thousands)	June 27, 2020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash outflows from operating leases	$	4,677

The following table shows the weighted-average lease terms and discount rates for operating leases:

	As of
	June 27, 2020
Operating leases:
Weighted-average remaining lease term (in years):	4.7
Weighted-average discount rate:	4.6	%

Future lease payments, excluding short-term leases, as of June 27, 2020, are detailed as follows:

(in thousands)	Operating leases
Remainder of 2020	$	1,658
2021	6,288
2022	5,635
2023	5,420
2024	2,985
Thereafter	4,385
Total minimum lease payments	26,371
Less: Interest	2,776
Present value of lease obligations	23,595
Less: Current portion	5,471
Long-term portion of lease obligations	$	18,124

Future lease payments under operating leases prior to adoption ASC 842 were as follows:

			Payments due by fiscal year
(in thousands)	Total		2020		2021		2022		2023		2024		Thereafter
Operating lease obligations (1)	$	16,273	$	4,089	$	2,576	$	2,182	$	1,967	$	1,822	$	3,637

(1)

Pursuant to ASC No. 840, Leases ("ASC 840"), for lessee's involvement in asset construction, the Company was considered to be the owner of the Building (as defined in Note 9 below) during the construction phase due to its involvement in the asset construction. As a result of the Company's continued involvement during the lease term, the Company did not fulfill the criteria to apply sale-leaseback accounting under ASC 840. Therefore, at completion of construction, the Building remained on the Consolidated Condensed Balance Sheet, and the corresponding financing obligation was reclassified to long-term liability. As of September 28, 2019, we recorded a financing obligation related to the Building of $15.0 million (see Note 9 below). The financing obligation is not reflected in the table above.

XML

DEBT AND OTHER OBLIGATIONS DEBT AND OTHER OBLIGATIONS (Notes)

9 Months Ended

Jun. 27, 2020

Debt Disclosure [Abstract]

Debt and Other Obligations

DEBT AND OTHER OBLIGATIONS

Financing Obligation

On December 1, 2013, Kulicke & Soffa Pte Ltd. (“Pte”), the Company's wholly owned subsidiary, signed a lease with DBS Trustee Limited as trustee of Mapletree Industrial Trust (the “Landlord”) to lease from the Landlord approximately 198,000 square feet, representing approximately 70% of a building in Singapore as our corporate headquarters, as well as a manufacturing, technology, sales and service center (the “Building”). The lease has a 10-year non-cancellable term (the "Initial Term") and contains options to renew for two further 10-year terms. The annual rent and service charge for the Initial Term range from $4 million to $5 million Singapore dollars.

Pursuant to legacy ASC No. 840, Leases ("ASC 840"), we have classified the Building (build-to-suit leasing arrangement) on our Consolidated Condensed Balance Sheet as property, plant and equipment, which we are depreciating over its estimated useful life of 25 years. We concluded that the term of the financing obligation is 10 years. This is equal to the non-cancellable term of our lease agreement with the Landlord. At the inception of the lease, the asset and financing obligation recorded on the Consolidated Condensed Balance Sheet was $20.0 million, which was based on an interest rate of 6.3% over the Initial Term. As of September 28, 2019, the financing obligation related to the Building was $15.0 million, which approximates fair value (Level 2). The financing obligation will be settled through a combination of periodic cash rental payments and the return of the leased property at the expiration of the lease. We do not report rent expense for the property, which is deemed owned for accounting purposes. Rather, rental payments required under the lease are considered debt service and applied to the deemed landlord financing obligation and interest expense. The Building and financing obligation are being amortized in a manner that will not generate a gain or loss upon lease termination.

The build-to-suit leasing arrangement was derecognized pursuant to the transition guidance provided in ASC 842, which was effective beginning with the first quarter of 2020. Accordingly, the lease has been reassessed as an operating lease as of the adoption date under ASC 842, and is included on the Consolidated Condensed Balance Sheet. The adoption has resulted in a decrease of approximately $14.5 million in financing obligation, decrease of approximately $15.3 million in property, plant and equipment, and an adjustment of $0.8 million to retained earnings after income tax effects on our Consolidated Condensed Balance Sheet.

Bank Guarantees

On November 22, 2013, the Company obtained a $5.0 million credit facility with Citibank in connection with the issuance of bank guarantees for operational purposes. As of June 27, 2020, the outstanding amount under this facility was $3.2 million.

Credit Facilities

On February 15, 2019, the Company entered into a Facility Letter and Overdraft Agreement (collectively, the “Facility Agreements”) with MUFG Bank, Ltd., Singapore Branch (the “Bank”). The Facility Agreements provide the Company with an overdraft facility of up to $150.0 million (the “Overdraft Facility”) for general corporate purposes. Amounts outstanding under the Overdraft Facility, including interest, are payable upon thirty days written demand by the Bank. Interest on the Overdraft Facility is calculated on a daily basis, and the applicable interest rate is calculated at the overnight U.S. Dollar LIBOR rate plus a margin of 1.5% per annum. The Overdraft Facility is an unsecured facility per the terms of the Facility Agreements. The Facility Agreements contain customary non-financial covenants, including, without limitation, covenants that restrict the Company’s ability to sell or dispose of its assets, cease owning at least 51% of one of its subsidiaries (the "Subsidiary"), or encumber its assets with material security interests (including any pledge of monies in the Subsidiary’s cash deposit account with the Bank). The Facility Agreements also contain typical events of default, including, without limitation, non-payment of financial obligations when due, cross defaults to other

material indebtedness of the Company or any breach of a representation or warranty under the Facility Agreements. As of June 27, 2020, there were no outstanding amounts under the Overdraft Facility.

XML

SHAREHOLDERS' EQUITY AND EMPLOYEE BENEFIT PLANS

9 Months Ended

Jun. 27, 2020

Share-based Payment Arrangement [Abstract]

SHAREHOLDERS’ EQUITY AND EMPLOYEE BENEFIT PLANS

SHAREHOLDERS’ EQUITY AND EMPLOYEE BENEFIT PLANS

Common Stock and 401(k) Retirement Plan

The Company has a 401(k) retirement plan (the “Plan”) for eligible U.S. employees. The Plan allows for employee contributions and matching Company contributions from 4% to 6% based upon terms and conditions of the 401(k) Plan.

The following table reflects the Company’s contributions to the Plan during the three and nine months ended June 27, 2020 and June 29, 2019:

	Three months ended				Nine months ended
(in thousands)	June 27, 2020		June 29, 2019		June 27, 2020		June 29, 2019
Cash	$	410	$	428	$	1,119	$	1,291

Stock Repurchase Program

On August 15, 2017, the Company’s Board of Directors authorized a program (the "Program") to repurchase up to $100 million of the Company’s common stock on or before August 1, 2020. In 2018 and 2019, the Board of Directors increased the share repurchase authorization under the Program to $200 million and $300 million, respectively. The Company has entered into a written trading plan under Rule 10b5-1 of the Exchange Act to facilitate repurchases under the Program. The Program may be suspended or discontinued at any time and is funded using the Company's available cash, cash equivalents and short-term investments. Under the Program, shares may be repurchased through open market and/or privately negotiated transactions at prices deemed appropriate by management. The timing and amount of repurchase transactions under the Program depend on market conditions as well as corporate and regulatory considerations. During the three and nine months ended June 27, 2020, the Company repurchased a total of 1.0 million and 2.1 million shares of common stock under the Program at a cost of $22.4 million and $46.2 million, respectively. The stock repurchases were recorded in the periods they were delivered and accounted for as treasury stock in the Company's Consolidated Condensed Balance Sheet. The Company records treasury stock purchases under the cost method using the first-in, first-out (FIFO) method. Upon reissuance of treasury stock, amounts in excess of the acquisition cost are credited to additional paid-in capital. If the Company reissues treasury stock at an amount below its acquisition cost and additional paid-in capital associated with prior treasury stock transactions is insufficient to cover the difference between acquisition cost and the reissue price, this difference is recorded against retained earnings. As of June 27, 2020, our remaining stock repurchase authorization under the Program was approximately $50.9 million.

On July 3, 2020, the Board of Directors increased the share repurchase authorization under the Company’s existing share repurchase program by an additional $100 million to $400 million, and extended its duration through August 1, 2022.

Dividends

On May 29, 2020, February 20, 2020 and December 12, 2019, the Board of Directors declared a quarterly dividend of $0.12 per share of common stock. Dividends paid during the three and nine months ended June 27, 2020 totaled $7.6 million and $22.8 million, respectively. The declaration of any future cash dividend is at the discretion of the Board of Directors and will depend on the Company's financial condition, results of operations, capital requirements, business conditions and other factors, as well as a determination that such dividends are in the best interests of the Company's shareholders.

Accumulated Other Comprehensive Income

The following table reflects accumulated other comprehensive loss reflected on the Consolidated Condensed Balance Sheets as of June 27, 2020 and September 28, 2019: 

	As of
(in thousands)	June 27, 2020			September 28, 2019
Loss from foreign currency translation adjustments	$	(5,321	)	$	(7,745	)
Unrecognized actuarial loss on pension plan, net of tax	(1,669		)	(1,598		)
Unrealized loss on hedging	(284		)	(597		)
Accumulated other comprehensive loss	$	(7,274	)	$	(9,940	)

Equity-Based Compensation

The Company has stockholder-approved equity-based employee compensation plans (the “Employee Plans”) and director compensation plans (the “Director Plans”) (collectively, the “Equity Plans”). As of June 27, 2020, 3.4 million shares of common stock are available for grant to its employees and directors under the 2017 Equity Plan, including previously registered shares that have been carried forward for issuance from the 2009 Equity Plan.

• Relative TSR Performance Share Units ("Relative TSR PSUs") entitle the employee to receive common shares of the Company on the award vesting date, if market performance objectives that measure relative total shareholder return (“TSR”) are attained. Relative TSR is calculated based upon the 90-calendar day average price of the Company's stock as compared to specific peer companies that comprise the GICS (45301020) Semiconductor Index. TSR is measured for the Company and each peer company over a performance period, which is generally three years. Vesting percentages range from 0% to 200% of awards granted. The provisions of the Relative TSR PSUs are reflected in the grant date fair value of the award; therefore, compensation expense is recognized regardless of whether the market condition is ultimately satisfied. Compensation expense is reversed if the award is forfeited prior to the vesting date.

• In general, stock options and Time-based Restricted Share Units ("Time-based RSUs") awarded to employees vest annually over a three-year period provided the employee remains employed by the Company. The Company follows the non-substantive vesting method for stock options and recognizes compensation expense immediately for awards granted to retirement eligible employees, or over the period from the grant date to the date retirement eligibility is achieved.

• Special/Growth Performance Share Units (“Special/Growth PSUs”) entitle the employee to receive common shares of the Company on the three-year anniversary of the grant date (if employed by the Company) if revenue growth targets set by the Management Development and Compensation Committee (“MDCC”) of the Board of Directors on the date of grant are met. If revenue growth targets are not met, the Special/Growth PSUs do not vest. Certain Special/Growth PSUs vest based on achievement of strategic goals over a certain time period or periods set by the MDCC. If the strategic goals are not achieved, the Special/Growth PSUs do not vest.

Equity-based compensation expense recognized in the Consolidated Condensed Statements of Operations for the three and nine months ended June 27, 2020 and June 29, 2019 was based upon awards ultimately expected to vest, with forfeitures accounted for when they occur.

The following table reflects Time-based RSUs, Relative TSR PSUs, Special/Growth PSUs and common stock granted during the three and nine months ended June 27, 2020 and June 29, 2019:

	Three months ended		Nine months ended
(shares in thousands)	June 27, 2020	June 29, 2019	June 27, 2020	June 29, 2019
Time-based RSUs	13	2	490	521
Relative TSR PSUs	5	1	163	166
Special/Growth PSUs	2	1	75	56
Common stock	9	10	26	28
Equity-based compensation in shares	29	14	754	771

The following table reflects total equity-based compensation expense, which includes Time-based RSUs, Relative TSR PSUs, Special/Growth PSUs and common stock, included in the Consolidated Condensed Statements of Operations during the three and nine months ended June 27, 2020 and June 29, 2019: 

	Three months ended				Nine months ended
(in thousands)	June 27, 2020		June 29, 2019		June 27, 2020		June 29, 2019
Cost of sales	$	182	$	161	$	597	$	471
Selling, general and administrative	2,676		2,616		8,106		7,871
Research and development	867		820		2,353		2,430
Total equity-based compensation expense	$	3,725	$	3,597	$	11,056	$	10,772

The following table reflects equity-based compensation expense, by type of award, for the three and nine months ended June 27, 2020 and June 29, 2019:  

	Three months ended				Nine months ended
(in thousands)	June 27, 2020		June 29, 2019		June 27, 2020		June 29, 2019
Time-based RSUs	$	2,366	$	2,182	$	7,130	$	6,455
Relative TSR PSUs	908		1,020		2,210		3,213
Special/Growth PSUs	266		173		1,087		492
Common stock	185		222		629		612
Total equity-based compensation expense	$	3,725	$	3,597	$	11,056	$	10,772

XML

REVENUE AND CONTRACT LIABILITIES

9 Months Ended

Jun. 27, 2020

Revenue from Contract with Customer [Abstract]

REVENUE AND CONTRACT LIABILITIES

REVENUE AND CONTRACT LIABILITIES

The Company recognizes revenue when we satisfy performance obligations as evidenced by the transfer of control of our products or services to customers. In general, the Company generates revenue from product sales, either directly to customers or to distributors. In determining whether a contract exists, we evaluate the terms of the agreement, the relationship with the customer or distributor and their ability to pay. Service revenue is generally recognized over time as the services are performed. For the three and nine months ended June 27, 2020, and June 29, 2019, the service revenue is not material. Please refer to Note 1: Basis of Presentation - Revenue Recognition, for disclosure on the Company's revenue recognition and Note 14: Segment Information for disclosure of revenue by reportable segment and disaggregated revenue.

Contract Liabilities

Our contract liabilities are primarily related to advance payments received from customers to secure product in future periods where we have received amounts in advance of satisfying performance obligations and are reported in the accompanying Consolidated Condensed Balance Sheets within accrued expenses and other current liabilities.

Contract liabilities increase as a result of receiving new advance payments from customers and decrease as revenue is recognized from customers purchasing product under advance payment arrangements upon meeting the performance obligations.

The following table shows the changes in contract liability balances during the three and nine months ended June 27, 2020 and March 30, 2019:

	Three months ended						Nine months ended
(in thousands)	June 27, 2020			June 29, 2019			June 27, 2020			June 29, 2019
Contract liabilities, beginning of period	$	10,358		$	581		$	1,896		$	997
Revenue recognized	(13,401		)	(1,392		)	(19,218		)	(6,909		)
Additions	5,245			1,806			19,524			6,907
Contract liabilities, end of period	$	2,202		$	995		$	2,202		$	995

XML

EARNINGS PER SHARE

9 Months Ended

Jun. 27, 2020

Earnings Per Share [Abstract]

EARNINGS PER SHARE

EARNINGS PER SHARE

Basic income per share is calculated using the weighted average number of shares of common stock outstanding during the period. Stock options and restricted stock are included in the calculation of diluted earnings per share, except when their effect would be anti-dilutive.

The following tables reflect a reconciliation of the shares used in the basic and diluted net income per share computation for the three and nine months ended June 27, 2020 and June 29, 2019: 

	Three months ended
(in thousands, except per share data)	June 27, 2020				June 29, 2019
	Basic		Diluted		Basic		Diluted
NUMERATOR:
Net income	$	11,151	$	11,151	$	1,287	$	1,287
DENOMINATOR:
Weighted average shares outstanding - Basic	62,313		62,313		64,683		64,683
Dilutive effect of Equity Plans			520				748
Weighted average shares outstanding - Diluted			62,833				65,431
EPS:
Net income per share - Basic	$	0.18	$	0.18	$	0.02	$	0.02
Effect of dilutive shares			—				—
Net income per share - Diluted			$	0.18			$	0.02

  

	Nine months ended
(in thousands, except per share data)	June 27, 2020					June 29, 2019
	Basic		Diluted			Basic		Diluted
NUMERATOR:
Net income	$	36,516	$	36,516		$	5,249	$	5,249
DENOMINATOR:
Weighted average shares outstanding - Basic	63,200		63,200			65,914		65,914
Dilutive effect of Equity Plans			555					683
Weighted average shares outstanding - Diluted			63,755					66,597
EPS:
Net income per share - Basic	$	0.58	$	0.58		$	0.08	$	0.08
Effect of dilutive shares			(0.01		)			—
Net income per share - Diluted			$	0.57				$	0.08

XML

INCOME TAXES

9 Months Ended

Jun. 27, 2020

Income Tax Disclosure [Abstract]

INCOME TAXES

INCOME TAXES

The following table reflects the provision for income taxes and the effective tax rate for the three and nine months ended June 27, 2020 and June 29, 2019: 

	Three months ended						Nine months ended
(dollar amounts in thousands)	June 27, 2020			June 29, 2019			June 27, 2020			June 29, 2019
Provision for income taxes	$	690		$	3,864		$	3,985		$	19,106
Effective tax rate	5.8		%	75.0		%	9.8		%	78.2		%

The decrease in provision for income taxes and in the effective tax rate for the three months ended June 27, 2020 as compared to the three months ended June 29, 2019 is primarily related to reversal of valuation allowances recorded against certain tax credits and loss carryforwards due to an increase in profitability in the corresponding jurisdictions in fiscal 2020. The decrease in provision for income taxes and the effective tax rate for the nine months ended June 27, 2020 as compared to the nine months ended June 29, 2019 is primarily related to reversal of valuation allowances recorded against certain tax credits and loss carryforwards due to an increase in profitability in the corresponding jurisdictions in fiscal 2020 and $10.2 million of provision for income taxes recorded

in the first and second quarter of fiscal 2019 as an adjustment to the U.S. one-time transition tax resulting from the enactment of the TCJA.

For the nine months ended June 27, 2020, the effective tax rate is lower than the U.S. federal statutory tax rate primarily due to tax benefits from foreign income earned in lower tax jurisdictions, tax incentives, and tax credits, partially offset by the foreign minimum tax, deemed dividends, valuation allowances recorded against certain loss carryforwards, foreign withholding taxes, and tax liabilities from foreign operations.

XML

SEGMENT INFORMATION

9 Months Ended

Jun. 27, 2020

Segment Reporting [Abstract]

SEGMENT INFORMATION

SEGMENT INFORMATION

Reportable segments are defined as components of an enterprise that engage in business activities for which discrete financial information is available and regularly reviewed by the chief operating decision maker (the “CODM”) in deciding how to allocate resources and to assess performance. The Company's Chief Executive Officer is the Company's CODM. The CODM does not review discrete asset information. The Company operates two reportable segments consisting of: (i) Capital Equipment; and (ii) Aftermarket Products and Services ("APS").

The following table reflects operating information by segment for the three and nine months ended June 27, 2020 and June 29, 2019: 

	Three months ended					Nine months ended
(in thousands)	June 27, 2020		June 29, 2019			June 27, 2020		June 29, 2019
Net revenue:
Capital Equipment	$	111,436	$	89,860		$	326,982	$	286,364
APS	39,014		37,249			118,506		113,861
Net revenue	150,450		127,109			445,488		400,225
Income/(loss) from operations:
Capital Equipment	1,045		(6,449		)	7,815		(10,563		)
APS	9,926		8,276			27,646		24,480
Income from operations	$	10,971	$	1,827		$	35,461	$	13,917

We have considered (1) information that is regularly reviewed by our CODM as defined by the authoritative guidance on segment reporting, in evaluating financial performance and (2) other financial data, including information that we include in our earnings releases but which is not included in our financial statements, to disaggregate revenues by end markets served. The principal category we use to disaggregate revenues is by the end markets served in the Capital Equipment segment.

The following table reflects net revenue by Capital Equipment end markets served for the three and nine months ended June 27, 2020 and June 29, 2019: 

	Three months ended				Nine months ended
(in thousands)	June 27, 2020		June 29, 2019		June 27, 2020		June 29, 2019
General Semiconductor	$	51,103	$	50,040	$	168,937	$	120,694
Automotive & Industrial	8,135		16,259		46,906		61,735
LED	36,135		15,194		58,193		39,730
Memory	5,618		2,501		25,471		41,813
Advanced Packaging	10,445		5,866		27,475		22,392
Total Capital Equipment revenue	$	111,436	$	89,860	$	326,982	$	286,364

The following table reflects capital expenditures, depreciation expense and amortization expense for the three and nine months ended June 27, 2020 and June 29, 2019.

	Three months ended				Nine months ended
(in thousands)	June 27, 2020		June 29, 2019		June 27, 2020		June 29, 2019
Capital expenditures:
Capital Equipment	$	1,329	$	646	$	3,215	$	4,118
APS	2,122		1,490		5,335		5,194
	$	3,451	$	2,136	$	8,550	$	9,312
Depreciation expense:
Capital Equipment	$	1,713	$	1,800	$	4,747	$	5,540
APS	1,542		1,352		4,399		3,872
	$	3,255	$	3,152	$	9,146	$	9,412
Amortization expense:
Capital Equipment	$	973	$	989	$	2,925	$	2,999
APS	841		854		2,526		2,590
	$	1,814	$	1,843	$	5,451	$	5,589

XML

COMMITMENTS, CONTINGENCIES AND CONCENTRATIONS (Notes)

9 Months Ended

Jun. 27, 2020

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS, CONTINGENCIES AND CONCENTRATIONS

COMMITMENTS, CONTINGENCIES AND CONCENTRATIONS

Warranty Expense

The Company's equipment is generally shipped with a one-year warranty against manufacturing defects. The Company establishes reserves for estimated warranty expense when revenue for the related equipment is recognized. The reserve for estimated warranty expense is based upon historical experience and management's estimate of future warranty costs, including product part replacement, freight charges and labor costs incurred in correcting product failures during the warranty period.

The following table reflects the reserve for warranty activity for the three and nine months ended June 27, 2020 and June 29, 2019: 

	Three months ended						Nine months ended
(in thousands)	June 27, 2020			June 29, 2019			June 27, 2020			June 29, 2019
Reserve for warranty, beginning of period	$	14,368		$	13,885		$	14,185		$	14,475
Provision for warranty	3,331			3,143			9,749			8,874
Utilization of reserve	(3,189		)	(3,073		)	(9,424		)	(9,394		)
Reserve for warranty, end of period	$	14,510		$	13,955		$	14,510		$	13,955

Other Commitments and Contingencies

The following table reflects obligations not reflected on the Consolidated Condensed Balance Sheet as of June 27, 2020:

			Payments due by fiscal year
(in thousands)	Total		2020		2021		2022		2023		2024		thereafter
Inventory purchase obligation (1)	$	125,803	$	125,803	$	—	$	—	$	—	$	—	$	—

(1) The Company orders inventory components in the normal course of its business. A portion of these orders are non-cancellable, however, some orders impose varying penalties and charges in the event of cancellation.

Concentrations

The following table reflects significant customer concentrations as a percentage of net revenue for the nine months ended June 27, 2020 and June 29, 2019:

	Nine months ended
	June 27, 2020	June 29, 2019
Micron Technology, Inc.	*	10.9	%

* Represented less than 10% of total net revenue

The following table reflects significant customer concentrations as a percentage of total accounts receivable as of June 27, 2020 and June 29, 2019:

	As of
	June 27, 2020		June 29, 2019
Xinye (HK) Electronics. Co (1)	14.9	%	*
Haoseng Industrial Company Limited (1)	13.1	%	*
Super Power International (1)	*		15.8	%
Forehope Electronic (Ningbo) Co Ltd	*		14.4	%
Micron Technology, Inc.	*		10.2	%

(1) Distributor of the Company's products.

* Represented less than 10% of total accounts receivable

XML

SUBSEQUENT EVENTS

9 Months Ended

Jun. 27, 2020

Subsequent Events [Abstract]

Subsequent Events

SUBSEQUENT EVENTS

On July 3, 2020, the Board of Directors increased the share repurchase authorization under the Company’s existing share repurchase program by an additional $100 million to $400 million, and extended its duration through August 1, 2022.

XML

BASIS OF PRESENTATION (Policies)

9 Months Ended

Jun. 27, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Consolidation

These consolidated condensed financial statements include the accounts of Kulicke and Soffa Industries, Inc. and its subsidiaries (the “Company”), with appropriate elimination of intercompany balances and transactions.

The interim consolidated condensed financial statements are unaudited and, in management's opinion, include all adjustments (consisting only of normal and recurring adjustments) necessary for a fair statement of results for these interim periods. The interim consolidated condensed financial statements do not include all of the information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and should be read in conjunction with the consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended September 28, 2019, filed with the Securities and Exchange Commission, which includes Consolidated Balance Sheets as of September 28, 2019 and September 29, 2018, and the related Consolidated Statements of Operations, Statements of Other Comprehensive Income, Changes in Shareholders' Equity and Cash Flows for each of the years in the three-year period ended September 28, 2019. The results of operations for any interim period are not necessarily indicative of the results of operations for any other interim period or for a full year.

Fiscal Year

Fiscal Year    

Each of the Company's first three fiscal quarters end on the Saturday that is 13 weeks after the end of the immediately preceding fiscal quarter. The fourth quarter of each fiscal year ends on the Saturday closest to September 30. Fiscal 2020 quarters end on December 28, 2019, March 28, 2020, June 27, 2020 and October 3, 2020. In fiscal years consisting of 53 weeks, the fourth quarter will consist of 14 weeks. Fiscal 2019 quarters ended on December 29, 2018, March 30, 2019, June 29, 2019 and September 28, 2019.

Nature of Business

Nature of Business

The Company designs, manufactures and sells capital equipment and tools as well as services, maintains, repairs and upgrades equipment, all used to assemble semiconductor devices. The Company's operating results depend upon the capital and operating expenditures of semiconductor device manufacturers, integrated device manufacturers, outsourced semiconductor assembly and test providers (“OSATs”), and other electronics manufacturers including automotive electronics suppliers, worldwide which, in turn, depend on the current and anticipated market demand for semiconductors and products utilizing semiconductors. The semiconductor industry is highly volatile and experiences downturns and slowdowns which can have a severe negative effect on the semiconductor industry's demand for semiconductor capital equipment, including assembly equipment manufactured and sold by the Company and, to a lesser extent, tools, including those sold by the Company. These downturns and slowdowns have in the past adversely affected the Company's operating results. The Company believes such volatility will continue to characterize the industry and the Company's operations in the future.

Use of Estimates

Use of Estimates

The preparation of consolidated condensed financial statements requires management to make assumptions, estimates and judgments that affect the reported amounts of assets and liabilities, net revenue and expenses during the reporting periods, and disclosures of contingent assets and liabilities as of the date of the consolidated condensed financial statements. On an ongoing basis, management evaluates estimates, including but not limited to, those related to accounts receivable, reserves for excess and obsolete inventory, carrying value and lives of fixed assets, goodwill and intangible assets, the valuation estimates and assessment of impairment and observable price adjustments, income taxes, equity-based compensation expense, and warranties. Management bases its estimates on historical experience and on various other assumptions believed to be reasonable. As a result, management makes judgments regarding the carrying values of the Company's assets and liabilities that are not readily apparent from other sources. Authoritative pronouncements, historical experience and assumptions also are used as the basis for making estimates, and on an ongoing basis, management evaluates these estimates. Actual results may differ from these estimates.

Due to the Coronavirus (“COVID-19”) pandemic, there has been uncertainty and disruption in the global economy and financial markets. The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of June 27, 2020. While there was not a material impact to our consolidated financial statements as of and for the quarter ended June 27, 2020, these estimates may change, as new events occur and additional information is obtained, as well as other factors related to COVID-19 that could result in material impacts to our consolidated financial statements in future reporting periods.

Vulnerability to Certain Concentrations

Vulnerability to Certain Concentrations

Financial instruments which may subject the Company to concentrations of credit risk as of June 27, 2020 and September 28, 2019 consisted primarily of trade receivables. The Company manages credit risk associated with investments by investing its excess cash in highly rated debt instruments of the U.S. government and its agencies, financial institutions, and corporations. The Company has established investment guidelines relative to diversification and maturities designed to maintain safety and liquidity. These guidelines are periodically reviewed and modified as appropriate. The Company does not have any exposure to sub-prime financial instruments or auction rate securities.

The Company's trade receivables result primarily from the sale of semiconductor equipment, related accessories and replacement parts, and tools to a relatively small number of large manufacturers in a highly concentrated industry. Write-offs of uncollectible accounts have historically not been significant. The Company actively monitors its customers' financial strength to reduce the risk of loss, including as a result of COVID-19.

The Company's products are complex and require raw materials, components and subassemblies having a high degree of reliability, accuracy and performance. The Company relies on subcontractors to manufacture many of these components and subassemblies and it relies on sole source suppliers for some important components and raw material inventory.

Foreign Currency Translation

Foreign Currency Translation and Remeasurement

The majority of the Company's business is transacted in U.S. dollars; however, the functional currencies of some of the Company's subsidiaries are their local currencies. In accordance with ASC No. 830, Foreign Currency Matters (“ASC 830”), for a subsidiary of the Company that has a functional currency other than the U.S. dollar, gains and losses resulting from the translation of the functional currency into U.S. dollars for financial statement presentation are not included in determining net income, but are accumulated in the cumulative translation adjustment account as a separate component of shareholders' equity (accumulated other comprehensive income). The tax effect of currency translation adjustments related to unremitted foreign earnings no longer deemed to be indefinitely reinvested outside the U.S. is reflected in the determination of the Company’s net income or other comprehensive income (“OCI”). Gains and losses resulting from foreign currency transactions are included in the determination of net income.

The Company's operations are exposed to changes in foreign currency exchange rates due to transactions denominated in currencies other than the location's functional currency. The Company is also exposed to foreign currency fluctuations that impact the remeasurement of net monetary assets of those operations whose functional currency, the U.S. dollar, differs from their respective local currencies, most notably in Israel, Singapore and Switzerland. In addition to net monetary remeasurement, the Company has exposures related to the translation of subsidiary financial statements from their functional currency, the local currency, into its reporting currency, the U.S. dollar, most notably in the Netherlands, China, Taiwan, Japan and Germany. The Company's U.S. operations also have foreign currency exposure due to net monetary assets denominated in currencies other than the U.S. dollar.

Derivative Financial Instruments

Derivative Financial Instruments

The Company’s primary objective for holding derivative financial instruments is to manage the fluctuation in foreign exchange rates and accordingly is not speculative in nature. The Company’s international operations are exposed to changes in foreign exchange rates as described above. The Company has established a program to monitor the forecasted transaction currency risk to protect against foreign exchange rate volatility. Generally, the Company uses foreign exchange forward contracts in these hedging programs. These instruments, which have maturities of up to twelve months, are recorded at fair value and are included in prepaid expenses and other current assets, or accrued expenses and other current liabilities.

Our accounting policy for derivative financial instruments is based on whether they meet the criteria for designation as a cash flow hedge. A designated hedge with exposure to variability in the functional currency equivalent of the future foreign currency cash flows of a forecasted transaction is referred to as a cash flow hedge. The criteria for designating a derivative as a cash flow hedge include the assessment of the instrument’s effectiveness in risk reduction, matching of the derivative instrument to its underlying transaction, and the assessment of the probability that the underlying transaction will occur. For derivatives with cash flow hedge accounting designation, we report the after-tax gain / (loss) from the effective portion of the hedge as a component of accumulated other comprehensive income / (loss) and reclassify it into earnings in the same period in which the hedged transaction affects earnings and in the same line item on the Consolidated Condensed Statement of Operations as the impact of the hedged transaction. Derivatives that we designate as cash flow hedges are classified in the Consolidated Condensed Statement of Cash Flows in the same section as the underlying item, primarily within cash flows from operating activities.

The hedge effectiveness of these derivative instruments is evaluated by comparing the cumulative change in the fair value of the hedge contract with the cumulative change in the fair value of the forecasted cash flows of the hedged item.

If a cash flow hedge is discontinued because it is no longer probable that the original hedged transaction will occur as previously anticipated, the cumulative unrealized gain or loss on the related derivative is reclassified from accumulated other comprehensive income / (loss) into earnings. Subsequent gain / (loss) on the related derivative instrument is recognized into earnings in each period until the instrument matures, is terminated, is re-designated as a qualified cash flow hedge, or is sold. Ineffective portions of cash flow hedges, as well as amounts excluded from the assessment of effectiveness, are recognized in earnings.

Cash Equivalents

Cash Equivalents

The Company considers all highly liquid investments with original maturities of three months or less when purchased to be cash equivalents. Cash equivalents are measured at fair value based on level one measurement, or quoted market prices, as defined by ASC No. 820, Fair Value Measurements and Disclosures.

Investments

Equity Investments

The Company invests in equity securities in companies to promote business and strategic objectives. Equity investments are measured and recorded as follows:

• Equity method investments are equity securities in investees that provide the Company with the ability to exercise significant influence in which it lacks a controlling financial interest. Our proportionate share of the income or loss is recognized on a one-quarter lag and is recorded as share of results of equity-method investee, net of tax.

•

Non-marketable equity securities are equity securities without readily determinable fair value that are measured and recorded using a measurement alternative that measures the securities at cost minus impairment, if any, plus or minus changes resulting from qualifying observable price changes.

Allowance for Doubtful Accounts

Allowance for Doubtful Accounts

The Company maintains allowances for doubtful accounts for estimated losses resulting from its customers' failure to make required payments. If the financial condition of the Company's customers were to deteriorate, resulting in an impairment of their ability to make payments, including as a result of COVID-19, additional allowances may be required. If global or regional economic conditions deteriorate or political conditions were to change in some of the countries where the Company does business, including as a result of COVID-19, it could have a significant impact on the results of operations, and the Company's ability to realize the full value of its accounts receivable.

Inventories

Inventories

Inventories are stated at the lower of cost (on a first-in first-out basis) or net realizable value. The Company generally provides reserves for obsolete inventory and for inventory considered to be in excess of demand. Demand is generally defined as 18 months forecasted future consumption for equipment, 24 months forecasted future consumption for spare parts, and 12 months forecasted future consumption for tools. Forecasted consumption is based upon internal projections, historical sales volumes, customer order activity and a review of consumable inventory levels at customers' facilities. The Company communicates forecasts of its future consumption to its suppliers and adjusts commitments to those suppliers accordingly. If required, the Company reserves the difference between the carrying value of its inventory and the lower of cost or net realizable value, based upon projections about future consumption, and market conditions. If actual market conditions are less favorable than projections, additional inventory reserves may be required.

Inventory reserve provision for certain subsidiaries is determined based on management's estimate of future consumption for equipment and spare parts. This estimate is based on historical sales volumes, internal projections and market developments and trends.

Property, Plant and Equipment

Property, Plant and Equipment

Property, plant and equipment are carried at cost. The cost of additions and those improvements which increase the capacity or lengthen the useful lives of assets are capitalized, while repair and maintenance costs are expensed as incurred. Depreciation and amortization are provided on a straight-line basis over the estimated useful lives as follows: buildings 25 years; machinery, equipment, furniture and fittings 3 to 10 years; toolings 1 year; and leasehold improvements are based on the shorter of the life of lease or life of asset. Purchased computer software costs related to business and financial systems are amortized over a five-year period on a straight-line basis. Land is not depreciated.

Valuation of Long-Lived Assets

Valuation of Long-Lived Assets

In accordance with ASC No. 360, Property, Plant & Equipment ("ASC 360"), the Company's property, plant and equipment is tested for impairment based on undiscounted cash flows when triggering events occur, and if impaired, written-down to fair value

based on either discounted cash flows or appraised values. ASC 360 also provides a single accounting model for long-lived assets to be disposed of by sale and establishes additional criteria that would have to be met to classify an asset as held for sale. The carrying amount of an asset or asset group is not recoverable to the extent it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset or asset group. Estimates of future cash flows used to test the recoverability of a long-lived asset or asset group must incorporate the entity's own assumptions about its use of the asset or asset group and must factor in all available evidence.

ASC 360 requires that long-lived assets be tested for recoverability whenever events or changes in circumstances indicate that their carrying amount may not be recoverable. Such events include significant under-performance relative to historical internal forecasts or projected future operating results; significant changes in the manner of use of the assets; significant negative industry or economic trends; or significant changes in market capitalization. During the three and nine months ended June 27, 2020, no "triggering" events occurred.

Accounting for Impairment of Goodwill

Accounting for Impairment of Goodwill

ASC No. 350, Intangibles-Goodwill and Other ("ASC 350") requires goodwill and other intangible assets with indefinite lives to be reviewed for impairment annually, or more frequently if circumstances indicate a possible impairment. We assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. If, after assessing the qualitative factors, a company determines that it is not more likely than not that the fair value of a reporting unit is less than its carrying value, then performing the impairment test is unnecessary. However, if a company concludes otherwise, then it is required to perform the goodwill impairment test. Following the Company's early adoption of ASU 2017-04, Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment in the third quarter of fiscal 2017, the requirement to perform a hypothetical purchase price allocation to measure goodwill impairment (i.e. step 2 of the goodwill impairment test) was eliminated. Accordingly, the Company's impairment test is performed by comparing the fair value of a reporting unit with its carrying value, and determining if the carrying amount exceeds its fair value.

As part of the annual evaluation, the Company performs an impairment test of its goodwill in the fourth quarter of each fiscal year to coincide with the completion of its annual forecasting and refreshing of its business outlook processes. On an ongoing basis, the Company monitors if a “triggering” event has occurred that may have the effect of reducing the fair value of a reporting unit below its respective carrying value. Adverse changes in expected operating results and/or unfavorable changes in other economic factors used to estimate fair values could result in a non-cash impairment charge in the future.

Impairment assessments inherently involve judgment as to the assumptions made about the expected future cash flows and the impact of market conditions on those assumptions. Future events and changing market conditions may impact the assumptions as to prices, costs, growth rates or other factors that may result in changes in the estimates of future cash flows. Although the Company believes the assumptions that it has used in testing for impairment are reasonable, significant changes in any one of the assumptions could produce a significantly different result. Indicators of potential impairment may lead the Company to perform interim goodwill impairment assessments, including significant and unforeseen customer losses, a significant adverse change in legal factors or in the business climate, a significant adverse action or assessment by a regulator, a significant stock price decline or unanticipated competition.

For further information on goodwill and other intangible assets, see Note 3 below.

Revenue Recognition

Revenue Recognition

In accordance with ASC No. 606, Revenue from Contracts with Customers, the Company recognizes revenue when we satisfy performance obligations as evidenced by the transfer of control of our products or services to customers. In general, the Company generates revenue from product sales, either directly to customers or to distributors. In determining whether a contract exists, we evaluate the terms of the agreement, the relationship with the customer or distributor and their ability to pay.

The Company recognizes revenue from sales of our products, including sales to our distributors, at a point in time, generally upon shipment or delivery to the customer or distributor, depending upon the terms of the sales order. Control is considered transferred when title and risk of loss pass, when the customer becomes obligated to pay and, where applicable, when the customer has accepted the products or upon expiration of the acceptance period. For sales to distributors, payment is due on our standard commercial terms and is not contingent upon resale of the products.

Our business is subject to contingencies related to customer orders, including:

• Right of Return: A large portion of our revenue comes from the sale of equipment used in the semiconductor assembly process. Other product sales relate to consumable products, which are sold in high-volume quantities, and are generally

maintained at low stock levels at customer's facility. Customer returns have historically represented a very small percentage of customer sales on an annual basis.

• Warranties: Our equipment is generally shipped with a one-year warranty against manufacturing defects. We establish reserves for estimated warranty expense when revenue for the related equipment is recognized. The reserve for estimated warranty expense is based upon historical experience and management's estimate of future expenses, including product parts replacement, freight charges and labor costs expected to be incurred to correct product failures during the warranty period.

• Conditions of Acceptance: Sales of our consumable products generally do not have customer acceptance terms. In certain cases, sales of our equipment have customer acceptance clauses which may require the equipment to perform in accordance with customer specifications or when installed at the customer's facility. In such cases, if the terms of acceptance are satisfied at our facility prior to shipment, the revenue for the equipment will be recognized upon shipment. If the terms of acceptance are satisfied at our customers' facilities, the revenue for the equipment will not be recognized until acceptance, which is typically obtained after installation and testing, is received from the customer.

Service revenue is generally recognized over time as the services are performed. For the three and nine months ended June 27, 2020, and June 29, 2019, the service revenue is not material.

The Company measures revenue based on the amount of consideration we expect to be entitled to in exchange for products or services. Any variable consideration such as sales incentives are recognized as a reduction of net revenue at the time of revenue recognition.

The length of time between invoicing and payment is not significant under our payment terms. In instances where the timing of revenue recognition differs from the timing of invoicing, we have determined our contracts generally do not include a significant financing component.

Shipping and handling costs billed to customers are recognized in net revenue. Shipping and handling costs paid by the Company are included in cost of sales.

Research and Development

Research and Development

The Company charges research and development costs associated with the development of new products to expense when incurred. In certain circumstances, pre-production machines that the Company intends to sell are carried as inventory until sold.

Income Taxes

Income Taxes

In accordance with ASC No. 740, Income Taxes, deferred income taxes are determined using the balance sheet method. The Company records a valuation allowance to reduce its deferred tax assets to the amount expected, on a more likely than not basis, to be realized. While the Company has considered future taxable income and ongoing tax planning strategies in assessing the need for the valuation allowance, if it were to determine that it would be able to realize its deferred tax assets in the future in excess of its net recorded amount, an adjustment to deferred tax assets would increase income in the period when such determination is made. Likewise, should the Company determine it would not be able to realize all or part of its deferred tax assets in the future, an adjustment to deferred tax assets would decrease income in the period when such determination is made.

The Company determines the amount of unrecognized tax benefit with respect to uncertain tax positions taken or expected to be

taken on its income tax returns in accordance with ASC No. 740 Topic 10, Income Taxes, General (“ASC 740.10”). Under ASC 740.10, the Company utilizes a two-step approach for evaluating uncertain tax positions. Step one, or recognition, requires a company to determine if the weight of available evidence indicates a tax position is more likely than not to be sustained upon examination solely based on its technical merit. Step two, or measurement, is based on the largest amount of benefit, which is more likely than not to be realized on settlement with the taxing authority, including resolution of related appeals or litigation processes, if any.

Equity-Based Compensation

Equity-Based Compensation

The Company accounts for equity-based compensation under the provisions of ASC No. 718, Compensation - Stock Compensation (“ASC 718”). ASC 718 requires the recognition of the fair value of the equity-based compensation in net income. Compensation expense associated with Relative TSR Performance Share Units is determined using a Monte-Carlo valuation model, and compensation expense associated with time-based and Special/Growth Performance Share Units is determined based on the number of shares granted and the fair value on the date of grant. See Note 10 for a summary of the terms of these performance-based awards. The fair value of the Company's stock option awards is estimated using a Black-Scholes option valuation model. The fair

value of equity-based awards is amortized over the vesting period of the award and the Company elected to use the straight-line method for awards granted after the adoption of ASC 718.

Earnings per Share

Earnings per Share

Earnings per share (“EPS”) are calculated in accordance with ASC No. 260, Earnings per Share. Basic EPS include only the weighted average number of common shares outstanding during the period. Diluted EPS include the weighted average number of common shares and the dilutive effect of stock options, restricted stock awards, performance share units and restricted share units outstanding during the period, when such instruments are dilutive.

Business Combinations

Accounting for Business Acquisitions

The Company accounts for business acquisitions in accordance with ASC No. 805, Business Combinations. The fair value of the net assets acquired and the results of operations of the acquired businesses are included in the Unaudited Consolidated Condensed Financial Statements from the acquisition date forward. The Company is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and results of operations during the reporting period. Estimates are used in accounting for, among other things, the fair value of acquired net operating assets, property, plant and equipment, deferred revenue, intangible assets and related deferred income taxes, useful lives of property, plant and equipment, and amortizable lives of acquired intangible assets. Any excess of the purchase consideration over the identified fair value of the assets and liabilities acquired is recognized as goodwill. The valuation of these tangible and identifiable intangible assets and liabilities is subject to further management review and may change materially between the preliminary allocation and end of the purchase price allocation period.

Costs Associated with Exit or Disposal Activities or Restructurings

Restructuring Charges

Restructuring charges may consist of voluntary or involuntary severance-related charges, asset-related charges and other costs due to exit activities. We recognize voluntary termination benefits when an employee accepts the offered benefit arrangement. We recognize involuntary severance-related charges depending on whether the termination benefits are provided under an ongoing benefit arrangement or under a one-time benefit arrangement. If the former, we recognize the charges once they are probable and the amounts are estimable. If the latter, we recognize the charges once the benefits have been communicated to employees.

Recent Accounting Pronouncements

Recent Accounting Pronouncements

Leases

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which requires the recognition of lease assets and lease liabilities by lessees for those leases classified as operating leases under current GAAP.

Subsequently in July 2018, the FASB issued ASU 2018-11, Leases (Topic 842): Targeted Improvements, which provides additional information concerning the new leases standard in ASU 2016-02, Leases (Topic 842). The targeted improvements provide entities with additional and optional transition methods.

In November 2018, the FASB issued ASU 2018-20, Leases (Topic 842): Narrow-Scope Improvements for Lessors. This ASU provides guidance in several areas, including the accounting policy election for sales taxes and other similar taxes collected from lessees, accounting for certain lessor costs and accounting for variable payments for contracts with lease and nonlease components.

We adopted these ASUs utilizing the modified retrospective transition method through a cumulative-effect adjustment at the beginning of the first quarter of fiscal 2020. In addition, we elected the package of practical expedients permitted under the transition guidance that allowed us to apply prior conclusions related to lease definition, classification and initial direct costs. Additionally, the lease previously identified as build-to-suit leasing arrangement under legacy lease accounting (ASC 840), was derecognized pursuant to the transition guidance provided for build-to-suit leases in ASC 842 (see Note 9 below). Accordingly, the lease has been reassessed as an operating lease as of the adoption date under ASC 842, and is included on the Consolidated Condensed Balance Sheets. The adoption of these ASUs has resulted in an increase of approximately $23.8 million in operating lease liabilities and $22.2 million in right-of-use assets, decrease of approximately $14.5 million in financing obligation, decrease of approximately $15.3 million in property, plant and equipment, and an adjustment of $0.8 million to retained earnings after income tax effects on our Consolidated Condensed Balance Sheets.

Financial Instruments

In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. This ASU replaces the impairment methodology in current GAAP, which delays recognition of credit losses until it is probable a loss has been incurred, with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. This ASU will be effective for us

beginning in our first quarter of fiscal 2021. We are currently evaluating the impact of the adoption of this ASU on our consolidated condensed financial statements.

Derivatives and Hedging

In August 2017, the FASB issued ASU 2017-12, Targeted Improvements to Accounting for Hedging Activities (Topic 815). The new guidance expands and refines hedge accounting for both financial and non-financial risks. The new guidance also modifies disclosure requirements for hedging activities. We adopted this ASU as of the beginning of the first quarter of 2020. The adoption of this ASU did not have a material impact on our consolidated condensed financial statements.

Collaborative Arrangements

In November 2018, the FASB issued ASU 2018-18, Collaborative Arrangements (Topic 808). This ASU clarifies that certain transactions between collaborative arrangement participants should be accounted for as revenue when the collaborative arrangement participant is a customer in the context of a unit of account and precludes recognizing as revenue consideration received from a collaborative arrangement participant if the participant is not a customer. This ASU will be effective for us in the first quarter of 2021 with early adoption permitted. This ASU requires retrospective adoption to the date we adopted ASC 606 by recognizing a cumulative-effect adjustment to the opening balance of retained earnings of the earliest annual period presented. We are currently evaluating the timing and the effects of the adoption of this ASU on our consolidated condensed financial statements.

Income Taxes

In February 2018, the FASB issued ASU 2018-02, Income Statement - Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects From Accumulated Other Comprehensive Income, which allows for a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the U.S. Tax Cuts and Jobs Act (the “TCJA”) and requires entities to provide certain disclosures regarding these stranded tax effects, if any. We adopted this ASU in the first quarter of 2020. The adoption did not have a material impact on our consolidated condensed financial statements.

In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740). The amendments in this ASU simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740 and clarify and amend existing guidance. This ASU will be effective for us in the first quarter of 2022 with early adoption permitted. We are currently evaluating the timing and the effects of the adoption of this ASU on our consolidated condensed financial statements.

XML

BALANCE SHEET COMPONENTS (Tables)

9 Months Ended

Jun. 27, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Components of significant balance sheet accounts

The following tables reflect the components of significant balance sheet accounts as of June 27, 2020 and September 28, 2019:

	As of
(in thousands)	June 27, 2020			September 28, 2019
Short-term investments, available-for-sale(1)	$	194,000		$	229,000
Inventories, net:
Raw materials and supplies	$	63,878		$	52,853
Work in process	41,757			32,026
Finished goods	39,663			33,742
	145,298			118,621
Inventory reserves	(31,104		)	(29,313		)
	$	114,194		$	89,308
Property, plant and equipment, net:
Land	$	2,182		$	2,182
Buildings and building improvements	22,542			41,961
Leasehold improvements	22,812			24,441
Data processing equipment and software	37,760			36,302
Machinery, equipment, furniture and fixtures	76,589			71,465
Construction in progress	6,578			6,512
	168,463			182,863
Accumulated depreciation	(112,637		)	(110,493		)
	$	55,826		$	72,370
Accrued expenses and other current liabilities:
Accrued customer obligations (2)	$	25,322		$	26,292
Wages and benefits	31,074			18,188
Dividend payable	7,431			7,582
Commissions and professional fees	2,486			2,024
Deferred rent	—			1,721
Severance	494			1,500
Other	7,817			7,226
	$	74,624		$	64,533

(1) All short-term investments were classified as available-for-sale and were measured at fair value based on level one measurement, or quoted market prices, as defined by ASC 820. The Company did not recognize any realized gains or losses on the sale of investments during the three and nine months ended June 27, 2020 and June 29, 2019.

(2)

Represents customer advance payments, customer credit program, accrued warranty expense and accrued retrofit obligations.

XML

GOODWILL AND INTANGIBLE ASSETS (Tables)

9 Months Ended

Jun. 27, 2020

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Goodwill

The following table summarizes the Company's recorded goodwill by reporting segments as of June 27, 2020 and September 28, 2019:

	As of
(in thousands)	June 27, 2020		September 28, 2019
Capital Equipment	$	29,765	$	29,480
Aftermarket Products and Services ("APS")	26,288		26,211
Total goodwill	$	56,053	$	55,691

Net intangible assets

The following table reflects net intangible assets as of June 27, 2020 and September 28, 2019: 

	As of						Average estimated
(dollar amounts in thousands)	June 27, 2020			September 28, 2019			useful lives (in years)
Developed technology	$	88,591		$	87,209		7.0 to 15.0
Accumulated amortization	(52,327		)	(48,718		)
Net developed technology	$	36,264		$	38,491
Customer relationships	$	35,586		$	35,180		5.0 to 6.0
Accumulated amortization	(34,218		)	(31,862		)
Net customer relationships	$	1,368		$	3,318
Trade and brand names	$	7,285		$	7,219		7.0 to 8.0
Accumulated amortization	(6,710		)	(6,377		)
Net trade and brand names	$	575		$	842
Other intangible assets	$	2,500		$	2,500		1.9
Accumulated amortization	(2,500		)	(2,500		)
Net other intangible assets	$	—		$	—
Net intangible assets	$	38,207		$	42,651

Estimated annual amortization expense related to intangible assets

The following table reflects estimated annual amortization expense related to intangible assets as of June 27, 2020:

	As of
(in thousands)	June 27, 2020
Remaining fiscal 2020	$	1,845
Fiscal 2021	5,346
Fiscal 2022	4,380
Fiscal 2023	4,284
Fiscal 2024	4,284
Thereafter	18,068
Total amortization expense	$	38,207

 

XML

CASH, CASH EQUIVALENTS, RESTRICTED CASH AND SHORT-TERM INVESTMENTS (Tables)

9 Months Ended

Jun. 27, 2020

Cash and Cash Equivalents [Abstract]

Cash, cash equivalents, restricted cash and short-term investments

Cash, cash equivalents, and short-term investments consisted of the following as of June 27, 2020:

(in thousands)	Amortized Cost		Unrealized Gains		Unrealized Losses		Estimated Fair Value
Current assets:
Cash	$	165,213	$	—	$	—	$	165,213
Cash equivalents:
Money market funds (1)	126,555		—		—		126,555
Time deposits (2)	30,007		—		—		30,007
Total cash and cash equivalents	$	321,775	$	—	$	—	$	321,775
Short-term investments (2):
Time deposits	95,000		—		—		95,000
Deposits (3)	99,000		—		—		99,000
Total short-term investments	$	194,000	$	—	$	—	$	194,000
Total cash, cash equivalents and short-term investments	$	515,775	$	—	$	—	$	515,775

(1) The fair value was determined using unadjusted prices in active, accessible markets for identical assets, and as such they were classified as Level 1 assets in the fair value hierarchy.

(2) Fair value approximates cost basis.

(3) Represents deposits that require a notice period of three months for withdrawal.

Cash, cash equivalents and short-term investments consisted of the following as of September 28, 2019:

(in thousands)	Amortized Cost		Unrealized Gains		Unrealized Losses		Estimated Fair Value
Current assets:
Cash	$	201,005	$	—	$	—	$	201,005
Cash equivalents:
Money market funds (1)	163,172		—		—		163,172
Time deposits (2)	7		—		—		7
Total cash and cash equivalents	$	364,184	$	—	$	—	$	364,184
Short-term investments (2):
Time deposits	130,000		—		—		130,000
Deposits (3)	99,000		—		—		99,000
Total short-term investments	$	229,000	$	—	$	—	$	229,000
Total cash, cash equivalents and short-term investments	$	593,184	$	—	$	—	$	593,184

(1) The fair value was determined using unadjusted prices in active, accessible markets for identical assets, and as such they were classified as Level 1 assets in the fair value hierarchy.

(2) Fair value approximates cost basis.

(3)

Represents deposits that require a notice period of three months for withdrawal.

XML

EQUITY INVESTMENTS (Tables)

9 Months Ended

Jun. 27, 2020

Equity Method Investments [Abstract]

Equity investments

Equity investments consisted of the following as of June 27, 2020 and September 28, 2019:

	As of
(in thousands)	June 27, 2020		September 28, 2019
Non-marketable equity securities (1)	$	6,275	$	5,000
Equity method investments	1,092		1,250
Total equity investments	$	7,367	$	6,250

(1)

On January 30, 2019, the Company made a $5.0 million investment in one of our collaborative partners, over which the Company does not have significant influence. During the three and nine months ended June 27, 2020, there was no impairment or adjustment to the observable price.

XML

DERIVATIVES FINANCIAL INSTRUMENTS (Tables)

9 Months Ended

Jun. 27, 2020

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value

The fair value of derivative instruments on our Consolidated Condensed Balance Sheet as of June 27, 2020 and September 28, 2019 was as follows:

	As of
	June 27, 2020					September 28, 2019
(in thousands)	Notional Amount		Fair Value (Liability) Derivatives(1)			Notional Amount		Fair Value (Liability) Derivatives(1)
Derivatives designated as hedging instruments:
Foreign exchange forward contracts (2)	$	37,383	$	(284	)	$	33,834	$	(597	)
Total derivatives	$	37,383	$	(284	)	$	33,834	$	(597	)

(1) The fair value of derivative liabilities is measured using level 2 fair value inputs and is included in accrued expenses and other current liabilities on our Consolidated Condensed Balance Sheet.

(2)

Hedged amounts expected to be recognized to income within the next twelve months.

Derivative Instruments, Gain (Loss)

The effects of derivative instruments designated as cash flow hedges in our Consolidated Condensed Statements of Comprehensive Income for the three and nine months ended June 27, 2020 and June 29, 2019 are as follows:

	Three months ended						Nine months ended
(in thousands)	June 27, 2020			June 29, 2019			June 27, 2020			June 29, 2019
Foreign exchange forward contract in cash flow hedging relationships:
Net gain/(loss) recognized in OCI, net of tax (1)	$	1,034		$	(49	)	$	(340	)	$	39
Net loss reclassified from accumulated OCI into income, net of tax(2)	$	(384	)	$	(33	)	$	(653	)	$	(1,165	)

(1) Net change in the fair value of the effective portion classified in OCI.

(2) Effective portion classified as selling, general and administrative expense.

XML

LEASES (Tables)

9 Months Ended

Jun. 27, 2020

Leases [Abstract]

Lease expense and components of lease expense

The following table shows the components of lease expense:

	Three months ended			Nine months ended
(in thousands)	June 27, 2020			June 27, 2020
Operating lease expense  (1)	$	(1,646	)	$	(5,030	)

(1)

Operating lease expense includes short-term lease expense, which is immaterial for the three and nine months ended June 27, 2020.

The following table shows the cash flows arising from lease transactions. Cash payments related to short-term leases are not included in the measurement of operating and finance lease liabilities, and, as such, are excluded from the amounts below:

	Nine months ended
(in thousands)	June 27, 2020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash outflows from operating leases	$	4,677

Weighted-average lease terms and discount rates

The following table shows the weighted-average lease terms and discount rates for operating leases:

	As of
	June 27, 2020
Operating leases:
Weighted-average remaining lease term (in years):	4.7
Weighted-average discount rate:	4.6	%

Future lease payments after ASC 842 adoption

Future lease payments, excluding short-term leases, as of June 27, 2020, are detailed as follows:

(in thousands)	Operating leases
Remainder of 2020	$	1,658
2021	6,288
2022	5,635
2023	5,420
2024	2,985
Thereafter	4,385
Total minimum lease payments	26,371
Less: Interest	2,776
Present value of lease obligations	23,595
Less: Current portion	5,471
Long-term portion of lease obligations	$	18,124

Future lease payments before ASC 842 adoption

Future lease payments under operating leases prior to adoption ASC 842 were as follows:

			Payments due by fiscal year
(in thousands)	Total		2020		2021		2022		2023		2024		Thereafter
Operating lease obligations (1)	$	16,273	$	4,089	$	2,576	$	2,182	$	1,967	$	1,822	$	3,637

(1)

Pursuant to ASC No. 840, Leases ("ASC 840"), for lessee's involvement in asset construction, the Company was considered to be the owner of the Building (as defined in Note 9 below) during the construction phase due to its involvement in the asset construction. As a result of the Company's continued involvement during the lease term, the Company did not fulfill the criteria to apply sale-leaseback accounting under ASC 840. Therefore, at completion of construction, the Building remained on the Consolidated Condensed Balance Sheet, and the corresponding financing obligation was reclassified to long-term liability. As of September 28, 2019, we recorded a financing obligation related to the Building of $15.0 million (see Note 9 below). The financing obligation is not reflected in the table above.

XML

SHAREHOLDERS' EQUITY AND EMPLOYEE BENEFIT PLANS (Tables)

9 Months Ended

Jun. 27, 2020

Share-based Payment Arrangement [Abstract]

Company’s matching contributions to the Plan

The following table reflects the Company’s contributions to the Plan during the three and nine months ended June 27, 2020 and June 29, 2019:

	Three months ended				Nine months ended
(in thousands)	June 27, 2020		June 29, 2019		June 27, 2020		June 29, 2019
Cash	$	410	$	428	$	1,119	$	1,291

Accumulated other comprehensive income reflected on the Consolidated Balance Sheets

The following table reflects accumulated other comprehensive loss reflected on the Consolidated Condensed Balance Sheets as of June 27, 2020 and September 28, 2019: 

	As of
(in thousands)	June 27, 2020			September 28, 2019
Loss from foreign currency translation adjustments	$	(5,321	)	$	(7,745	)
Unrecognized actuarial loss on pension plan, net of tax	(1,669		)	(1,598		)
Unrealized loss on hedging	(284		)	(597		)
Accumulated other comprehensive loss	$	(7,274	)	$	(9,940	)

Restricted stock and common stock granted

The following table reflects Time-based RSUs, Relative TSR PSUs, Special/Growth PSUs and common stock granted during the three and nine months ended June 27, 2020 and June 29, 2019:

	Three months ended		Nine months ended
(shares in thousands)	June 27, 2020	June 29, 2019	June 27, 2020	June 29, 2019
Time-based RSUs	13	2	490	521
Relative TSR PSUs	5	1	163	166
Special/Growth PSUs	2	1	75	56
Common stock	9	10	26	28
Equity-based compensation in shares	29	14	754	771

Equity-based compensation expense

The following table reflects total equity-based compensation expense, which includes Time-based RSUs, Relative TSR PSUs, Special/Growth PSUs and common stock, included in the Consolidated Condensed Statements of Operations during the three and nine months ended June 27, 2020 and June 29, 2019: 

	Three months ended				Nine months ended
(in thousands)	June 27, 2020		June 29, 2019		June 27, 2020		June 29, 2019
Cost of sales	$	182	$	161	$	597	$	471
Selling, general and administrative	2,676		2,616		8,106		7,871
Research and development	867		820		2,353		2,430
Total equity-based compensation expense	$	3,725	$	3,597	$	11,056	$	10,772

The following table reflects equity-based compensation expense, by type of award, for the three and nine months ended June 27, 2020 and June 29, 2019:  

	Three months ended				Nine months ended
(in thousands)	June 27, 2020		June 29, 2019		June 27, 2020		June 29, 2019
Time-based RSUs	$	2,366	$	2,182	$	7,130	$	6,455
Relative TSR PSUs	908		1,020		2,210		3,213
Special/Growth PSUs	266		173		1,087		492
Common stock	185		222		629		612
Total equity-based compensation expense	$	3,725	$	3,597	$	11,056	$	10,772

XML

REVENUE AND CONTRACT LIABILITIES (Tables)

9 Months Ended

Jun. 27, 2020

Revenue from Contract with Customer [Abstract]

Contract Liabilities

The following table shows the changes in contract liability balances during the three and nine months ended June 27, 2020 and March 30, 2019:

	Three months ended						Nine months ended
(in thousands)	June 27, 2020			June 29, 2019			June 27, 2020			June 29, 2019
Contract liabilities, beginning of period	$	10,358		$	581		$	1,896		$	997
Revenue recognized	(13,401		)	(1,392		)	(19,218		)	(6,909		)
Additions	5,245			1,806			19,524			6,907
Contract liabilities, end of period	$	2,202		$	995		$	2,202		$	995

XML

EARNINGS PER SHARE (Tables)

9 Months Ended

Jun. 27, 2020

Earnings Per Share [Abstract]

Reconciliation of shares used in the basic and diluted net income per share computation

The following tables reflect a reconciliation of the shares used in the basic and diluted net income per share computation for the three and nine months ended June 27, 2020 and June 29, 2019: 

	Three months ended
(in thousands, except per share data)	June 27, 2020				June 29, 2019
	Basic		Diluted		Basic		Diluted
NUMERATOR:
Net income	$	11,151	$	11,151	$	1,287	$	1,287
DENOMINATOR:
Weighted average shares outstanding - Basic	62,313		62,313		64,683		64,683
Dilutive effect of Equity Plans			520				748
Weighted average shares outstanding - Diluted			62,833				65,431
EPS:
Net income per share - Basic	$	0.18	$	0.18	$	0.02	$	0.02
Effect of dilutive shares			—				—
Net income per share - Diluted			$	0.18			$	0.02

  

	Nine months ended
(in thousands, except per share data)	June 27, 2020					June 29, 2019
	Basic		Diluted			Basic		Diluted
NUMERATOR:
Net income	$	36,516	$	36,516		$	5,249	$	5,249
DENOMINATOR:
Weighted average shares outstanding - Basic	63,200		63,200			65,914		65,914
Dilutive effect of Equity Plans			555					683
Weighted average shares outstanding - Diluted			63,755					66,597
EPS:
Net income per share - Basic	$	0.58	$	0.58		$	0.08	$	0.08
Effect of dilutive shares			(0.01		)			—
Net income per share - Diluted			$	0.57				$	0.08

XML

INCOME TAXES (Tables)

9 Months Ended

Jun. 27, 2020

Income Tax Disclosure [Abstract]

Provision for income taxes and the effective tax rate

The following table reflects the provision for income taxes and the effective tax rate for the three and nine months ended June 27, 2020 and June 29, 2019: 

	Three months ended						Nine months ended
(dollar amounts in thousands)	June 27, 2020			June 29, 2019			June 27, 2020			June 29, 2019
Provision for income taxes	$	690		$	3,864		$	3,985		$	19,106
Effective tax rate	5.8		%	75.0		%	9.8		%	78.2		%

XML

SEGMENT INFORMATION (Tables)

9 Months Ended

Jun. 27, 2020

Segment Reporting [Abstract]

Operating information by segment

The following table reflects operating information by segment for the three and nine months ended June 27, 2020 and June 29, 2019: 

	Three months ended					Nine months ended
(in thousands)	June 27, 2020		June 29, 2019			June 27, 2020		June 29, 2019
Net revenue:
Capital Equipment	$	111,436	$	89,860		$	326,982	$	286,364
APS	39,014		37,249			118,506		113,861
Net revenue	150,450		127,109			445,488		400,225
Income/(loss) from operations:
Capital Equipment	1,045		(6,449		)	7,815		(10,563		)
APS	9,926		8,276			27,646		24,480
Income from operations	$	10,971	$	1,827		$	35,461	$	13,917

Schedule of net revenue by Capital Equipment end markets

The following table reflects net revenue by Capital Equipment end markets served for the three and nine months ended June 27, 2020 and June 29, 2019: 

	Three months ended				Nine months ended
(in thousands)	June 27, 2020		June 29, 2019		June 27, 2020		June 29, 2019
General Semiconductor	$	51,103	$	50,040	$	168,937	$	120,694
Automotive & Industrial	8,135		16,259		46,906		61,735
LED	36,135		15,194		58,193		39,730
Memory	5,618		2,501		25,471		41,813
Advanced Packaging	10,445		5,866		27,475		22,392
Total Capital Equipment revenue	$	111,436	$	89,860	$	326,982	$	286,364

Capital expenditures, depreciation and amortization expense

The following table reflects capital expenditures, depreciation expense and amortization expense for the three and nine months ended June 27, 2020 and June 29, 2019.

	Three months ended				Nine months ended
(in thousands)	June 27, 2020		June 29, 2019		June 27, 2020		June 29, 2019
Capital expenditures:
Capital Equipment	$	1,329	$	646	$	3,215	$	4,118
APS	2,122		1,490		5,335		5,194
	$	3,451	$	2,136	$	8,550	$	9,312
Depreciation expense:
Capital Equipment	$	1,713	$	1,800	$	4,747	$	5,540
APS	1,542		1,352		4,399		3,872
	$	3,255	$	3,152	$	9,146	$	9,412
Amortization expense:
Capital Equipment	$	973	$	989	$	2,925	$	2,999
APS	841		854		2,526		2,590
	$	1,814	$	1,843	$	5,451	$	5,589

XML

COMMITMENTS, CONTINGENCIES AND CONCENTRATIONS (Tables)

9 Months Ended

Jun. 27, 2020

Commitments and Contingencies Disclosure [Abstract]

Reserve for product warranty activity

The following table reflects the reserve for warranty activity for the three and nine months ended June 27, 2020 and June 29, 2019: 

	Three months ended						Nine months ended
(in thousands)	June 27, 2020			June 29, 2019			June 27, 2020			June 29, 2019
Reserve for warranty, beginning of period	$	14,368		$	13,885		$	14,185		$	14,475
Provision for warranty	3,331			3,143			9,749			8,874
Utilization of reserve	(3,189		)	(3,073		)	(9,424		)	(9,394		)
Reserve for warranty, end of period	$	14,510		$	13,955		$	14,510		$	13,955

Obligations not reflected on the Consolidated Balance Sheet

The following table reflects obligations not reflected on the Consolidated Condensed Balance Sheet as of June 27, 2020:

			Payments due by fiscal year
(in thousands)	Total		2020		2021		2022		2023		2024		thereafter
Inventory purchase obligation (1)	$	125,803	$	125,803	$	—	$	—	$	—	$	—	$	—

(1) The Company orders inventory components in the normal course of its business. A portion of these orders are non-cancellable, however, some orders impose varying penalties and charges in the event of cancellation.

Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]

The following table reflects significant customer concentrations as a percentage of net revenue for the nine months ended June 27, 2020 and June 29, 2019:

	Nine months ended
	June 27, 2020	June 29, 2019
Micron Technology, Inc.	*	10.9	%

* Represented less than 10% of total net revenue

Significant customer concentrations as a percentage of total accounts receivable

The following table reflects significant customer concentrations as a percentage of total accounts receivable as of June 27, 2020 and June 29, 2019:

	As of
	June 27, 2020		June 29, 2019
Xinye (HK) Electronics. Co (1)	14.9	%	*
Haoseng Industrial Company Limited (1)	13.1	%	*
Super Power International (1)	*		15.8	%
Forehope Electronic (Ningbo) Co Ltd	*		14.4	%
Micron Technology, Inc.	*		10.2	%

(1) Distributor of the Company's products.

* Represented less than 10% of total accounts receivable

XML

BASIS OF PRESENTATION (Inventories) (Narrative) (Details)	9 Months Ended
	Jun. 27, 2020
Equipment [Member]
Inventory [Line Items]
Reserves For Inventory In Excess Of Demand Inventory Future Consumption Period	18 months
Spare Parts [Member]
Inventory [Line Items]
Reserves For Inventory In Excess Of Demand Inventory Future Consumption Period	24 months
Expendable Tools [Member]
Inventory [Line Items]
Reserves For Inventory In Excess Of Demand Inventory Future Consumption Period	12 months

XML

BASIS OF PRESENTATION (Property, Plant and Equipment) (Narrative) (Details)	9 Months Ended
	Jun. 27, 2020
Building
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	25 years
Leaseholds and Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Estimated Useful Lives	based on the shorter of the life of lease or life of asset
Software and Software Development Costs [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	5 years
Tools, Dies and Molds [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	1 year
Minimum | Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	3 years
Maximum | Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	10 years

XML

BASIS OF PRESENTATION (Recent Accounting Pronouncements) (Narrative) (Details) - USD ($) $ in Thousands	Jun. 27, 2020	Sep. 29, 2019	Sep. 28, 2019	Sep. 29, 2018
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Operating lease liabilities	$ 23,595
Operating lease, right-of-use asset	22,192		$ 0
Property, plant and equipment, net	$ 55,826		72,370
Cumulative effect of accounting changes			(769)	$ 534
Accounting Standards Update 2016-02
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Operating lease liabilities		$ 23,800
Operating lease, right-of-use asset		22,200
Financing obligation		(14,500)
Property, plant and equipment, net		(15,300)
Cumulative effect of accounting changes		$ (800)
Retained Earnings
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cumulative effect of accounting changes			$ (769)	$ 534

XML

BALANCE SHEET COMPONENTS (Components of significant balance sheet accounts) (Details) - USD ($) $ in Thousands		Jun. 27, 2020	Sep. 28, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Short-term investments	[1]	$ 194,000	$ 229,000
Inventories, net:
Raw materials and supplies		63,878	52,853
Work in process		41,757	32,026
Finished goods		39,663	33,742
Inventory, gross		145,298	118,621
Inventory reserves		(31,104)	(29,313)
Inventories, net		114,194	89,308
Property, plant and equipment, net:
Land		2,182	2,182
Buildings and building improvements		22,542	41,961
Leasehold improvements		22,812	24,441
Data processing equipment and software		37,760	36,302
Machinery, equipment, furniture and fixtures		76,589	71,465
Construction in progress		6,578	6,512
Property, plant and equipment, gross		168,463	182,863
Accumulated depreciation		(112,637)	(110,493)
Property, plant and equipment, net		55,826	72,370
Accrued expenses and other current liabilities:
Accrued customer obligations (2)	[2]	25,322	26,292
Wages and benefits		31,074	18,188
Dividend payable		7,431	7,582
Commissions and professional fees		2,486	2,024
Deferred rent		0	1,721
Severance		494	1,500
Other		7,817	7,226
Accrued expenses and other current liabilities		$ 74,624	$ 64,533

[1] All short-term investments were classified as available-for-sale and were measured at fair value based on level one measurement, or quoted market prices, as defined by ASC 820. The Company did not recognize any realized gains or losses on the sale of investments during the three and nine months ended June 27, 2020 and June 29, 2019.

[2] Represents customer advance payments, customer credit program, accrued warranty expense and accrued retrofit obligations.

XML

GOODWILL AND INTANGIBLE ASSETS (Summary of Goodwill) (Details) - USD ($) $ in Thousands	Jun. 27, 2020	Sep. 28, 2019
Goodwill [Line Items]
Goodwill	$ 56,053	$ 55,691
Capital Equipment [Member]
Goodwill [Line Items]
Goodwill	29,765	29,480
Aftermarket Products and Services [Member]
Goodwill [Line Items]
Goodwill	$ 26,288	$ 26,211

XML

GOODWILL AND INTANGIBLE ASSETS (Net intangible assets) (Details) - USD ($) $ in Thousands	9 Months Ended
	Jun. 27, 2020	Sep. 28, 2019
Finite-Lived Intangible Assets [Line Items]
Net intangible assets	$ 38,207	$ 42,651
Developed technology [Member]
Finite-Lived Intangible Assets [Line Items]
Gross intangible assets	88,591	87,209
Accumulated amortization	(52,327)	(48,718)
Net intangible assets	36,264	38,491
Customer relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Gross intangible assets	35,586	35,180
Accumulated amortization	(34,218)	(31,862)
Net intangible assets	1,368	3,318
Trade name [Member]
Finite-Lived Intangible Assets [Line Items]
Gross intangible assets	7,285	7,219
Accumulated amortization	(6,710)	(6,377)
Net intangible assets	575	842
Other intangible assets [Member]
Finite-Lived Intangible Assets [Line Items]
Gross intangible assets	2,500	2,500
Accumulated amortization	(2,500)	(2,500)
Net intangible assets	$ 0	$ 0
Average estimated useful lives (in years)	1 year 10 months 24 days
Minimum | Developed technology [Member]
Finite-Lived Intangible Assets [Line Items]
Average estimated useful lives (in years)	7 years
Minimum | Customer relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Average estimated useful lives (in years)	5 years
Minimum | Trade name [Member]
Finite-Lived Intangible Assets [Line Items]
Average estimated useful lives (in years)	7 years
Maximum | Developed technology [Member]
Finite-Lived Intangible Assets [Line Items]
Average estimated useful lives (in years)	15 years
Maximum | Customer relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Average estimated useful lives (in years)	6 years
Maximum | Trade name [Member]
Finite-Lived Intangible Assets [Line Items]
Average estimated useful lives (in years)	8 years

XML

GOODWILL AND INTANGIBLE ASSETS (Estimated annual amortization expense) (Details) $ in Thousands	Jun. 27, 2020 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Remaining fiscal 2020	$ 1,845
Fiscal 2021	5,346
Fiscal 2022	4,380
Fiscal 2023	4,284
Fiscal 2024	4,284
Thereafter	18,068
Total amortization expense	$ 38,207

XML

CASH, CASH EQUIVALENTS, RESTRICTED CASH AND SHORT-TERM INVESTMENTS (Details) - USD ($) $ in Thousands		Jun. 27, 2020		Sep. 28, 2019
Cash, Cash Equivalents, Restricted Cash and Short-Term Investments [Line Items]
Cash		$ 165,213		$ 201,005
Cash and Cash Equivalents, Amortized Cost		321,775		364,184
Cash and Cash Equivalents, Unrealized Gain		0		0
Cash and Cash Equivalents, Unrealized Loss		0		0
Cash and Cash Equivalents, Estimated Fair Value		321,775		364,184
Short-term investments	[1]	194,000		229,000
Short-term Investments, Unrealized Gain		0		0
Short-term Investments, Unrealized Loss		0		0
Short-term Investments, Estimated Fair Value		194,000		229,000
Cash, Cash Equivalents, Restricted Cash, Restricted Cash Equivalents, and Short-Term Investments, Amortized Cost		515,775		593,184
Cash, Cash Equivalents, Restricted Cash, Restricted Cash Equivalents, and Short-Term Investments, Unrealized Gain		0		0
Cash, Cash Equivalents, Restricted Cash, Restricted Cash Equivalents, and Short-Term Investments, Unrealized Loss		0		0
Cash, Cash Equivalents, Restricted Cash, Restricted Cash Equivalents, and Short-Term Investments, Estimated Fair Value		515,775		593,184
Money market funds
Cash, Cash Equivalents, Restricted Cash and Short-Term Investments [Line Items]
Cash Equivalents, Amortized Cost		126,555		163,172
Cash Equivalents, Unrealized Gain		0		0
Cash Equivalents, Unrealized Loss		0		0
Cash Equivalents, Estimated Fair Value		126,555	[2]	163,172	[3]
Time deposits
Cash, Cash Equivalents, Restricted Cash and Short-Term Investments [Line Items]
Cash Equivalents, Amortized Cost		30,007		7
Cash Equivalents, Unrealized Gain		0		0
Cash Equivalents, Unrealized Loss		0		0
Cash Equivalents, Estimated Fair Value		30,007	[4]	7	[5]
Short-term investments		95,000		130,000
Short-term Investments, Unrealized Gain		0		0
Short-term Investments, Unrealized Loss		0		0
Short-term Investments, Estimated Fair Value		95,000	[4]	130,000	[3]
Deposits
Cash, Cash Equivalents, Restricted Cash and Short-Term Investments [Line Items]
Short-term investments		99,000	[6]	99,000	[7]
Short-term Investments, Unrealized Gain		0		0
Short-term Investments, Unrealized Loss		0		0
Short-term Investments, Estimated Fair Value		$ 99,000	[4],[6]	$ 99,000	[5],[7]

[1] All short-term investments were classified as available-for-sale and were measured at fair value based on level one measurement, or quoted market prices, as defined by ASC 820. The Company did not recognize any realized gains or losses on the sale of investments during the three and nine months ended June 27, 2020 and June 29, 2019.

[2] The fair value was determined using unadjusted prices in active, accessible markets for identical assets, and as such they were classified as Level 1 assets in the fair value hierarchy.

[3] The fair value was determined using unadjusted prices in active, accessible markets for identical assets, and as such they were classified as Level 1 assets in the fair value hierarchy.

[4] Fair value approximates cost basis.

[5] Fair value approximates cost basis.

[6] Represents deposits that require a notice period of three months for withdrawal.

[7] Represents deposits that require a notice period of three months for withdrawal.

XML

EQUITY INVESTMENTS (Details) - USD ($) $ in Thousands	Jun. 27, 2020		Sep. 28, 2019		Jan. 30, 2019
Equity Method Investments [Abstract]
Non-marketable equity securities(1)	$ 6,275	[1]	$ 5,000	[1]	$ 5,000
Equity method investments	1,092		1,250
Equity investments	$ 7,367		$ 6,250

[1] On January 30, 2019, the Company made a $5.0 million investment in one of our collaborative partners, over which the Company does not have significant influence. During the three and nine months ended June 27, 2020, there was no impairment or adjustment to the observable price.

XML

DERIVATIVES FINANCIAL INSTRUMENTS (Fair value of derivative instruments) (Details) - USD ($) $ in Thousands		9 Months Ended
		Jun. 27, 2020	Sep. 28, 2019
Derivatives, Fair Value [Line Items]
Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimate of Time to Transfer		12 months
Total derivative, Notional Amount		$ 37,383	$ 33,834
Designated as Hedging Instrument [Member] | Foreign Exchange Forward [Member]
Derivatives, Fair Value [Line Items]
Foreign exchange forward contract, term of contract		12 months
Total derivative, Notional Amount		$ 37,383	33,834
Accrued Liabilities [Member]
Derivatives, Fair Value [Line Items]
Derivative Liability, Fair Value, Gross Liability	[1],[2]	(284)	(597)
Accrued Liabilities [Member] | Designated as Hedging Instrument [Member] | Foreign Exchange Forward [Member]
Derivatives, Fair Value [Line Items]
Derivative Liability, Fair Value, Gross Liability	[1],[2]	$ (284)	$ (597)

[1] Hedged amounts expected to be recognized to income within the next twelve months.

[2] The fair value of derivative liabilities is measured using level 2 fair value inputs and is included in accrued expenses and other current liabilities on our Consolidated Condensed Balance Sheet.

XML

DERIVATIVES FINANCIAL INSTRUMENTS (Gain (loss) of derivative instruments) (Details) - Foreign Exchange Forward [Member] - Designated as Hedging Instrument [Member] - Cash Flow Hedging [Member] - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Jun. 27, 2020	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019
Other Comprehensive Income (Loss) [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Net gain (loss) recognized in OCI, net of tax	[1]	$ 1,034	$ (49)	$ (340)	$ 39
Selling, General and Administrative Expenses [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Net gain (loss) reclassified from accumulated OCI into income, net of tax	[2]	$ (384)	$ (33)	$ (653)	$ (1,165)

[1] Net change in the fair value of the effective portion classified in OCI.

[2] Effective portion classified as selling, general and administrative expense.

XML

LEASES - Narrative (Details) $ in Thousands	9 Months Ended
	Jun. 27, 2020 USD ($) extend_options	Sep. 28, 2019 USD ($)	Dec. 01, 2013 USD ($)
Lessee, Lease, Description [Line Items]
Options to extend | extend_options	1
Financing obligation	$ 0	$ 14,207	$ 20,000
Current and Noncurrent Portion
Lessee, Lease, Description [Line Items]
Financing obligation		$ 15,000
Building
Lessee, Lease, Description [Line Items]
Property, plant and equipment, useful life	25 years
Minimum
Lessee, Lease, Description [Line Items]
Operating lease, term of contract	1 year
Maximum
Lessee, Lease, Description [Line Items]
Operating lease, term of contract	20 years

XML

LEASES - Lease Expense (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Jun. 27, 2020	Jun. 27, 2020
Lease, Cost [Abstract]
Operating lease expense	$ (1,646)	$ (5,030)
Cash Flow, Operating Activities, Lessee [Abstract]
Operating cash outflows from operating leases		$ 4,677

XML

LEASES - Lease Terms and Discount Rates (Details)	Jun. 27, 2020
Leases [Abstract]
Weighted-average remaining lease term	4 years 8 months 12 days
Weighted-average discount rate	4.60%

XML

LEASES - Future Lease Payments After Adoption ASC 842 (Details) - USD ($) $ in Thousands	Jun. 27, 2020	Sep. 28, 2019
Lessee, Operating Lease, Liability, Payment, Due [Abstract]
Remainder of 2020	$ 1,658
2021	6,288
2022	5,635
2023	5,420
2024	2,985
Thereafter	4,385
Total minimum lease payments	26,371
Less: Interest	2,776
Present value of lease obligations	23,595
Less: Current portion	5,471	$ 0
Long-term portion of lease obligations	$ 18,124	$ 0

XML

LEASES - Future Lease Payments Prior Adoption ASC 842 (Details) $ in Thousands	Sep. 28, 2019 USD ($)	[1]
Leases [Abstract]
Total	$ 16,273
2020	4,089
2021	2,576
2022	2,182
2023	1,967
2024	1,822
Thereafter	$ 3,637

[1] Pursuant to ASC No. 840, Leases ("ASC 840"), for lessee's involvement in asset construction, the Company was considered to be the owner of the Building (as defined in Note 9 below) during the construction phase due to its involvement in the asset construction. As a result of the Company's continued involvement during the lease term, the Company did not fulfill the criteria to apply sale-leaseback accounting under ASC 840. Therefore, at completion of construction, the Building remained on the Consolidated Condensed Balance Sheet, and the corresponding financing obligation was reclassified to long-term liability. As of September 28, 2019, we recorded a financing obligation related to the Building of $15.0 million (see Note 9 below). The financing obligation is not reflected in the table above.

XML

DEBT AND OTHER OBLIGATIONS DEBT AND OTHER OBLIGATIONS (Details) $ in Thousands, $ in Millions		9 Months Ended	12 Months Ended
	Dec. 01, 2013 SGD ($) renewal_option	Jun. 27, 2020 USD ($)	Sep. 28, 2019 USD ($)	Sep. 29, 2019 USD ($)	Feb. 15, 2019 USD ($)	Sep. 29, 2018 USD ($)	Dec. 01, 2013 USD ($) ft²	Nov. 22, 2013 USD ($)
Capital Leased Assets [Line Items]
Financing obligation		$ 0	$ 14,207				$ 20,000
Property, plant and equipment, net		55,826	72,370
Cumulative effect of accounting changes			(769)			$ 534
Short-term debt		$ 0	60,904
K&S Corporate Headquarters [Member]
Capital Leased Assets [Line Items]
Lease Agreement Term	10 years	10 years
Lessee Leasing Arrangements, Capital Leases, Number of Renewal Options | renewal_option	2
Lessee Leasing Arrangements, Capital Leases, Renewal Term	10 years
Annual Rent and Service Charge Minimum Range	$ 4
Annual Rent and Service Charge Maximum Range	$ 5
Area of Land | ft²							198,000
Percentage Of Building Area To Be Leased From Landlord							70.00%
Capital Lease Obligations, Interest Rate, Effective Percentage							6.30%
Citibank [Member]
Capital Leased Assets [Line Items]
Capacity under credit facility								$ 5,000
Outstanding amounts under credit facility		$ 3,200
Current and Noncurrent Portion
Capital Leased Assets [Line Items]
Financing obligation			$ 15,000
Facility Agreements [Member] | MUFG Bank, Ltd., Singapore Branch [Member]
Capital Leased Assets [Line Items]
Capacity under credit facility					$ 150,000
London Interbank Offered Rate (LIBOR) [Member] | Facility Agreements [Member] | MUFG Bank, Ltd., Singapore Branch [Member]
Capital Leased Assets [Line Items]
Debt instrument, basis spread on variable rate			1.50%
Building
Capital Leased Assets [Line Items]
Property, plant and equipment, useful life		25 years
Accounting Standards Update 2016-02
Capital Leased Assets [Line Items]
Financing obligation				$ (14,500)
Property, plant and equipment, net				(15,300)
Cumulative effect of accounting changes				$ (800)

XML

SHAREHOLDERS' EQUITY AND EMPLOYEE BENEFIT PLANS (Narrative) (Details) - USD ($) $ / shares in Units, $ in Thousands, shares in Millions				3 Months Ended						9 Months Ended
	May 29, 2020	Feb. 20, 2020	Dec. 12, 2019	Jun. 27, 2020	Mar. 28, 2020	Dec. 28, 2019	Jun. 29, 2019	Mar. 30, 2019	Dec. 29, 2018	Jun. 27, 2020	Jun. 29, 2019	Jul. 03, 2020	Jan. 31, 2019	Jul. 10, 2018	Aug. 15, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Description Of Maximum Percentage Of Employee Contributions and Matching Contributions Based Upon Years Of Service										employee contributions and matching Company contributions from 4% to 6%
Stock repurchase program, authorized amount													$ 300,000	$ 200,000	$ 100,000
Shares repurchased in period (shares)				(1.0)						(2.1)
Value of shares acquired				$ 22,358	$ 18,522	$ 5,369	$ 33,177	$ 26,922	$ 25,485	$ 46,200
Remaining repurchase authorized amount				50,900						50,900
Cash dividends declared per share (in dollars per share)	$ 0.12	$ 0.12	$ 0.12
Common stock cash dividends paid				$ (7,600)						$ (22,796)	$ (23,902)
Relative Total Shareholder Return Average Stock Price Calculation Period										90 days
Total Shareholder Return Award Performance Measurement Period										3 years
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay										4.00%
Share Based Compensation Arrangement By Share Based Payment Award Vesting Percentage				0.00%						0.00%
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay										6.00%
Share Based Compensation Arrangement By Share Based Payment Award Vesting Percentage				200.00%						200.00%
Equity Incentive Plan 2017 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant				3.4						3.4
Subsequent Event [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock repurchase program, authorized amount												$ 400,000
Authorized amount, additional amount												$ 100,000

XML

SHAREHOLDERS' EQUITY AND EMPLOYEE BENEFIT PLANS (Matching contributions to the Plan) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jun. 27, 2020	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019
401(k) Cash Contributions
Cash	$ 410	$ 428	$ 1,119	$ 1,291

XML

SHAREHOLDERS' EQUITY AND EMPLOYEE BENEFIT PLANS (Accumulated other comprehensive income) (Details) - USD ($) $ in Thousands	Jun. 27, 2020	Sep. 28, 2019
Share-based Payment Arrangement [Abstract]
Loss from foreign currency translation adjustments	$ (5,321)	$ (7,745)
Unrecognized actuarial loss on pension plan, net of tax	(1,669)	(1,598)
Unrealized loss on hedging	(284)	(597)
Accumulated other comprehensive loss	$ (7,274)	$ (9,940)

XML

SHAREHOLDERS' EQUITY AND EMPLOYEE BENEFIT PLANS (Restricted stock and common stock granted) (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Jun. 27, 2020	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity-based compensation in shares	29	14	754	771
Relative TSR PSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity-based compensation in shares	5	1	163	166
Time-based RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity-based compensation in shares	13	2	490	521
Special/Growth PSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity-based compensation in shares	2	1	75	56
Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity-based compensation in shares	9	10	26	28

XML

SHAREHOLDERS' EQUITY AND EMPLOYEE BENEFIT PLANS (Total equity-based compensation expense) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jun. 27, 2020	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total equity-based compensation expense	$ 3,725	$ 3,597	$ 11,056	$ 10,772
Relative TSR PSU [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total equity-based compensation expense	908	1,020	2,210	3,213
Time-based RSUs
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total equity-based compensation expense	2,366	2,182	7,130	6,455
Special/Growth PSUs
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total equity-based compensation expense	266	173	1,087	492
Common Stock
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total equity-based compensation expense	185	222	629	612
Cost of sales [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total equity-based compensation expense	182	161	597	471
Selling, general and administrative (1) [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total equity-based compensation expense	2,676	2,616	8,106	7,871
Research and development [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total equity-based compensation expense	$ 867	$ 820	$ 2,353	$ 2,430

XML

REVENUE AND CONTRACT LIABILITIES (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jun. 27, 2020	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019
Change in Contract with Customer, Liability [Roll Forward]
Contract liabilities, beginning of period	$ 10,358	$ 581	$ 1,896	$ 997
Revenue recognized	13,401	1,392	19,218	6,909
Additions	5,245	1,806	19,524	6,907
Contract liabilities, end of period	$ 2,202	$ 995	$ 2,202	$ 995

XML

EARNINGS PER SHARE (Reconciliation of the shares used in the basic and diluted net income per share computation) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended						9 Months Ended
	Jun. 27, 2020	Mar. 28, 2020	Dec. 28, 2019	Jun. 29, 2019	Mar. 30, 2019	Dec. 29, 2018	Jun. 27, 2020	Jun. 29, 2019
NUMERATOR:
Net income	$ 11,151	$ 11,888	$ 13,477	$ 1,287	$ (3,555)	$ 7,517	$ 36,516	$ 5,249
DENOMINATOR:
Weighted average shares outstanding - Basic (in shares)	62,313			64,683			63,200	65,914
Dilutive Securities, Effect on Basic Earnings Per Share, Options and Restrictive Stock Units	$ 520			$ 748			$ 555	$ 683
Weighted average shares outstanding - Diluted	62,833			65,431			63,755	66,597
EPS:
Net income per share - Basic (in dollars per share)	$ 0.18			$ 0.02			$ 0.58	$ 0.08
Effect of dilutive shares (in dollars per share)	0			0			0.01	0
Net income per share - Diluted (in dollars per share)	$ 0.18			$ 0.02			$ 0.57	$ 0.08

XML

INCOME TAXES (Provision for income taxes and the effective tax rate) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jun. 27, 2020	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019
Income Tax Disclosure [Abstract]
Provision for income taxes	$ 690	$ 3,864	$ 3,985	$ 19,106
Effective tax rate	5.80%	75.00%	9.80%	78.20%

XML

INCOME TAXES (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended	9 Months Ended
	Jun. 27, 2020	Jun. 29, 2019	Mar. 30, 2019	Jun. 27, 2020	Jun. 29, 2019
Income Tax Disclosure [Abstract]
Provision for income taxes	$ 690	$ 3,864		$ 3,985	$ 19,106
Tax cuts and jobs act of 2017 income tax expense (benefit)			$ 10,200

XML

SEGMENT INFORMATION (Operating information by segment) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jun. 27, 2020	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019
Net revenue:
Revenues	$ 150,450	$ 127,109	$ 445,488	$ 400,225
Income from operations:
Income from operations	10,971	1,827	35,461	13,917
Capital Equipment [Member]
Net revenue:
Revenues	111,436	89,860	326,982	286,364
Income from operations:
Income from operations	1,045	(6,449)	7,815	(10,563)
Aftermarket Products and Services (APS) [Member]
Net revenue:
Revenues	39,014	37,249	118,506	113,861
Income from operations:
Income from operations	$ 9,926	$ 8,276	$ 27,646	$ 24,480

XML

SEGMENT INFORMATION (Schedule of net revenue by Capital Equipment end markets (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jun. 27, 2020	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	$ 150,450	$ 127,109	$ 445,488	$ 400,225
Capital Equipment [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	111,436	89,860	326,982	286,364
Capital Equipment [Member] | General Semiconductor [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	51,103	50,040	168,937	120,694
Capital Equipment [Member] | Automotive and Industrial [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	8,135	16,259	46,906	61,735
Capital Equipment [Member] | LED [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	36,135	15,194	58,193	39,730
Capital Equipment [Member] | Memory [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	5,618	2,501	25,471	41,813
Capital Equipment [Member] | Advanced Packaging [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	$ 10,445	$ 5,866	$ 27,475	$ 22,392

XML

SEGMENT INFORMATION (Capital expenditures, depreciation and amortization expense by segment) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jun. 27, 2020	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019
Segment Reporting, Other Significant Reconciling Item [Line Items]
Property, Plant and Equipment, Additions	$ 3,451	$ 2,136	$ 8,550	$ 9,312
Depreciation and amortization expense:
Depreciation expense	3,255	3,152	9,146	9,412
Amortization expense	1,814	1,843	5,451	5,589
Capital Equipment [Member]
Segment Reporting, Other Significant Reconciling Item [Line Items]
Property, Plant and Equipment, Additions	1,329	646	3,215	4,118
Depreciation and amortization expense:
Depreciation expense	1,713	1,800	4,747	5,540
Amortization expense	973	989	2,925	2,999
Aftermarket Products and Services (APS) [Member]
Segment Reporting, Other Significant Reconciling Item [Line Items]
Property, Plant and Equipment, Additions	2,122	1,490	5,335	5,194
Depreciation and amortization expense:
Depreciation expense	1,542	1,352	4,399	3,872
Amortization expense	$ 841	$ 854	$ 2,526	$ 2,590

XML

SEGMENT INFORMATION (Narrative) (Details)	9 Months Ended
	Jun. 27, 2020 segment
Segment Reporting Information [Line Items]
Number of reportable segments	2

XML

COMMITMENTS, CONTINGENCIES AND CONCENTRATIONS (Reserve for product warranty activity) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jun. 27, 2020	Jun. 29, 2019	Jun. 27, 2020	Jun. 29, 2019
Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward]
Reserve for warranty, beginning of period	$ 14,368	$ 13,885	$ 14,185	$ 14,475
Provision for warranty	3,331	3,143	9,749	8,874
Utilization of reserve	(3,189)	(3,073)	(9,424)	(9,394)
Reserve for warranty, end of period	$ 14,510	$ 13,955	$ 14,510	$ 13,955

XML

COMMITMENTS, CONTINGENCIES AND CONCENTRATIONS (Obligations not reflected on the Consolidated Balance Sheet) (Details) $ in Thousands	Jun. 27, 2020 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Inventory purchase obligation	$ 125,803	[1]
Inventory purchase obligation, Payments due by fiscal year 2020	125,803	[1]
Inventory purchase obligation, Payments due by fiscal year 2021	0	[1]
Inventory purchase obligation, Payments due by fiscal year 2022	0	[1]
Inventory purchase obligation, Payments due by fiscal year 2023	0	[1]
Inventory purchase obligation, Payments due by fiscal year 2024	0	[1]
Inventory purchase obligation, Payments due by fiscal year thereafter	$ 0

[1] The Company orders inventory components in the normal course of its business. A portion of these orders are non-cancellable, however, some orders impose varying penalties and charges in the event of cancellation.

XML

COMMITMENTS, CONTINGENCIES AND CONCENTRATIONS (Significant customer concentrations as a percentage of net revenue) (Details)	9 Months Ended
	Jun. 29, 2019
Micron Technology, Inc | Accounts Receivable [Member] | Customer Concentration Risk [Member]
Concentration Risk [Line Items]
Customer concentrations risk percentage	10.90%

XML

COMMITMENTS, CONTINGENCIES AND CONCENTRATIONS (Significant customer concentrations as a percentage of total accounts receivable) (Details) - Accounts Receivable [Member] - Customer Concentration Risk [Member]		9 Months Ended
		Jun. 27, 2020	Jun. 29, 2019
Xinye(HK) Electronics.Co [Member]
Concentration Risk [Line Items]
Customer concentrations risk percentage	[1]	14.90%
Super Power International [Member]
Concentration Risk [Line Items]
Customer concentrations risk percentage	[1]		15.80%
Forehope Electronic (Ningbo) Co Ltd [Member]
Concentration Risk [Line Items]
Customer concentrations risk percentage			14.40%
Haoseng Industrial Company Limited [Member]
Concentration Risk [Line Items]
Customer concentrations risk percentage	[1]	13.10%
Micron Technology, Inc
Concentration Risk [Line Items]
Customer concentrations risk percentage			10.20%

[1] Distributor of the Company's products.

XML

COMMITMENTS, CONTINGENCIES AND CONCENTRATIONS (Narrative) (Details) - USD ($) $ in Thousands	9 Months Ended
	Jun. 27, 2020	Sep. 28, 2019	Dec. 01, 2013
Other Commitments [Line Items]
Period Of Warranty For Manufacturing Defects	1 year
Lease Expiration Year	2027
Financing obligation	$ 0	$ 14,207	$ 20,000
Current and Noncurrent Portion
Other Commitments [Line Items]
Financing obligation		$ 15,000
Building
Other Commitments [Line Items]
Property, plant and equipment, useful life	25 years

XML

SUBSEQUENT EVENTS (Details) - USD ($) $ in Thousands	9 Months Ended
	Jun. 27, 2020	Jul. 03, 2020	Sep. 28, 2019	Jan. 31, 2019	Jul. 10, 2018	Aug. 15, 2017
Subsequent Event [Line Items]
Stock repurchase program, authorized amount				$ 300,000	$ 200,000	$ 100,000
Total derivative, Notional Amount	$ 37,383		$ 33,834
Subsequent Event [Member]
Subsequent Event [Line Items]
Authorized amount, additional amount		$ 100,000
Stock repurchase program, authorized amount		$ 400,000
Foreign Exchange Forward [Member] | Designated as Hedging Instrument [Member]
Subsequent Event [Line Items]
Total derivative, Notional Amount	$ 37,383		$ 33,834
Foreign exchange forward contract, term of contract	12 months